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Cells  in  our  body  must  divide  to  allow  growth  or  the  renewal  of  tissues.  In  the  
process  of  cell  division,  it  is  essential  that  the  two  copies  of  the  genetic  material  inside  
every   cell   are   equally   divided   into   the   two   new   emerging   cells.   Our   genetic  
information  is  stored  as  DNA,  which  can  be  described  as  a  blueprint  explaining  how  
components  of   the  cells  are  made.  Therefore,   it  can  have  dramatic   consequences  
when  the  DNA  is  not  distributed  correctly  between  dividing  cells.  The  consequences  
can  be,  for  example,  problems  in  development  or  contribution  to  cancer  formation.  
Because  the  length  of  our  DNA  is  about  2  meters  per  cell,  it  is  necessary  that  DNA  is  
packed   into  chromosomes  which  form  typical  X-­‐like  structures.  Each  half  of   the  X-­‐
shaped   chromosome   contains   the   same   genetic   material,   forming   two   sister  
chromatids.  In  the  process  of  cell  division,  all  chromosomes  align  in  the  middle  of  the  
cell  and  in  a  subsequent  step  each  sister  chromatid  is  pulled  to  opposite  sites  within  
the  cell  by  dynamic  rod-­‐like  structures  called  microtubules.  The  complex  process  of  
how  microtubules  attach  to  chromosomes  is  precisely  controlled  by  the  Chromosome  
Passenger  Complex  (CPC).  The  CPC  localises  at  the  centromere  of  a  chromosome,  a  
region   which   is   usually   at   the   constriction   site   of   chromosomes   and   also   where  
microtubules  attach.  
It  was   recently   shown   that   the  binding  of  a  protein   called  Heterochromatin  
Protein  1  (HP1)  is  essential  for  correct  function  of  the  CPC.  Interestingly,  cells  that  
were  taken  from  cancer  tissue  show  a  reduced  amount  of  HP1  bound  to  the  CPC  and  
less  HP1  at  centromeres.  This  could  be  a  reason  why  cancer  cells  have  a  higher  rate  
of  wrongly  dividing  chromosomes.  Therefore,  I  tested  whether  increasing  the  amount  
of  HP1  at  centromeres  could  reduce  the  rate  of  improperly  segregated  chromosomes  
in  cancer  cells.  I  used  a  synthetic  biology  approach,  which  means  creating  a  protein  
that  does  not  exist  like  this   in  our  cells,  but  helps  to  analyse  and  understand  how  
processes  normally  work.  The  artificial  protein  consists  of  HP1  fused  to  a  protein  that  




region.  However,  it  appears  that  simply  placing  HP1  to  the  centromere  in  this  way  
does  not  have  a  positive  effect  on  chromosome  segregation.  
Nevertheless,   the   artificial   protein   helped  me   to   reveal   a   strong   interaction  
between  HP1  and   the  CPC  even  at  stages  of   the  cell   cycle  prior   to   the  process  of  
chromosome  segregation.  My  results  indicate  that  an  interaction  with  HP1  is  the  first  
step  that  concentrates  the  CPC  at  its  site  of  action  and  helps  us  to  understand  how  
this  important  complex  is  activated.  Interestingly,  HP1-­‐driven  CPC  clustering  is  a  new  
mode   of   CPC   localisation,   in   addition   to   two   earlier   discovered   ways   of   CPC  
localisation  at  centromeres.  This  novel  way  of  HP1-­‐driven  CPC  localisation  could  help  
to   identify   new   targets   for   cancer   therapy   because   previous   studies   reported   an  
altered  HP1-­‐CPC  interaction  in  cancer  cells  compared  to  normal  cells.  Therefore,  it  
might  be  possible  to  identify  therapeutic  targets  that  are  specific  in  cancer  cells  and  
thus  potentially  allow  a  more  precise  therapy  with  fewer  side  effects.  






The  ultimate  goal  of  mitosis  is  the  equal  distribution  of  chromosomes  between  
the   two  daughter   cells.  One  of   the  key  players   that  ensures   faithful   chromosome  
segregation  is  the  chromosomal  passenger  complex  (CPC).  CPC  localisation  to  mitotic  
centromeres   is   complex,   involving   interactions   with   Shugoshin   and   binding   to  
phosphorylated  histone  H3T3.  It  was  recently  reported  that  Heterochromatin  Protein  
1  (HP1)  has  a  positive  impact  on  CPC  function  during  mitosis.  The  interaction  between  
HP1  and  the  CPC  appears  to  be  perturbed   in  cancer-­‐derived  cell   lines,  resulting  in  
decreased   HP1   levels   at   mitotic   centromeres   and   may   be   a   potential   cause   for  
increased  chromosome  mis-­‐segregation  rates.    
In   this   study,   I   tethered   HP1α   to   centromeres   via   the   DNA-­‐binding   domain  
CENP-­‐B.  However,   instead  of   improving   the   rate  of   chromosome  mis-­‐segregation,  
HP1α   tethering   resulted   in   activity   of   the   spindle   assembly   checkpoint   and  
destabilisation  of  kinetochore-­‐microtubule  attachments,  most   likely  caused  by  the  
robust  recruitment  of  the  CPC.  Tethered  HP1α  even  traps  the  CPC  at  centromeres  
during   mitotic   exit,   resulting   in   a   catalytically   active   CPC   throughout   interphase.  
However,  it  was  not  clear  whether  endogenous  HP1  contributes  to  CPC  localisation  
and  function  prior  to  mitosis.  Here  I  also  describe  a  substantial  interaction  between  
endogenous  HP1  and  the  CPC  during  the  G2  stage  of  the  cell  cycle.  The  two  isoforms  
HP1α  and  HP1γ  contribute  to  the  clustering  of  the  CPC  into  active  foci  in  G2  cells,  a  
process  that  is  independent  of  CDK1  kinase  activity.  Furthermore,  the  H3S10ph  focus  
formation  in  the  G2  phase  appears  to  be  independent  of  H3T3ph  and  H2AT120ph,  the  
two  histone  marks  that  determine  the  CPC  localisation  in  early  mitosis.  
Together,  my  results  indicate  that  HP1  contributes  to  CPC  concentration  and  
activation   at   pericentromeric   heterochromatin   in   G2.   This   novel   mode   of   CPC  
localisation  occurs  before  the  Aurora  B-­‐driven  methyl/phos  switch  releases  HP1  from  
chromatin,  which  possibly  enables  the  H3T3ph  and  H2AT120ph  driven  localisation  of  
the  CPC  during  mitosis.  
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1   Introduction  
  
1.1   The  cell  division  cycle  
Cell   division   is   the   process   of   how   cells  multiply   to   fulfil   growth   and   tissue  
turnover  in  multicellular  organisms.  Most  molecular  mechanisms  of  cell  division  are  
conserved   and   many   processes   described   in   this   introduction   were   initially  
discovered  in  single-­‐celled  eukaryotes.  Before  a  cell  can  divide,  crucial  steps  of  cell  
growth  and  genome  replication  are  necessary.  This  is  done  in  the  so-­‐called  interphase  
of   the   cell   cycle,  which   typically   can   be   subdivided   into   three   distinct   parts.   DNA  
synthesis  takes  place  in  S-­‐Phase  (S)  and  is  flanked  by  gap  phase  1  (G1)  and  gap  phase  
2  (G2),  in  which  cell  growth  and  further  preparation  for  the  cell  division  occur  (Fig.  1).  
The   step   of   genome   segregation   happens   in   mitosis   (M)   and   takes   only   a   small  
fraction  (~  1  h)  of  the  whole  cell  cycle  duration,  which  is  typically  20  to  24  h  in  cultured  
human  cells.  The  step  of  cytokinesis  completes  cell  division  in  which  two  individual  
daughter  cells  form.  Cells  that  do  not  divide,  exit  the  cell  cycle  and  stay  in  the  so-­‐
called  G0  phase.    
Cyclin-­‐dependent  kinases  (CDKs)  drive  the  progression  of  the  cell  cycle.  Their  
activity  is  regulated  by  cyclins,  which  are  essential  subunits  for  the  kinase  function  
(Evans  et  al.,  1983;  Booher  et  al.,  1989).  The  CDK/cyclin  system  is  regulated  through  
timely   specific   ubiquitin-­‐dependent   proteolysis   of   cyclins,   as   the   CDK   kinases   are  
expressed  throughout  the  cell  cycle  (Glotzer  et  al.,  1991).  A  further  regulatory  system  
is  well  described  for  the  CDK1  kinase.  The  nuclear  Wee1  kinase  and  the  cytoplasmic  
Myt1  kinase  inactives  CDK1  through  phosphorylation  of  residues  threonine  14  and  
tyrosine  15  (Parker  and  Piwnica-­‐Worms,  1992;  Mueller  et  al.,  1995b).  This  control  is  
subject   to  a  double  negative   feedback  mechanism:  Once  CDK1  becomes  active,   it  
phosphorylates  and  inactivates  Wee1  (Mueller  et  al.,  1995a;  Harvey  et  al.,  2005;  Kim  
and   Ferrell,   2007).   Additionally,   CDK1   activity   simulates   CDC25   which  
dephosphorylates   inhibitory   phosphorylations   on   CDK1   (Gautier   et   al.,   1991;  




Various   combinations   of   CDK   and   cyclin   complexes   exist   that   are   active   at  
different  stages  of  the  cell  cycle  and  responsible  for  cell  cycle  progression:  CDK4/6  
and  cyclin  D  are  associated  with  the  G1  phase  and  together  with  CDK2  and  cyclin  E  
mediate  the  transition  to  S  phase.  CDK2  and  cyclin  A  drive  the  progression  from  S-­‐
phase  onward,  but  the  kinase  required  for  the  G2/M  transition  is  CDK1  in  conjunction  
with  cyclin  B  and  A  (Sherr,  1993;  van  den  Heuvel  and  Harlow,  1993).  However,  more  
recent   studies   suggest   reconsidering   this   “classical   model”   of   specific   CDK/cyclin  
functions,  based  on  work  with  knockout  mice,  which  proposes  overlapping  functions  






Figure  1:  Scheme  of  the  eukaryotic  cell  division  cycle.  
This   simplified  scheme  shows   the  different   stages  of   the  cell  cycle   in  eukaryotes  and   the  





The  packaging  of  DNA  is  essential,  as  a  total  length  of  about  two  meters  of  DNA  
needs   to   be   incorporated   into   the   nucleus   of   human   cells,   which   is   only   a   few  
micrometres  wide.  The  core  unit  of  DNA  packaging  is  the  nucleosome,  consisting  of  
two  copies  of  each  histone  protein  H2A,  H2B,  H3,  and  H4,  forming  an  octamer  with  
146   bp   of   DNA   wrapped   around   it   (Luger   et   al.,   1997).   Importantly,   histone   N-­‐
terminal   tails   are   subject   to   post-­‐translational  modifications   (PTMs)   that   have   an  
influence  on  nucleosome  organisation  and  function.  These  consequences  of  histone  
PTMs  are  the  basis  of  much  of  the  field  of  epigenetics.  
Nucleosomes  are  organised   together  with  DNA,  RNA  and  a   large  number  of  
further   structural   and   functional   proteins   in   chromatin.   Various   higher   order  
assembly   and   packing   mechanism   lead   to   the   compact   structure   of   mitotic  
chromosomes,   allowing   to   segregate   the   genetic   material   in   a   highly   organised  
manner  during  mitosis.    
  
1.2   Stages  of  mitosis  
Mitosis  describes  the  cellular  process  by  which  the  genome  segregates  into  two  
daughter  cells.  I  will  describe  this  process  as  it  occurs  in  metazoan  cells  that  undergo  
an  open  mitosis  (e.g.  where  the  nucleus  disassembles  during  mitosis).  The  nucleus  
exhibits   drastic   morphological   changes,   which   involves   the   formation   of   mitotic  
chromosomes  that  eventually  separate  into  the  two  emerging  cells.  This  elaborate  
procedure   can   be   subdivided   into   the   five   stages   of   prophase,   prometaphase,  
metaphase,  anaphase,  and  telophase,  followed  by  cytokinesis  in  which  two  separate  
daughter  cells  are  formed  (Fig.  2).  Based  on  microscopy  observations,  the  different  
stages  of  mitosis  were  already  described  in  the  19th  century  (Flemming,  1882)  and  are  
still  nowadays  defined  as  following:  
In  prophase,  centrosomes,   from  which  spindle  microtubules  emanate  during  
mitosis,  separate  and  move  to  opposite  sides  of  the  nucleus.  Besides  centrosomes,  
MT  can  also  originate  from  chromosomes,  particularly  from  kinetochores,  or  directly  




chromosomes  start  to  condense  and  their   typical  structure  becomes  visible  within  
the  intact  nuclear  envelope.  
Prometaphase  begins  with  the  breakdown  of  the  nuclear  envelope  apparently  
initiated   by   the   phosphorylation   of   lamins   (Peter   et   al.,   1990).   Additionally,  
phosphorylation  induced  dissociation  of  the  nuclear  pore  complexes  and  microtubule  
mediated   tearing   contribute   to   the   disassembly   of   the   nuclear   membrane  
(Beaudouin  et  al.,  2002;  Laurell  et  al.,  2011).  The  nuclear  envelope  breakdown  allows  
the  mitotic  spindle  to  access  the  chromosomes.  With  the  help  of  the  mitotic  spindle,  
the  initially  randomly  arranged  chromosomes  start  to  align  at  the  spindle  equator.    
Metaphase   describes   the   crucial   stage   of   mitosis   in   which   chromosome  
congression  is  completed  and  the  so-­‐called  metaphase  plate  is  formed.  However,  the  
spindle   assembly   checkpoint   inhibits   the   onset   of   the   next  mitotic   stage   until   all  
chromosomes   successfully   attach   to   the   microtubules   of   the   mitotic   spindle   and  
thereby  bi-­‐orientate.  This  checkpoint  ensures  that  chromosome  segregation  does  not  
occur  prematurely  and  thus  prevents  chromosome  mis-­‐segregation  (see  section  1.5.1  
for  further  detail).  
With   the   onset   of   anaphase,   the   sister   chromatids   fully   separate   through  
cleavage  of  the  remaining  cohesin  complexes  that  hold  sister  chromatids  together.  
Forces  generated  by  the  mitotic  spindle  pull  the  separated  chromatids  towards  the  
opposing  spindle  poles.  
During   telophase,   the   chromatids   are   pulled   further   apart   and   a   cleavage  
furrow   at   the   spindle   midzone   starts   to   form.   The   microtubules   of   the   midzone  
continue  to   ingress  and  eventually   form  the  compact  midbody.  At  the  same  time,  
chromatids  begin  to  decondense  and  the  nuclear  envelope  starts  to  form  again.  
The   process   of   cell   division   is   completed   with   the   step   of   cytokinesis.   The  





















Figure  2:  Stages  of  mitosis.  
Chromosomes  are  shown  in  blue,  the  microtubules  and  centrosomes  are  depicted  in  green,  and  red  




1.3   The  centromere    
During  mitosis,  chromatin  is  condensed  and  assembled  into  characteristically  
shaped  chromosomes.  These  consist  of  two  sister  chromatids,  which  contain  a  typical  
primary   constriction   at   which   sister   chromatids   are   not   resolved.   This   chromatin  
structure  is  called  the  centromere  and  is  usually  where  kinetochores  are  established  
to  facilitate  the  complex  process  of  chromosome  segregation  (Hinshaw  and  Harrison,  
2018).   Secondary   constrictions   are   typically   formed   at   the   nucleolus   organizer  
regions   and   contain   genes   coding   for   ribosomal   RNA,   but   are   not   linked   to  
kinetochore  formation  (Henderson  et  al.,  1972;  Goodpasture  and  Bloom,  1975).  
Besides  serving  as  the  chromatin  region  for  kinetochore  assembly,  centromeres  
also  contribute  to  chromosome  segregation  through  maintaining  cohesion  between  
the  sister  chromatids  until  anaphase  onset.  The  cohesin  protein  complex  is  protected  
specifically  at   centromeres   through   shugoshin  and  by   resisting  their   separation,   it  
enables   the   orientation   of   the   two   sister   kinetochores   to   opposite   spindle   poles  
(Haarhuis  et  al.,  2014).  
The  centromeric  DNA  of  humans  and  other  primates  consists  of  a-­‐satellite  DNA  
with  highly  repetitive  sequences.  These  arrays  contain  a  typical  171  bp  consensus  
sequence   and   arrange   in   higher-­‐order   repeat   pattern   (Fukagawa   and   Earnshaw,  
2014).  A  further  distinguishing  feature  of  centromeres  is  the  flanking  pericentromeric  
heterochromatin.   It  contains  divergent  a-­‐satellite  monomers  with  no  higher-­‐order  
repeat   organisation   and   is   enriched   in   histone   H3   trimethylated   on   lysine   9  
(H3K9me3)   (Nakayama   et   al.,   2001;   Schueler   et   al.,   2001).   The   exact   function   of  
pericentromeric  heterochromatin  remains  elusive,  however,  it  might  act  as  a  barrier  
between   the   kinetochore   and   flanking   euchromatin   regions   and   thus   prevent  
centromere  migration  (Fukagawa  and  Earnshaw,  2014),  as  it  was  previously  shown  
that  the  exact  centromere  position  can  “drift”  a  certain  distance  along  chromatin  in  
vertebrate   cells   after  many   cell   divisions   (Hori   et   al.,   2017).      The   contribution   of  
pericentromeric  heterochromatin  to  centromere  cohesion  was  studied  particularly  in  




mitotic  sister  chromosome  cohesion  in  higher  eukaryotes  is  controversial  (Koch  et  al.,  
2008;  Gartenberg,  2009;  Serrano  et  al.,  2009;  Kang  et  al.,  2011;  Hahn  et  al.,  2013).    
   Importantly,  the  formation  of  centromeres  in  humans  does  not  seem  to  be  
based   on   a   specific   DNA   sequence,   which   became   first   apparent   through   the  
observation   of   dicentric   chromosomes   that   show  a-­‐satellite   repeats   at   which   no  
kinetochores  form  (Earnshaw  and  Migeon,  1985).  Further  proof  came  from  clinical  
samples  where  so-­‐called  neocentromeres  form  on  regions  on  chromosome  arms  that  
lack  a-­‐satellite  repeats  (du  Sart  et  al.,  1997;  Marshall  et  al.,  2008).  This  suggests  that  
human  centromeres  are  not  defined  by  the  DNA  sequence  but  rather  by  epigenetic  
mechanisms  (Earnshaw  et  al.,  1989).  
  
1.3.1   Centromere  proteins  
   A   hallmark   of   centromeres   is   the   enrichment   of   CENP-­‐A,   which   was   first  
identified   together   with   two   other   human   centromere   proteins   (CENPs)   using  
antibodies  from  serum  of  patients  with  CREST  syndrome  (Earnshaw  and  Rothfield,  
1985).  These  antibodies  recognise  the  three  centromere  proteins,  named  CENP-­‐A,  
CENP-­‐B,  and  CENP-­‐C,  which  form  together  with  other  factors  the  foundation  of  the  
kinetochore.  
  
1.3.1.1   CENP-­‐A  
CENP-­‐A   is   a   variant   of   histone   H3   and   a   distinct   feature   of   eukaryotic  
centromeres  across  the  evolutionary  spectrum.  It  replaces  the  canonical  histone  H3  
in  ~  4  %  of  nucleosomes  at  centromeres  resulting  in  ~  400  molecules  of  CENP-­‐A  per  
typical  human  centromere  (Bodor  et  al.,  2014).  Although  this  appears  only  as  a  low  
ratio,  it  is  a  ∼50-­‐fold  enrichment  compared  to  the  overall  genome.  The  C-­‐terminal  
domain   of   human  CENP-­‐A   shares   a   great   sequence   identity  with   the   histone   fold  
domain  of  histone  H3,  whereas  the  N-­‐terminus  forms  a  unique  domain,  which  could  
explain  its  specific  functions  at  centromeres  (Sullivan  et  al.,  1994).  Despite  its  feature  
of  centromere  specification,  CENP-­‐A  itself  is  not  sufficient  to  establish  centromere  




though  ectopic  CENP-­‐A   is  able   to   recruit   certain   kinetochore  proteins,   it   lacks   the  
ability  to  induce  neocentromere  formation,  suggesting  that  further  components  or  
events  are  necessary  to  achieve  full  kinetochore  assembly.  However,  in  Drosophila  
overexpression  of  the  CENP-­‐A  homologue  CID  leads  to  stable  CID  accumulation  close  
to  heterochromatic  regions  and  ectopic  kinetochore  formation  (Olszak  et  al.,  2011).  
Furthermore,  a  tethering  approach  using  a  CID-­‐LacI  fusion  protein  and  lac  operator  
arrays  showed  that  clustered  CID  is  sufficient  for  functional  kinetochore  assembly  at  
these  ectopic  sites  (Mendiburo  et  al.,  2011).  In  line  with  this,  LacI  tethering  of  HJURP,  
which  is  a  crucial  deposition  factor  for  CENP-­‐A,  also  leads  to  kinetochore  assembly  at  
lac   operator   arrays   in   human   cells,   suggesting   that   a   local   clustering   of   CENP-­‐A  
nucleosomes  is  crucial  for  centromere  formation  (Barnhart  et  al.,  2011).    
Surprisingly,   a   recent   study   focusing   on   the   kinetochore   components   in  
kinetoplastid   revealed   no   homology   to   conventional   kinetochore   proteins   and  
indicates  that  for  example  in  Trypanosoma  brucei  kinetochores  are  assembled  in  the  
absence  of  CENP-­‐A  (Akiyoshi  and  Gull,  2014).  
  
1.3.1.2   CENP-­‐B  
CENP-­‐B   is   a   centromere   protein   localised   from   the   inner   kinetochore   down  
through   the  central   domain  of   the  centromere   (Cooke  et  al.,   1990).   It   is   the  only  
characterised  human  centromere  protein  that  binds  DNA  in  a  sequence-­‐dependent  
way.   The   recognised   sequence   is   a   17   bp   motif   within   the  a-­‐satellite   repeats   of  
human   centromeres,   known   as   the   CENP-­‐B   box   (Masumoto  et   al.,   1989).   CENP-­‐B  
recognises  this  motive  via  its  N-­‐terminal  DNA  binding  domain  (Pluta  et  al.,  1992).A  
further  feature  of  this  80  kDa  protein  is  a  C-­‐terminal  dimerisation  domain,  suggesting  
that   it   can   capture   two  distant   CENP-­‐B   boxes   simultaneously   (Tawaramoto  et   al.,  
2003).    
The   precise   centromeric   role   and   significance   of   CENP-­‐B   long   remained  
uncertain.   Cell   lines   containing   chromosomes   with   neocentromeres   suggest   a  
dispensable   role   for   CENP-­‐B   in   centromere   function.   Experiments   using   patient-­‐




region  of  inactive  centromeres  (Earnshaw  et  al.,  1989).  However,  in  contrast  to  CENP-­‐
A  which  is  present  exclusively  at  the  neocentromere,  CENP-­‐B  does  not  locate  at  the  
newly   formed  neocentromere   due   to   the   absence   of   CENP-­‐B   boxes   (Amor  et   al.,  
2004;  Bassett  et  al.,  2010).  Furthermore,  CENP-­‐B  knockout  mice  are  viable  and  able  
to  assemble  functional  kinetochores  (Hudson  et  al.,  1998;  Kapoor  et  al.,  1998;  Perez-­‐
Castro   et   al.,   1998)   and   CENP-­‐B   is   not   present   at   the   centromeric   alpha-­‐satellite  
repeats  of  the  human  Y  chromosome  (Earnshaw  et  al.,  1991).  
However,  a  more   recent   study   focusing  on   the   functional   role   of  CENP-­‐B  at  
human   centromeres   revealed   that   CENP-­‐B   enhances   the   fidelity   of   human  
centromere   function   through   CENP-­‐C   stabilisation   and   kinetochore   nucleation  
(Fachinetti   et   al.,   2015).   Additionally,   this   study   demonstrated   that   the   Y   and  
neocentromere  chromosomes,  both  lacking  centromeric  CENP-­‐B,  show  a  higher  mis-­‐
segregation  frequency  compared  to  chromosomes  that  have  CENP-­‐B  at  centromeres  
(Fachinetti  et  al.,  2015).  
  
The   work   of   Fachinetti   and   colleagues,   together   with   previous   studies,  
suggested   that   CENP-­‐A,   CENP-­‐B,   and   CENP-­‐C   interact   to   establish   centromeric  
chromatin  and  form  the  foundation  for  kinetochore  nucleation  (Ando  et  al.,  2002;  
Amor  et  al.,  2004;  Fachinetti  et  al.,  2015;  Musacchio  and  Desai,  2017).  CENP-­‐C  plays  
a  crucial  role  in  this  process  as  it  links  centromeric  nucleosomes  to  subcomplexes  of  
the  outer  kinetochore,  which  I  will  introduce  in  the  following  section.  
  
1.4   The  kinetochore  
In  this  section,  I  give  an  overview  of  how  mitotic  chromosomes  are  linked  to  
spindle  microtubules.  This  is  achieved  through  the  multi-­‐protein  complex  named  the  
kinetochore   that   assembles   at   active   centromeres.   Studies   have   discovered  more  
than   100   different   kinetochore   components,   most   of   which   are   organized   into  





1.4.1   Kinetochore  structure  
As  discussed  in  the  previous  section,  the  first  discovered  human  centromere  
proteins  CENP-­‐A,  CENP-­‐B,  and  CENP-­‐C  form  a  portion  of  the  inner  kinetochore  that  
interacts  directly  with  centromeric  chromatin.  They  are  part  of  a  group  of  proteins  
that   interact  with   centromeres   throughout   the  cell   cycle,   termed   the  constitutive  
centromere   associated   network   (CCAN)   (Cheeseman   and   Desai,   2008).   The   CCAN  
serves  as  the  platform  linking  the  centromere  chromatin  with  the  protein  complexes  
of   the   outer   kinetochore.   The   main   platform   necessary   for   microtubule   end-­‐on  
binding  is  the  outer  kinetochore  KMN  network,  named  after  the  scaffolding  protein  
Knl1,  the  Mis12  complex,  and  the  Ndc80  complex.  In  contrast  to  the  constitutively  
localised  proteins  of  the  CCAN,  the  outer  kinetochore  complexes  assemble  on  the  
CCAN  platform   at   different   stages   of   the   cell   cycle.   The  Mis12   complex   and   Knl1  
localise   to   the   centromere   in   S   phase   and   the   Ndc80   complex   is   recruited   to  
kinetochores  in  late  G2  (Gascoigne  and  Cheeseman,  2013).  CENP-­‐C  is  a  link  between  
the  centromere  nucleosomes  and  the  outer  kinetochore  Mis12  complex  (Screpanti  
et  al.,  2011).  The  Mis12  complex  then  promotes  outer-­‐kinetochore  assembly  through  
its   interaction   with   Knl1   and   the   Ndc80   complex,   with   the   latter   being   the   key  
microtubule-­‐binding  component  of  the  kinetochore  (Cheeseman  et  al.,  2006;  DeLuca  
et  al.,  2006).    
  
1.4.1.1   Mis12  complex  
The  human  Mis12  complex  consists  of  the  four  subunits  Mis12,  Dsn1,  Nsl1  and  
Pmf1.  Crystal  structures  of  the  complex  revealed  that  it  is  an  extended  rod  of  ~  20  
nm  length  and  the  subunits  form  two  distinct  subcomplexes,  Mis12  with  Pmf1  and  
Dsn1  with  Nsl1  (Petrovic  et  al.,  2016).  Cross-­‐linking  experiments  showed  that  the  C-­‐
terminal  end  of  Nsl1  makes  individually  contacts  with  Knl1  and  the  Ndc80  complex,  
highlighting   the  “hub”   function   of   the  Mis12  complex   for  KMN  complex  assembly  
(Petrovic  et  al.,  2010).  The  Aurora  B  kinase  phosphorylates  the  Dsn1  subunit  at  serine  
residues  100  and  109  (Yang  et  al.,  2008;  Welburn  et  al.,  2010).  Interestingly,  it  was  




complex  and  CENP-­‐C   (Kim  and  Yu,  2015).  However,   the   stronger   interaction  upon  
phosphorylation   is   not   achieved   by   creating   a   binding   site   but   probably   rather  
through  removing  an  inhibitory  mechanism  by  which  unphosphorylated  Dsn1  hinders  
the  interaction  of  CENP-­‐C  with  the  Mis12  complex  (Kim  and  Yu,  2015;  Petrovic  et  al.,  
2016).  
  
1.4.1.2   Knl1  
Knl1   is  a   large  outer  kinetochore  protein  that  serves  as  a  signalling  platform  
within  the  KMN  network.  It  is  critical  for  processes  such  as  chromosome  congression  
and   spindle   assembly   checkpoint   (SAC)   signalling   (Caldas   and   DeLuca,   2014).   The  
structure   of   Knl1   appears   to   be   mostly   intrinsically   disordered,   but   a   structured  
domain   at   its   C-­‐terminal   end   is   responsible   for   the   interaction   with   the   Mis12  
complex  (Petrovic  et  al.,  2010).    
A  role  of  Knl1  in  chromosome  congression  became  apparent  in  Knl1  depletion  
experiments,  resulting  in  partial  chromosome  alignment  defects  (Cheeseman  et  al.,  
2008).   However,   the   exact   molecular   mechanism   remains   elusive   and   different  
hypotheses   exist,   explaining   how   Knl1   depletion   could   perturb   kinetochore-­‐
microtubule  attachments  (Caldas  and  DeLuca,  2014).  
The  molecular   role   of   Knl1   in   the  mitotic   checkpoint   is   understood   in  more  
detail.   Knl1   serves   as   the   binding   scaffold   for   proteins   involved   in   SAC   signalling.  
Phosphorylation  of  the  Knl1  MELT  motifs  creates  a  binding  site  for  the  Bub  complex  
(the   role   of   Bubs   will   be   discussed   in   section   1.5.1).   The   MELT   motifs   are   well  
conserved  between  Knl1  homologues,  however,  the  number  of  MELT  motifs  is  highly  
variable  among  different  species  (Vleugel  et  al.,  2012).    
  
1.4.1.3   Ndc80  complex  
The  Ndc80  complex  is  the  key  component  of  the  KMN  network  for  microtubule  
attachments.   It   is   composed   of   the   four   subunits  Hec1   (also   called  Ndc80),  Nuf2,  
Spc24,  and  Spc25,  which  form  an  extended  rod-­‐like  structure  with  globular  domains  




binding   site   through   their   N-­‐terminal   regions   and   the   Spc24   and   Spc25   subunits  
compose  the  kinetochore  binding  module  via  their  C-­‐terminal  end.  The  microtubule  
binding  region  of  Nuf2  and  Hec1  consists  of  a  calponin  homology  (CH)  domain  and  an  
unstructured  N-­‐terminal  tail,  both  positively  charged  (Wei  et  al.,  2007;  Ciferri  et  al.,  
2008).  Besides  this  information  revealed  by  crystal  structures,  functional  studies  also  
demonstrate  an  important  contribution  of  the  highly  basic  N-­‐terminal  Hec1  tail  for  
the   Ndc80   interaction  with  microtubules   (Cheeseman   et   al.,   2006;   DeLuca   et   al.,  
2006).  However,  N-­‐terminal  Hec1  tail  deletion  mutants   in  model  organisms   like  S.  
cerevisiae  and  in  C.  elegans  do  not  result  in  the  severe  phenotypes  expected  from  
disrupted   kinetochore-­‐microtubule   attachments,   indicating   that   the   precise  
molecular  role  of  the  N-­‐terminal  Hec1  tail  requires  further  investigation  (Musacchio  
and  Desai,  2017).  
  
Overall,  the  KMN  network  is  a  crucial  part  of  the  outer  kinetochore,  providing  
the  platform  for  microtubule  binding  and  allowing  through  its  multicomplex  structure  
monitoring  and  modulation  of  microtubule  attachments.    
  
1.4.2   Chromosome  congression  and  kinetochore-­‐microtubule  attachments    
Starting  with   an   initially   random  distribution   of   chromosomes   upon  nuclear  
envelope  breakdown,  chromosome  congression  is  necessary  to  align  chromosomes  
at   the   spindle   equator   to   eventually   enable   correct   chromosome   segregation.  
Different  mechanisms  are  responsible  for  chromosome  congression,  depending  on  
the   initial   positioning   of   the   chromosomes   relative   to   the   spindle.   “Direct  
congression”  is  achieved  by  direct  attachment  of  microtubules  to  kinetochores  in  an  
end-­‐on   fashion,   whereas   “peripheral   congression”   applies   mostly   only   to  
chromosomes   close   to   the   spindle   poles   and   depends   on   lateral   microtubule  
attachments   to   bring   these   chromosomes   to   the   spindle   equator   (Maiato   et   al.,  
2017).  The  lateral  transport  along  microtubules  depends  on  the  kinetochore  motor  
protein  CENP-­‐E  and  is  directed  by  post-­‐translational  modifications  of  tubulin  (Barisic  




are  turned   into  stable  plus-­‐end  microtubule  attachments,  a  process  depending  on  
the  microtubule  depolymerising  kinesin  MCAK  (Shrestha  and  Draviam,  2013).    
  
Stable   and   correct   end-­‐on   kinetochore-­‐microtubule   attachments   result   in  
chromosome   bi-­‐orientation   and   are   a   prerequisite   for   faithful   chromosome  
segregation.   Bi-­‐orientation   requires   the   amphitelic   configuration   of   microtubule  
attachments  with  one  kinetochore  attached  to  microtubules  emerging  from  only  one  
spindle  pole  and  microtubules  attached   to   the   sister  kinetochore  arising   from   the  
opposite   pole.   However,   the   process   of   microtubule   attachments   occurs   in   a  
stochastic   manner,   resulting   in   the   existence   of   transient   erroneous   microtubule  
attachments  that  do  not  result  in  chromosome  bi-­‐orientation  (Tanaka,  2010).  
   Possible  erroneous  configurations  are  syntelic  attachments,  when  both  sister  
kinetochores   attach   to   microtubules   from   the   same   spindle   pole   and   merotelic  
attachments  with   one   kinetochore   attached   to  microtubules   emerging   from  both  
poles  at  the  same  time  (Fig.  3).  These  attachment  geometries  would  not  allow  faithful  
chromosome   segregation.   Therefore,   mechanisms   are   necessary   that   resolve  
incorrect  attachments  and  halt  mitotic  progression.  Additionally,  in  situations  with  
monotelic   attachments,   i.e.   only   one   of   the   sister   kinetochores   is   attached   to  
microtubules,  or  when  chromosomes  completely  lack  microtubule  attachments,  the  
onset  of  anaphase  and  thus  sister  chromatid  segregation  has  to  be  delayed  (Tanaka,  
2010).   This   is   ensured   through   the   spindle   assembly   checkpoint,   which   prevents  




















Figure  3:  Different  modes  of  microtubule-­‐kinetochore  attachments.  
Chromosomes  are  shown  in  blue,  microtubules  and  spindle  poles   in  green  and  kinetochores   in  
red.   (A)   represents   the   amphitelic  mode   in  which   chromosomes   bi-­‐orientate.   (B)   represents  
syntelic   attachments   where   both   sister   kinetochores   attach   to   microtubules   from   the   same  
spindle   pole.   (C)   represents   merotelic   attachments   where   one   kinetochore   is   attached   to  
microtubules   that   emerge   from   both   poles   at   the   same   time.   (D)   represents   monotelic  
attachments  where  only  one  of  the  sister  kinetochores  is  attached  to  microtubules  (after  (Krenn  




1.5   Control  mechanism  of  chromosome  segregation    
During  mitosis,   the   sister   chromatids   are   held   together   through   the   protein  
complex  cohesin.  Once  chromosomes  are  aligned  and  form  the  metaphase  plate,  the  
kleisin   subunit  of   cohesin   is   cleaved  by   the  protease  Separase,  allowing   the   sister  
chromatids   to   segregate   and   form   two   new   daughter   cells   (Ciosk   et   al.,   1998;  
Cheeseman,  2014).  However,  to  prevent  chromosome  mis-­‐segregation,  it  is  crucial  
that  this  process  is  initiated  only  after  chromosomes  are  bi-­‐  orientated.  The  spindle  
assembly  checkpoint  (SAC)  is  a  feedback  system  that  monitors  the  attachment  status  
of   kinetochores   and   prevents   mitotic   progression   until   all   kinetochores   have  
microtubule  attachments.  However,  the  merotelic  configuration  does  not  induce  a  
SAC-­‐dependent   arrest   and   is   therefore   a  major   risk   for   chromosome   segregation  
errors  (Gregan  et  al.,  2011).  
  
1.5.1   Spindle  Assembly  Checkpoint  (SAC)    
The  SAC  detects  whether  kinetochores   lack  proper  microtubule  attachments  
and   remains   active   even   if   only   a   single   kinetochore   is   unattached   (Rieder  et   al.,  
1994).  Until   today  it   is  unclear  how  exactly  the  SAC  monitors  whether  unattached  
kinetochores  are  present,  but  the  molecular  mechanism  of  how  the  SAC  components  
mediate  the  downstream  signalling  of  the  “anaphase  halt  signal”  is  well  understood.    
Besides  being  the  anchor  point  for  microtubules,  the  KMN  complex  serves  also  
as  a  platform  for  the  assembly  of  SAC  components,  such  as  Mad1,  Mad2,  Bub1,  Bub3,  
and  BubR1.  The  KMN  subunit  Knl1  is  phosphorylated  by  the  Mps1  kinase  at  its  MELT  
motifs,  creating  a  binding  site   for  the  Bub  complex,  consisting  of  Bub1,  Bub3,  and  
BubR1  (Taylor  et  al.,  1998;  Yamagishi  et  al.,  2012).  The  C-­‐terminal  end  of  Mad1  binds  
Bub1  and  facilitates  Mad2  recruitment  to  unattached  kinetochores  (Kim  et  al.,  2012).    
The  SAC  key  player  Mad2   (mitotic  arrest  deficient  2)  exists   in  a  “closed”   (C-­‐
Mad2)  or  “open”  (O-­‐Mad2)  structural  configuration,  with  the  latter  being  the  inactive  




complex,  Mad2  exists  in  the  closed,  thus  active  configuration  (De  Antoni  et  al.,  2005).  
C-­‐Mad2   is  able   to   induce  a   conformational   change   in  O-­‐Mad2,   turning   it   into   the  
active   state.   Activated   C-­‐Mad2   then   diffuses   away   from   kinetochores   and   forms  
together  with   BubR1   and   Bub3   the  mitotic   checkpoint   complex   (MCC).   The  MCC  
inhibits   Cdc20,   which   is   a   critical   co-­‐factor   of   the   anaphase   promoting   complex  
(APC/C).  The  E3  ubiquitin  ligase  APC/C  targets  proteins  for  proteasomal  degradation  
to   allow   anaphase   onset   (Chang   and  Barford,   2014).   The   targets   include   cyclin   B,  
whose  degradation  results  in  a  reduction  of  CDK1  activity  and  hence  initiates  mitotic  
exit  (Glotzer  et  al.,  1991).  Another  of  the  APC/C  key  targets  is  Securin,  an  inhibitory  
factor  of  the  protease  Separase  (Zou  et  al.,  1999).  Once  active,  Separase  cleaves  the  
cohesin  molecules  holding  the  two  sister  chromatids  together.  Therefore,  a  crucial  
task  of  the  MCC  is   to  keep  the  APC/C   inactive  by  sequestering  Cdc20  and  thereby  
inhibiting  anaphase  initiation.  Additionally,  recent  work  suggests  that  the  MCC  is  able  
to  bind  to  a  second  Cdc20,  which  is  part  of  an  active  APC/C-­‐Cdc20  complex  (Izawa  
and  Pines,  2015).  This  interaction  occurs  via  BubR1  and  appears  to  be  essential  for  
SAC  functionality.      
The  SAC  is  “satisfied”  once  correct  microtubule  attachments  are  established  at  
every   kinetochore   and   needs   to   be   inactivated   to   allow  mitotic   progression.   The  
inactivation  of  the  SAC  signalling  is  supported  by  various  mechanisms,  including  the  
inhibition  of  Mad2  by  p31comet,  which  competes  with  O-­‐Mad2  for  the  binding  to  C-­‐
Mad2  (Xia  et  al.,  2004;  Mapelli  et  al.,  2006).  Additionally,  the  removal  of  SAC  proteins  
from  kinetochores  by  the  cytoskeletal  motor  protein  dynein,  which  is  recruited  partly  
by  the  Rod/Zw10/Zwilch  (RZZ)  complex  contributes  to  SAC  inactivation  (Starr  et  al.,  
1998;   Howell   et   al.,   2001).   Furthermore,   phosphatase   activity   contributes   to   SAC  
silencing:  The  protein  phosphatase  1  (PP1)  is  recruited  to  the  RVSF  motif  of  Knl1  and  
might  dephosphorylate  its  MELT  motifs,  disrupting  the  Knl1  binding  site  of  the  Bub  
complex   (Liu   et   al.,   2010;   London   et   al.,   2012).   Additionally,   PP1   also  
dephosphorylates  the  C-­‐terminus  of  zwint-­‐1,  a  Zw10  binding  protein,  and  is  necessary  





1.5.2   Error  correction  
The   SAC   serves   as   a   roadblock   to   prevent   mitotic   progression   when  
kinetochores   lack   proper  microtubule   attachments.   As   described   in   section   1.4.2,  
microtubule  attachments  to  kinetochores  occur  in  a  stochastic  manner.  Therefore,  it  
is  not  sufficient  to  simply  delay  mitotic  progression  through  the  SAC.  In  addition,  a  
second   control   mechanism   is   necessary   that   resolves   erroneous   microtubule  
attachments.  This  mechanism  is  termed  “error  correction”  and  is,  in  contrast  to  the  
SAC,  a  local  process  destabilising  microtubule  attachments  that  are  attached  in  an  
incorrect   configuration,   such   as   merotelic   or   syntelic   attachments   (Krenn   and  
Musacchio,  2015).  The  mechanism  of  error  correction  is  assumed  to  depend  on  the  
ability  of  the  Chromosomal  Passenger  Complex  (CPC)  to  respond  to  a  lack  of  tension  
at   centromeres   and   kinetochores,   which   can   be   a   consequence   of   improperly  
attached  microtubules  (Tanaka  et  al.,  2002;  Lampson  et  al.,  2004;  Liu  et  al.,  2009).  
The   destabilisation   of   the   kinetochore-­‐microtubule   attachments   results   in   a  
disruption  of  end-­‐on  attachments  (Kalantzaki  et  al.,  2015).  Therefore,  it  is  suggested  
that  the  error  correction  mechanism  might  also  contribute  to  the  maintenance  of  
SAC   signal   activity   until   all   chromosomes   have   correct   kinetochore-­‐microtubule  
attachments  (Pinsky  et  al.,  2006).  A  weakening  of  the  microtubule  binding  affinity  is  
achieved  through  phosphorylation  of  kinetochore  components  and  is  a  key  function  
of  the  CPC,  mediated  through  its  kinase  Aurora  B  (Tanaka  et  al.,  2002;  Lampson  et  al.,  
2004;   Cheeseman   et   al.,   2006;   DeLuca   et   al.,   2006;   Tanaka,   2010).   Due   to   the  
significance  of  the  CPC  for  this  project,  I  will  introduce  the  CPC  and  its  mode  of  action  




1.6     Chromosomal  Passenger  Complex  (CPC)  
The  CPC  is  a  key  regulator  that  controls  various  processes  in  mitosis  and  shows  
a  highly  mobile  but  distinct  localisation  at  different  stages  of  mitosis.  First,  the  CPC  is  
localised  at  chromosome  arms  and  the  centromere  region.  With  the  progression  into  
prometaphase,   the   CPC   starts   to   accumulate   at   centromeres   where   it   controls  
chromosome  behaviour   in  metaphase.  Upon  anaphase  onset,   the  CPC   localisation  
shifts   from  centromeres  to  the  spindle  midzone  and  eventually  midbody  region  at  
which  it  functions  in  cytokinesis  (Ruchaud  et  al.,  2007).  
  
1.6.1   The  CPC  subunits  
The   CPC   consists   of   two   functional   domains:   the   kinase   module   and   the  
localisation  module,  which  are  connected  through  the  scaffold  component  INCENP  
(Cooke  et  al.,  1987)  (Fig.  4).  The  localisation  module  is  composed  of  borealin,  survivin  
and   the  N-­‐terminus   of   INCENP.   They   are   linked  with   each   other   via   a   three-­‐helix  
bundle  and  determine  the  mitotic  localisation  of  the  CPC  (Jeyaprakash  et  al.,  2007).  
The  Aurora  B  kinase  and  the  C-­‐terminus  of  INCENP  called  the  IN-­‐box  are  the  kinase  
module,  which  delivers  the  catalytic  activity  of  the  CPC  (Adams  et  al.,  2000;  Honda  et  
al.,  2003).  The  interaction  between  Aurora  B  and  INCENP  plays  a  crucial  role  in  CPC  
activation  and  will  be  discussed  in  the  section  1.6.1.1  “Aurora  B”.  
The  exact  stoichiometry  of  the  CPC  subunits  remains  elusive.  However,  purified  
borealin  and  survivin  interact  in  a  1:1  ratio  and  together  with  the  N-­‐terminal  INCENP  
peptide  (1-­‐58)  a  1:1:1  complex   is   formed  (Bourhis  et  al.,  2007;   Jeyaprakash  et  al.,  
2007).  Furthermore,  structural  experiments  suggest  that  Aurora  B  and  the  INCENP  C-­‐





Figure  4:  Subunits  of  the  chromosomal  passenger  complex.  
  
Survivin,   borealin   and   the   N-­‐terminus   of   INCENP   interact   via   a   three-­‐helix-­‐bundle   and   form   the  
localisation  module.  Aurora  B  and  the  C-­‐terminus  of  INCENP  form  the  kinase  module.  Adapted  from  









1.6.1.1   Aurora  B  
Aurora  B   is  a  serine/threonine  protein  kinase  and  responsible   for  the  kinase  
activity  of  the  CPC.  Two  further  members  of  the  Aurora  kinase  family  exist,  named  
Aurora  A  and  Aurora  C.  Aurora  A  localises  at  centrosomes  and  plays  a  role  in  their  
maturation  (Hannak  et  al.,  2001).  Aurora  C   is  mainly  involved   in  male  meiosis  and  
mutations  result   in   infertility,  but   it   is  considered  that  Aurora  C   is  not  needed  for  
somatic  mitosis  (Dieterich  et  al.,  2007;  Kimmins  et  al.,  2007),  though  it  may  become  
abundant  in  cancer  (Kimura  et  al.,  1999).  
Activation  of  Aurora  B  is  a  multistep  process  involving  the  phosphorylation  of  
the   INCENP   IN-­‐box   and  Aurora   B   kinase   itself.   After   binding   to   INCENP,   Aurora   B  
phosphorylates   a   threonine-­‐serine-­‐serine   (TSS)   motif   at   the   INCENP   C-­‐terminus  
(Bishop  and  Schumacher,  2002;  Honda  et  al.,  2003;  Sessa  et  al.,  2005).  Additionally,  
auto-­‐phosphorylation  of  the  Aurora  B  T-­‐loop  at  threonine  232  further  contributes  to  
the   activation   of   the   Aurora   B   kinase   (Yasui   et   al.,   2004).   Both   of   these  
phosphorylations  most  likely  occur  in  trans,  which  serves  as  a  feasible  explanation  
why  the  CPC  is  activated  through  local  enrichment:  Previous  studies  demonstrated  
that  Aurora  B  activation  occurs  through  increased  local  concentration  and  induced  
clustering  using  anti-­‐INCENP  antibodies  or  INCENP  tethering  (Kelly  et  al.,  2007;  Wang  
et  al.,  2011a).  Additionally,  microtubules  are  able  to  activate  the  CPC,  presumably  
through  the  same  mechanism  of  local  enrichment  (Tseng  et  al.,  2010).    
Phosphatases  regulate  Aurora  B  kinase  activity  in  complex  feedback  networks,  
counteracting   phosphorylation   of   Aurora   B   substrates   at   centromeres   and  
kinetochores,  which  is  reviewed  in  detail  by  (Trivedi  and  Stukenberg,  2016).  The  two  
main  phosphatases  involved  in  these  processes  are  PP1  and  PP2A.  Different  pools  of  
PP1  regulate  CPC  localisation  and  dephosphorylate  CPC  substrates.  Interestingly,  the  
recruitment   of   those   PP1   pools   is   counteracted   by   Aurora   B   activity:   Aurora   B  
catalysed   phosphorylation   of   Knl1   disrupts   PP1   recruitment   to   kinetochores   and  
phosphorylation  of  Repo-­‐man  perturbs  the  chromatin  binding  of  the  Repo-­‐man-­‐PP1  
complex  (Liu  et  al.,  2010;  Qian  et  al.,  2013).  In  general,  Aurora  B  phosphorylation  at  




mitosis  (Kim  et  al.,  2010;  Nasa  et  al.,  2018).  Besides  dephosphorylation  of  Aurora  B  
substrates,  PP2A  also  removes  the  activating  phosphorylation  in  the  Aurora  B  T-­‐loop  
region   at   threonine   232,   resulting   in   reduced  CPC   activity   (Nijenhuis  et   al.,   2014;  
Meppelink  et  al.,  2015).  Aurora  B  is  ultimately  thought  to  be  regulated  through  its  
proteasomal  degradation  mediated  by  Cdh1  during  mitotic  exit.  (Nguyen  et  al.,  2005;  
Stewart  and  Fang,  2005).  
  
1.6.1.2   INCENP  
INCENP  was  identified  in  a  screen  for  new  chromosome  scaffold  components  
and  was  the  first  CPC  subunit  to  be  discovered  (Cooke  et  al.,  1987).  The  protein  was  
named  due  to  is  localisation  in  the  first  part  of  mitosis  (inner  centromere  protein)  and  
surprised   researchers   with   its   unheard-­‐of   shift   from   centromeres   to   the   spindle  
midzone  upon  anaphase  onset  and  its  midbody  localisation  in  telophase  cells.  This  
dramatic  change  in  mitotic  localisation  is  a  hallmark  of  the  CPC  and  will  be  discussed  
further  in  section  1.6.2  “Localisation  of  the  CPC”.    
Acting   as   the   main   scaffold   component,   INCENP   links   the   two   functional  
domains  of  the  CPC:  The  C-­‐terminal  end  of  INCENP  contains  the  IN-­‐box  domain,  which  
is  responsible  for  binding  and  activating  the  Aurora  B  kinase.  The  INCENP  N-­‐terminus  
interacts  with  borealin  and  survivin,  forming  a  three-­‐helix  bundle  which  acts  as  the  
CPC  localisation  module  (Vader  et  al.,  2006;  Jeyaprakash  et  al.,  2007).  
INCENP  interacts  through  a  PxVxL/I  motif  with  the  chromo  shadow  domain  of  
heterochromatin  protein  1  (HP1)  (Ainsztein  et  al.,  1998;  Nozawa  et  al.,  2010;  Kang  et  
al.,  2011).  This  interaction  is  dispensable  for  correct  mitotic  localisation  of  INCENP  
but   necessary   to   localise   INCENP   to   heterochromatin   in   interphase   cells,  
demonstrated  in  experiments  using  INCENP  mutants  missing  the  PxVxL/I  motif  region  
(Kang  et  al.,  2011).    
The   INCENP   region   that   links   the   targeting   and   kinase   module   is   of   low-­‐
complexity  and  unlikely  to  form  a  tertiary  structure.  However,  the  central  region  of  




assumed  coiled-­‐coil  domain  (Samejima  et  al.,  2015).  The  SAH  can  stretch  under  force  
and  might  allow  the  kinase  domain  of  the  CPC  to  act  on  outer  kinetochore  substrates  
despite  the  targeting  of  the  CPC  localisation  module  to  the  inner  centromere.  This  
“dog  leash”  model  is  reviewed  in  detail  by  Krenn  and  Musacchio  and  can  provide  an  
explanation  for  the  variable  Aurora  B  phosphorylation  gradient  upon  increased  intra-­‐
kinetochore  tension  (Krenn  and  Musacchio,  2015).  
  
1.6.1.3   Borealin  
Borealin  is  also  known  as  Dasra,  because  it  was  discovered  simultaneously  in  
two  independent  studies  (Gassmann  et  al.,  2004;  Sampath  et  al.,  2004).  As  described  
above,  the  N-­‐terminal  end  of  borealin  forms  together  with  survivin  and  INCENP  the  
triple-­‐helix  bundle  of  the  targeting  module.  CDK1  phosphorylates  borealin,  which  is  
necessary  for  its  interaction  with  shugoshin  (Tsukahara  et  al.,  2010).  The  targeting  of  
the  CPC  to  mitotic  centromeres  is  in  part  achieved  through  the  binding  of  shugoshin  
to  phosphorylated  histone  H2A.  The  exact  centromere  recruitment  of  the  CPC  will  be  
discussed  in  subsection  “Localisation  of  the  CPC”  of  this  chapter.    
Besides   the  well-­‐characterised   interaction   of   the   CPC  member   INCENP  with  
HP1,  a  recent  study  suggests  a  direct  interaction  also  of  the  borealin  C-­‐terminus  with  
HP1  (Liu  et  al.,  2014).  A  mass  spectrometry  screen  identified  borealin  as  one  of  the  
proteins   binding   to   the   chromo   shadow   domain   of   HP1   (Nozawa   et   al.,   2010).  
However,  borealin  does  not  contain  a  typical  PxVxL/I  motif,  but  rather  is  supposed  to  
interact  with  HP1  through  a  conserved  LTVPV  sequence  (Liu  et  al.,  2014).    
  
1.6.1.4   Survivin  
Survivin   was   first   identified   as   an   anti-­‐apoptotic   protein,   mainly   expressed  
during  development  and  in  transformed  cell  lines  (Ambrosini  et  al.,  1997).  It  contains  
a  N-­‐terminal  baculovirus  IAP  repeat  (BIR)  domain,  which  is  found  in  members  of  the  
“inhibitor   of   apoptosis   protein”   (IAP)   family.   However,   the   anti-­‐apoptotic   role   of  
survivin  is  controversial.  For  instance,  its  BIR  domain  binds  phosphorylated  histone  




Furthermore,  survivin  is  part  of  the  CPC  localisation  module  and  its  C-­‐terminal  helical  
domain  forms  together  with  INCENP  and  borealin  a  triple  helical  bundle  as  described  
earlier.   Interestingly,   most   of   the   survivin   protein   is   in   complex   with   borealin   in  
synchronised  mitotic  HeLa  cells  (Gassmann  et  al.,  2004).  The  contribution  of  survivin  
in  recognising  mitotic  phosphorylation  marks  and  positioning  the  CPC   in  mitosis   is  
discussed  in  section  1.6.2.1  in  greater  detail.    
  
1.6.2   Localisation  of  the  CPC    
By   identifying   the   first   CPC   subunit   INCENP,   Cooke   and   colleagues   first  
described  the  typical  localisation  of  the  CPC  at  chromosome  arms  and  centromeres  
in  early  mitosis  with  the  continued  accumulation  at  centromeres  until  metaphase,  
followed  by   the   shift   to   the   spindle  midzone   upon   anaphase   onset   (Cooke  et   al.,  
1987).   Since   then   a   great   number   of   studies   focused   on   dissecting   the  molecular  
mechanisms  involved  in  the  localisation  of  the  CPC  throughout  mitosis  (Ruchaud  et  
al.,   2007;   Hindriksen   et   al.,   2017).   A   breakthrough   was   the   discovery   that   the  
centromere   localisation   of   the   CPC   in   mitosis   is   defined   by   the   two   histone  
phosphorylation  marks  H3T3ph  and  H2AT120ph.  Due  to  the  relevance  for  this  work,  
I  will  discuss  these  two  histone  marks  in  detail  and  focus  mainly  on  the  mechanism  
of  centromere  localisation  of  the  CPC  in  this  section.  
  
1.6.2.1   Histone  H3  threonine  3  phosphorylation  
Haspin   kinase   phosphorylates   histone   H3   at   threonine   3   (H3T3ph)   during  
mitosis  (Dai  et  al.,  2005).  Survivin  binds  this  mark  via  its  BIR  domain  and  locates  the  
CPC  to  centromeres  (Kelly  et  al.,  2010;  Wang  et  al.,  2010).  Depletion  of  Haspin  kinase  
or  mutation   of   the   survivin   BIR   domain   result   in   dispersed   CPC   localisation   along  
chromosome   arms   instead   of   centromeric   concentration   in   mitosis   (Wang   et   al.,  
2010).  
Although   no   one   has   yet   visualized   the   endogenous   protein   by   indirect  
immunofluorescence,  Haspin  binds  the  cohesin  protein  complex,  which  links  sister  




cohesin   is   indirect   via   the   cohesin  modulator   Pds5   (Zhou  et   al.,   2017).   Cohesin   is  
removed   from   chromosome   arms   in   the   prophase   pathway,   which   is   believed   to  
concentrate  Haspin  at  centromeres.  An  experiment  supporting  this  model  reported  
an   increased  amount   of  CPC   localised   to   chromosome  arms  upon  Wapl  depletion  
(Haarhuis  et  al.,  2013).  Similar  to  the  stable  localisation  of  cohesin  between  the  sister  
chromatids  at  the  centromere  region,  the  H3T3ph  mark  is  also  specifically  detected  
at  the  inner  centromere  in  chromosome  spreads  (Wang  et  al.,  2010).    
The  enrichment  of  the  H3T3  mark  at  centromeres  is  also  regulated  by  Aurora  
B   itself   through  various  mechanisms.  Wang  and  colleagues   showed   that  Aurora  B  
activates  Haspin  through  direct  phosphorylation  (Wang  et  al.,  2011b).  This  possibly  
results  in  a  positive  feedback  loop,  concentrating  H3T3ph  and  thereby  Aurora  B  itself  
at  centromeres.  Opposing  this,  the  H3T3ph  mark  is  removed  by  the  Repo-­‐man-­‐PP1  
complex.   However,   Aurora   B   counteracts   the   Repo-­‐man-­‐PP1   function   by  
phosphorylating   Repo-­‐man   residue   serine   893   (Qian   et   al.,   2013).   The   chromatin  
binding  of  Repo-­‐man  is  perturbed  when  serine  893  is  phosphorylated,  and  therefore,  
H3T3ph  might  be  protected  at  sites  where  Aurora  B  is  active.  Additionally,  CDK1  and  
Plk1  catalysed  phosphorylation  of  Haspin  also  contributes  to  fully  activate  the  kinase  
and  to  promote  CPC  localisation  to  centromeres  (Ghenoiu  et  al.,  2013;  Zhou  et  al.,  
2014).  
  
1.6.2.2   Histone  H2A  threonine  120  phosphorylation  
A   second  mark   that   concentrates   the   CPC   at   centromeres   is   histone   H2A  
phosphorylated  at  threonine  120  (H2AT120ph)  (Yamagishi  et  al.,  2010).  This  residue  
is   phosphorylated   by   the   Bub1   kinase,   which   is   recruited   to   kinetochores   upon  
phosphorylation  of  Knl1  by  the  Mps1  kinase  (Kawashima  et  al.,  2010;  London  et  al.,  
2012).  In  contrast  to  H3T3ph,  the  H2AT120ph  mark  is  not  directly  recognised  by  a  
CPC  subunit.  Instead,  shugoshin  recognises  H2AT120ph  and  then  binds  the  borealin  
subunit  of  the  CPC.  According  to  the  “tag  along  model”,  shugoshin  binds  H2AT120ph  
and   recruits   the   CPC   to   the   kinetochore-­‐proximal   centromere   (Hindriksen   et   al.,  




shugoshin   shifts   to   cohesin   binding   at   the   inner   centromere.   However,   it   is  
controversial  whether   shugoshin   can  bind  cohesin  and   the  CPC   simultaneously  or  
whether   the   binding   is   mutually   exclusive,   and   therefore,   two   different   pools   of  
shugoshin  may  exist  at  centromeres,  with  one  binding  the  CPC  and  the  other  binding  
cohesin  (Trivedi  and  Stukenberg,  2016).    
Similar  to  the  H3T3ph  mark,  Aurora  B  has  also  a  positive  feedback  loop  in  the  
H2AT120ph   recruitment   pathway.   Aurora   B   activity   indirectly   protects   the  Mps1  
phosphorylation  mark   on   Knl1   by   perturbing   PP1   phosphatase   activity   (Liu  et   al.,  
2010).  This  ensures  that  Bub1  binds  Knl1,  H2AT120  is  phosphorylated,  and  the  CPC  is  
recruited.  
  
1.6.2.3   CPC  localisation  upon  anaphase  onset  
The  CPC  begins  to  shift  from  centromeres  to  the  central  spindle  and  the  cell  
cortex  at  the  region  of  the  contractile  ring  with  the  onset  of  anaphase  (Earnshaw  and  
Cooke,   1991).   This   is   facilitated   by   the   removal   of   CPC   targeting   marks   from  
chromatin  and  also  through  the  transfer  of  the  CPC  from  chromatin  to  the  central  
spindle.  
With  the  onset  of  anaphase  and  the  concomitant  decrease   in  CDK1  kinase  
activity,  binding  of  the  PP1  phosphatase  to  Repo-­‐man  is  no  longer  inhibited  (Qian  et  
al.,  2015).  This  results  in  an  active  Repo-­‐man-­‐PP1  complex  that  removes  the  histone  
mark  H3T3ph  from  chromatin  (Qian  et  al.,  2011).  Targeting  the  CPC  to  the  spindle  
midzone   requires   the   kinesin   protein  Mklp2   (mitotic   kinesin-­‐like   protein   2).  Upon  
removal  of  the  CDK1-­‐catalysed  phosphorylation  on  INCENP,  Mklp2  associates  with  
INCENP  and  translocates  with  the  CPC  to  the  microtubules  of  the  spindle  midzone  
(Hümmer   and  Mayer,   2009).   Furthermore,   the   E3   ligase   Cul3   and   the   substrate-­‐
specific  adaptors  KLHL9  and  KLHL13  promote  the  transfer  of  the  CPC  from  chromatin  
to  the  central  spindle  and  the  cell  cortex  with  the  onset  of  anaphase  (Sumara  et  al.,  
2007).  Interestingly,  the  CPC  transfer  to  the  spindle  midzone  requires  higher  Aurora  





1.6.2.4   CPC  localisation  in  interphase  
The   interphase   localisation   of   the   CPC   is   not   nearly   as   well   studied   as   its  
localisation  in  mitosis.  Aurora  B  is  expressed  from  S-­‐phase  onwards  and  the  protein  
levels  peak  in  mitosis  (Stewart  and  Fang,  2005).  Various  studies  reported  that  Aurora  
B   localises   at   pericentromeric   regions   in   G2   cells,   with   Monier   and   colleagues  
highlighting  that  Aurora  B  accumulates  especially  at  large  pericentromeric  regions,  
such  as  of  chromosome  1  (Zeitlin  et  al.,  2001;  Monier  et  al.,  2007;  Hayashi-­‐Takanaka  
et  al.,  2009).  Additionally,  the  CPC  subunit  survivin  also  clusters  at  pericentromeres  
in  G2  cells  (Beardmore  et  al.,  2004).  A  more  detailed  study  focusing  on  the  interphase  
localisation  of  INCENP  revealed  that  the  clustering  of  INCENP  in  G2  cells  depends  on  
its  interaction  with  HP1.  This  was  demonstrated  by  the  use  of  INCENP  mutants  either  
lacking   the   PxVxL/I   motif   or   containing   alanine   substitutions   in   this   motif,   both  
resulting  in  a  disruption  of  the  interaction  with  HP1.  As  a  consequence,  both  INCENP  
mutants  failed  to  localise  to  the  centromere  region  in  interphase  and  instead  were  
enriched  in  nucleoli  (Kang  et  al.,  2011).    
  
1.6.3   Mitotic  function  of  the  CPC  
The  CPC  acts  in  various  processes  during  mitosis:  These  include  chromosome  
condensation,  sister  chromatid  cohesion,  kinetochore  assembly  (Haase  et  al.,  2017),  
the  release  of  erroneous  chromosome-­‐microtubule  attachments,  SAC  regulation,  and  
cytokinesis.   The   molecular   function   of   the   CPC   in   these   processes   is   reviewed  
extensively   by   (Carmena   et   al.,   2012;   van   der   Waal   et   al.,   2012;   Trivedi   and  
Stukenberg,   2016).   Furthermore,   Trivedi   and   Stukenberg   highlight   that   a   complex  
signalling  network  of  phosphatases  regulates  the  centromeric  function  of  the  CPC  by  
counteracting  Aurora  B  activity.  These  phosphatases  are  particularly  PP1  and  PP2A,  
which  dephosphorylate  Aurora  B  substrates,  but  also  have  an  effect  on  CPC  function  
by  affecting  CPC  activity  and  localisation.  Due  to  the  relevance  to  this  project,  I  will  
focus   on   the   CPC   function   at   centromeres   in   terms   of   regulation   of   chromosome  





1.6.3.1   Correction  of  erroneous  kinetochore-­‐microtubule  attachments    
The  purpose  of  mitosis  is  the  equal  distribution  of  chromosomes  between  the  
two  daughter  cells.  Sister-­‐chromatid  bi-­‐orientation  ensures  error-­‐free  segregation  as  
spindle  microtubules   from  opposite   poles   bind   to   the   kinetochores   of   each   sister  
chromatid   (see   section   1.4.2   for   further   details).   In   cases   where   erroneous  
microtubule   attachments   occur,   the   CPC   is   able   to  weaken   those   interactions   by  
phosphorylating   kinetochore   components   and   thereby   lowering   their   affinity   for  
microtubules  (Lampson  et  al.,  2004).    
One   of   the   most   extensively   studied   Aurora   B   substrates   is   the   outer  
kinetochore  protein  Hec1,  which   is  part  of  the  Ndc80  complex  and  contributes  to  
microtubule  binding.  (Cheeseman  et  al.,  2006;  DeLuca  et  al.,  2006;  Wei  et  al.,  2007;  
Miller   et   al.,   2008).   The   phosphorylation   of   several   Hec1   N-­‐terminal   serine   and  
threonine   residues   by   Aurora   B   results   in   a   decreased   microtubule   affinity  
(Cheeseman   et   al.,   2006;   DeLuca   et   al.,   2006;   Alushin   et   al.,   2010).   Non-­‐
phosphorylatable  mutants  of  Hec1  exhibit  defects  in  chromosome  congression  and  
hyper-­‐stretched   centromeres   due   to   overly   stabilised   microtubule   attachments  
(DeLuca   et   al.,   2006,   2011).   In   line   with   this,   mutations   that   mimic   constitutive  
phosphorylation   perturb   kinetochore-­‐microtubule   attachments   (Guimaraes   et   al.,  
2008).  The  phosphorylation  of  the  Hec1  N-­‐terminus  is  strongest  in  early  mitosis  when  
bi-­‐orientation  is  not  yet  established,  and  therefore,  the  tension  at  kinetochores  is  low  
(DeLuca  et  al.,  2011).  
Besides  Hec1,  Aurora  B  also  phosphorylates  other  KMN  network  components,  
including   the   Dsn1   subunit   of   the   Mis12   complex   and   the   microtubule   binding  
domain   of   Knl1   (Yang  et   al.,   2008;  Welburn  et   al.,   2010).   An   additional   Aurora   B  
substrate  is  the  Ska  complex,  which  contributes  to  the  stabilisation  of  microtubule  
attachments.   Upon   Aurora   B   catalysed   phosphorylation   of   the   Ska   complex,   its  
interaction   with   the   KMN   network   is   perturbed   and   the   formation   of   stable  





1.6.3.2   Role  of  the  CPC  in  SAC  activity  
The  above  described  ability  of  Aurora  B  to  weaken  kinetochore-­‐microtubule  
interactions   suggests   that   the   CPC   contributes   to   SAC   activity   through   this   error  
correction  pathway.  Unattached  kinetochores  trigger  continuous  activity  of  the  SAC,  
as  described  in  detail  in  section  1.5.  Moreover,  the  CPC  contributes  also  directly  to  
SAC  activity  by  facilitating  the  recruitment  of  SAC  key  component  Mps1  (Saurin  et  al.,  
2011).  However,  Aurora  B  activity  does  not  create  a  binding  site  for  Mps1.  Instead,  
Mps1   deletion   mutants   rather   suggest   that   Aurora   B   phosphorylation   causes   a  
conformational   change   of   Mps1   itself,   necessary   for   its   kinetochore   binding  
(Nijenhuis  et  al.,  2013).  Once  Mps1   is  recruited  to  kinetochores,   it  phosphorylates  
the  kinetochore  protein  Knl1.  The  phosphorylation  of  the  Knl1  MELT  motifs  recruits  
further   downstream   SAC   components,   which   facilitate   the   active   SAC   signalling  
(Yamagishi  et  al.,  2012).  
  
Overall,  the  correction  of  erroneous  kinetochore-­‐microtubule  attachments  by  
the  CPC  and  its  direct  role  in  SAC  activity  allows  chromosomes  to  bi-­‐orientate,  and  




1.7   Histone  H3  serine  10  phosphorylation  
In  addition  to  the  chromatin  marks  H3T3ph  and  H2AT120ph  that  define  CPC  
localisation  in  mitosis  introduced  above,  a  further  important  mitotic  chromatin  mark  
is  histone  H3  phosphorylated  at  serine  10  (H3S10ph).  The  CPC  produces  the  H3S10ph  
mark  and  this  is  one  of  the  most  widely  studied  products  of  Aurora  B  kinase  activity  
(Hsu  et  al.,  2000;  Adams  et  al.,  2001;  Hauf  et  al.,  2003).  
Aurora   B   catalysed   phosphorylation   of   H3S10ph   typically   emerges   at  
pericentromeres  in  the  G2  phase  of  the  cell  cycle  (Hendzel  et  al.,  1997;  Crosio  et  al.,  
2002;  Monier  et  al.,  2007;  Hayashi-­‐Takanaka  et  al.,  2009).  With  progression  toward  
the  G2/M  transition  the  H3S10ph  mark  spreads  through  the  nucleus,  resulting  in  a  
prominent  mark  all  over  chromatin  in  prophase  (Hendzel  et  al.,  1997;  Crosio  et  al.,  
2002)  The  H3S10ph  signal  is  maintained  in  mitosis  but  starts  to  decrease  with  the  
shift  of   the  CPC   from  chromatin   to   the   spindle  midzone   in  anaphase.  Besides   the  
relocation  of  the  responsible  kinase  from  chromatin,  phosphatases  also  contribute  
to  the  active  removal  of  H3S10ph.  PP1  was  identified  as  the  phosphatase  removing  
H3S10ph  and  thus  counteracting  the  activity  of  Aurora  B  homologues  in  S.  cerevisiae  
and  C.  elegans.  (Hsu  et  al.,  2000).  Later  on,  it  was  shown  that  PP1g  removes  H3S10ph  
in  vertebrate  cells  and  a  contribution  of  the  PP1g  targeting  subunit  Repo-­‐man  was  
demonstrated  in  Repo-­‐man  depletion  experiments  (Qian  et  al.,  2011;  Vagnarelli  et  
al.,  2011).    
Besides   the   strong   H3S10ph   signal   produced   by   Aurora   B   in  mitotic   cells,  
H3S10ph   can   be   also   found   under   certain   circumstances   in   interphase   cells   as   a  
product   of   other   kinases.   Upstream   environmental   influences   such   as   ultraviolet  
radiation,  cytokines,  and  heat  shocks  activate  these  kinases  and  are  typically  linked  
to  gene  expression  (Baek,  2011;  Watson  and  Higgins,  2016).  The  response  to  these  
stimuli  is  mediated  through  the  ERK  and  p38MAP  kinase  pathways  with  MSK1/2  as  
the  effector  kinases  that  phosphorylate  histone  H3S10,  thereby  contributing  to  the  
induction   of   certain   immediate-­‐early  genes   (Thomson  et   al.,   1999;   Soloaga  et   al.,  
2003).   Tissue   necrosis   factor   a   (TNFa)   also   stimulates   IKKa   catalysed  




et  al.,  2003;  Yamamoto  et  al.,  2003).  Furthermore,  the  serine/threonine  kinase  PIM1  
phosphorylates  H3S10  at  MYC  binding  sites  upon  growth  factor  stimulation  and   is  
important  for  MYC  dependent  transcriptional  activation  (Zippo  et  al.,  2007).    
  
The   exact   function   of   the   Aurora   B-­‐catalysed   H3S10ph   foci   in   G2   cells   is  
unclear.  However,  the  emergence  of  H3S10ph  differs  between  cell  types  and  the  later  
that  H3S10ph  foci  emerge  in  interphase,  i.e.  closer  to  the  G2/M  transition,  the  more  
likely  chromosome  segregation  errors  are  to  occur  during  mitosis  (Hayashi-­‐Takanaka  
et  al.,  2009).  Moreover,   the  role  of  the  prominent  H3S10ph  chromatin   labelling   in  
mitotic  cells  is  controversial.  H3S10ph  is  often  linked  to  chromosome  condensation,  
as  already  early  studies  described  a  correlation  between  histone  H3  phosphorylation  
and  chromosome  condensation,  suggesting  a  histone  H3  phosphorylation  mediated  
chromosome  condensation  model  (Gurley  et  al.,  1974,  1978).  It  is  without  a  doubt  
that   chromosome   condensation   is   accompanied   by   a   strong   histone   H3  
phosphorylation  in  mitosis.  However,  various  studies  did  not  find  a  role  of  H3S10ph  
in   chromosome   condensation.   In   vitro   experiments   imply   that   phosphorylation   of  
histone  H3S10   is  not   important   for  chromosome  condensation  (De  La  Barre  et  al.,  
2001).  Additionally,  in  vivo  studies  preventing  H3S10  phosphorylation  by  perturbing  
Aurora  B  activity  either  through  depletion  of  INCENP  or  the  use  of  specific  Aurora  B  
inhibitors   suggest   that   a   lack   of   H3S10ph   has   no   dramatic   effect   on   mitotic  
chromosome  condensation  (Adams  et  al.,  2001;  Ditchfield  et  al.,  2003;  Hauf  et  al.,  
2003;  Xu  et  al.,  2009).  Two  studies  focusing  on  genetic  alteration  of  the  histone  H3  
sequence   provide   the   strongest   evidence   for   an   actual   role   of   H3S10ph   in  
chromosome  condensation.  Wei  and  colleagues  studied  chromosome  condensation  
in  the  model  organism  Tetrahymena,  using  a  mutant  histone  H3  gene  that  codes  for  
an   alanine   residue   at   position   10   instead   of   serine   (S10A).   This   caused   improper  
chromosome   segregation   and   defects   in   chromosome   condensation,   particularly  
evident  during  meiotic  chromosome  condensation  (Wei  et  al.,  1999).  Another  study  
that   suggested   a   contribution   of   H3S10ph   to   chromosome   condensation   used   a  




and  subsequently  analysing  anaphase  hypercondensation  of  an  artificially  generated  
extra-­‐long  chromosome  arm  (Neurohr  et  al.,  2011).    
An   alternative   proposed   function   for   H3S10ph   is   as   a   molecular   switch.  
Adjacent  to  the  serine  10  residue  on  histone  H3  is  a  lysine  residue  localised  at  position  
9   that   is   usually   di-­‐   or   tri-­‐methylated   (H3K9me2/3)   in   heterochromatin   regions.  
Various   proteins,   which   are   typically   linked   to   heterochromatin,   recognise   the  
H3K9me2/3  mark,  with  HP1  being  the  most  widely  studied  example  (Yun  et  al.,  2011).  
Phosphorylation  of  the  adjacent  H3S10  appears  to  disrupt  the  binding  site  provided  
by  methylated  H3K9.  Specific  antibodies  that  recognise  simultaneously  the  presence  
of  the  dual-­‐mark  H3K9me2/3  +  H3S10ph  revealed  the  role  of  H3S10ph  in  HP1  release  
from  chromatin,  emphasising   that   the  H3K9me2/3  mark   is   still   present  upon  HP1  
release   (Fischle  et  al.,   2005;  Hirota  et  al.,   2005).  The   concept  of   the  methyl/phos  
switch  applies  not  only  to  H3K9/H3S10,  but  several  other  methylated  lysine  residues  
on   histone   tails   exist   in   the   direct   vicinity   of   phosphorylatable   residues,   such   as  
H3K27/H3S28   and  H3T3/H3K4,   and   presumably   also   undergo  methyl/phos   switch  




1.8   Chromatin  states  and  heterochromatin  protein  1  
  
1.8.1   Euchromatin  and  heterochromatin    
The   genetic  material   in   the   nucleus   can   be   classified   into   the   two   general  
categories:   euchromatin   and   heterochromatin.   This   classification   was   originally  
described  by  Emil  Heitz  based  on  cytological  observations  of  darker  heterochromatin  
staining,   and   therefore,   indicating   greater   compaction,   whereas   brighter   regions  
represent   euchromatin.   (Heitz,   1929;   Jost   et   al.,   2012).   The   distinction   of  
euchromatin   and   heterochromatin   still   applies   today,   but   the   states   are   defined  
molecularly,  mainly  based  on  specific  histone  modifications.    
Euchromatin   is   also   termed   “open-­‐chromatin”   and   encompasses  
chromosome   regions   that   are   gene-­‐rich   and   actively   transcribed.   Histone  
acetylations  are  typically  found  in  euchromatin  and  are  associated  with  chromatin  
accessibility   (Hebbes   et   al.,   1988;   Shogren-­‐Knaak   et   al.,   2006).   By   contrast,  
heterochromatin   describes   the   “closed-­‐chromatin”   state   and   covers  mainly   gene-­‐
poor   regions   that   are   transcriptionally   repressed.   An   important   feature   of  
heterochromatin  is  a  lack  of  histone  acetylation,  due  to  histone  deacetylase  (HDAC)  
activity,  which  was  demonstrated  by  HDAC  inhibition  experiments  (Neill  and  Turner,  
1995;  Taddei  et  al.,  2001;  Toth  et  al.,  2004).  In  addition  to  the  absence  of  histone  
acetylation,   the   presence   of   tri-­‐methylation   of   histone   H3K9   and   H4K20   defines  
heterochromatic   regions.   These   histone   marks   are   typically   present   in   highly  
repetitive  genome  regions,  such  as  the  satellite  repeats  of  pericentromeric  regions  
and  the  telomeres,  or  retrotransposons  and  endogenous  retroviruses,  which  bear  a  
risk  of  self-­‐amplification.  It  is  thought  that  transcriptional  repression  is  important  to  
keep  genome  integrity  and  is  achieved  through  heterochromatin  that  makes  these  
regions   inaccessible   to   the   transcription   machinery.   This   so-­‐called   constitutive  
heterochromatin  is  present  in  all  cell  lineages  and  phases  of  the  cell  cycle  (Becker  et  
al.,  2016).  In  contrast,  facultative  heterochromatin  is  cell-­‐type  specific  and  depends  
on  the  histone  mark  tri-­‐methylated  H3K27  and  the  Polycomb  repressive  complexes  




extensively  reviewed   in  the   literature,   for  example  by  (Simon  and  Kingston,  2009;  
Aloia   et   al.,   2013),   but   due   to   the   focus   of   this   work,   I   limit   this   introduction   to  
constitutive  heterochromatin.    
Histone  H3K9  methyltransferases  of   the  Suv39   family,   together  with  HDAC  
activity,  are  necessary  to  initiate  and  maintain  constitutive  heterochromatin  (Wang  
et   al.,   2016).   HP1   binds   methylated   H3K9   and   recruits   further   heterochromatin  
factors,  such  as  DNA  methyltransferases  and  the  histone  methyltransferase  Suv4-­‐20h  
that  catalyses  the  methylation  of  histone  H4K20  (Fuks  et  al.,  2003;  Hahn  et  al.,  2013).  
Additionally,   HP1   secures   its   own   recruitment   to   heterochromatin   by   binding   the  
methyltransferase  Suv39h1,  which  creates  the  HP1  binding  site  methylated  histone  
H3K9   in   an   amplification   loop   (Yamamoto   and   Sonoda,   2003).   Overall,   HP1   is   an  
important  chromatin  mark  reader  that  is  able  to  recruit  various  proteins  responsible  
for  heterochromatin  fidelity.    
  
1.8.2   Heterochromatin  protein  1  
HP1   is   a   crucial   component   of   heterochromatin   and   has   three   isoforms   in  
mammals,  called  HP1a,  HP1b,  and  HP1g  (Singh  et  al.,  1991;  Saunders  et  al.,  1993).  
The  three  isoforms  have  similar  sequences,  but  various  studies  describe  differences  
in   their   localisations   and   functions.   For   example,   HP1g   localises   besides   to  
heterochromatin   also   to   euchromatic   regions,   which   is   associated   with   the  
phosphorylation  of  the  HP1g   residue  serine  83.   (Minc  et  al.,  2000;  Lomberk  et  al.,  
2006).  Furthermore,  the  localisation  of  HP1g  to  heterochromatin  foci  appears  to  be  
lost  upon  HP1a  and  HP1b  depletion  (Dialynas  et  al.,  2007).  On  the  contrary,  HP1a  
and   HP1g   seem   to   preferentially   interact   with   Suv39h1   in   heterochromatin   foci  
compared   to   HP1b,   suggesting   similarities   between   HP1a   and   HP1g   in   terms   of  
binding  partner   interactions  (Bosch-­‐Presegué  et  al.,  2017).  Additionally,  HP1a  and  
HP1g  appear  to  have  redundant  roles  in  protecting  sister  chromatid  cohesion  (Yi  et  
al.,  2018).  
To   dissect   the   function   of   the   individual  HP1   isoforms   in   heterochromatin  




embryonic  fibroblasts  (Bosch-­‐Presegué  et  al.,  2017).  Bosch-­‐Presegué  and  colleagues  
reported  that  a  KO  of  HP1a  leads  to  an  increase  of  the  histone  marks  H4K20me3  and  
H3K27me3   in   pericentromeric   heterochromatin   compared   to   HP1b   or   HP1g  
depletion.  Furthermore,  Suv4-­‐20h2  interacts  preferentially  with  HP1b  and  chromatin  
containing  HP1b  is  enriched  in  the  histone  H4K20me3  mark,  compared  to  HP1a  or  
HP1g  containing  chromatin.    
The   individual   depletion   of   the   HP1   isoforms   results   in   different   defects  
affecting  genome  stability.  While  HP1a  KO  leads  to  an  increased  frequency  of  syntelic  
and  merotelic  attachments,  the  KO  of  HP1b  results  in  an  increased  number  of  cells  
with  multipolar   spindles.   Interestingly,  HP1g   depletion   results   in   a  mixture   of   the  
defects  found  in  HP1a  or  HP1b  KO  cells  and  Bosch-­‐Presegué  et  al.  conclude  that  HP1g  
shares  redundant  functions  with  the  two  other  HP1  isoforms  (Bosch-­‐Presegué  et  al.,  
2017).    
Overall,   small   differences   in   the   sequence   and   post   translational  
modifications  of  the  individual  HP1  isoforms  seem  to  have  an  influence  on  function  
and  localisation.  This  led  to  the  comparison  of  the  HP1  isoforms  to  histone  variants,  
which  have  a  high  degree  of  sequence  similarity,  but  fulfil  different  functions  (Canzio  
et  al.,  2014).    
  
Despite  the  described  differences  among  the  HP1  paralogues,  work  focusing  
on  heterochromatin  formation  through  nucleosome  binding  of  HP1  did  not  describe  
a   difference   between   the   three   HP1   isoforms   (Machida   et   al.,   2018).   This   recent  
study,   using   cryo-­‐electron   microscopy,   revealed   the   structure   how   HP1   binds  
H3K9me3   of   two   neighbouring   nucleosomes.   HP1   forms   a   symmetric   dimer   and  
bridges  two  nucleosomes  without  directly  interacting  with  the  linker  DNA  (Machida  
et  al.,  2018).  Earlier  studies  demonstrated  that  HP1  binds  nucleosomes  at  histone  
H3K9me2/3  via  an  N-­‐terminal  chromo  domain  (CD)  (Bannister  et  al.,  2001;  Lachner  
et   al.,   2001;  Nakayama  et   al.,   2001).   Additionally,  methylated   lysine   26   on   linker  





The   C-­‐terminal   chromo   shadow   domain   (CSD)   is   responsible   for   HP1  
dimerisation  and  interaction  with  HP1  binding  proteins  that  characteristically  contain  
a   PxVxL/I   motif   (Aasland   and   Stewart,   1995;   Brasher   et   al.,   2000;   Smothers   and  
Henikoff,  2000;  Nozawa  et  al.,  2010).  Additionally,  it  was  shown  that  murine  HP1a,  
HP1b  and,  HP1g  can  heterodimerise  in  vitro  and  in  vivo  (Nielsen  et  al.,  2001).    
In   a   detailed   study   of   HP1   binding   partners,   Nozawa   and   colleagues  
performed  a  proteomic  analysis  using  various  HP1a  deletion  mutants  and  amino  acid  
residue  substitutions  that  perturb  specific  HP1  functions  (Nozawa  et  al.,  2010).  The  
approach  of  HP1  immunoprecipitation  and  subsequent  mass  spectrometry  revealed  
82   HP1   binding   partners   in   total,   of   which   85   %   depended   on   CSD   interaction.  
Importantly,   the   CPC   members   borealin,   INCENP,   and   Aurora   B   were   identified,  
further  confirming  an  interaction  of  HP1  with  the  CPC  (Nozawa  et  al.,  2010).    
In  interphase  nuclei,  HP1  typically  localises  to  heterochromatin  foci  that  are  
enriched  in  the  H3K9me2/3  mark  (Lachner  et  al.,  2001).  Recent  studies  reported  that  
HP1a   contributes   to   heterochromatin   formation   through   its   phase   separation  
properties,   allowing   liquid-­‐like   fusion   of   heterochromatin   domains   (Larson   et   al.,  
2017;   Strom   et   al.,   2017).   Additionally,   co-­‐localisation   of   HP1a   and   HP1g   with  
promyelocytic  leukemia  (PML)  nuclear  bodies  was  described,  however,  the  functional  
relevance  remains  unclear  (Seeler  et  al.,  1998;  Hayakawa  et  al.,  2003).    
Upon  mitotic  entry,  a  clear  displacement  of  HP1  from  chromatin  occurs.  Two  
separate   studies   reported   that   phosphorylation   of   the   adjacent   serine   10   residue  
disrupts  HP1  binding  to  H3K9me2/3  (Fischle  et  al.,  2005;  Hirota  et  al.,  2005).  In  vitro  
experiments  demonstrated  a  clear  decrease  in  HP1  binding  affinity  for  H3K9me2/3  if  
the  H3S10ph  mark  is  present  (Fischle  et  al.,  2005).  Furthermore,  inhibition  of  Aurora  
B,  resulting  in  a  lack  of  H3S10ph,  results  in  HP1  retention  all  over  chromosomes  in  
mitosis  (Fischle  et  al.,  2005;  Hirota  et  al.,  2005;  Nozawa  et  al.,  2010).  Interestingly,  
the   potential   HP1   binding   site   methylated   histone   H1.4K26   undergoes   a   similar  
methyl/phos   switch   regulation   through  phosphorylation  of   the  adjacent   serine  27  




Despite  the  displacement  of  HP1  from  chromatin  by  the  methyl/phos  switch,  
a  small  fraction  of  HP1  can  be  found  at  mitotic  centromeres.  In  contrast  to  interphase  
chromatin  binding,  the  inner  centromere  localisation  of  HP1  during  mitosis  depends  
on  the  CSD  rather  than  the  CD  (Hayakawa  et  al.,  2003).  This  suggests  that  a  binding  
partner   recruits   HP1   to   mitotic   centromeres.   Indeed,   Kang   and   colleagues  
demonstrated  by  use  of  an  INCENP  deletion  mutant,  lacking  the  PxVxL/I  motif,  that  
HP1   recruitment   to  mitotic   centromeres  depends  on   the   interaction  with   INCENP  
(Kang  et  al.,  2011).    
Importantly,   recent   work   revealed   that   the   HP1   binding   to   the   CPC   is  
necessary  for  full  Aurora  B  activity  in  mitosis  (Abe  et  al.,  2016).  Abe  and  colleagues  
observed   reduced   levels   of   HP1   at   mitotic   centromeres   in   cancer-­‐derived   cells,  
compared  to  non-­‐transformed  cell   lines,  due  to  a  reduced  association  of  HP1  with  
INCENP  in  the  cancer-­‐derived  cells.  Furthermore,  in  vitro  assays  revealed  that  Aurora  
B  catalyses  substrate  phosphorylation  with  a  higher  efficiency  in  the  presence  of  HP1  
than  in  its  absence,  which  is  mainly  achieved  through  an  increased  reaction  rate  and  
only   to   a   lesser   extent   by   increased   substrate   affinity   (Abe   et   al.,   2016).   The  
decreased  levels  of  HP1-­‐bound  CPC  in  cancer-­‐derived  cells  result  in  impaired  Aurora  
B  activity,  demonstrated  by  decreased  levels  of  phosphorylated  Dsn1  compared  to  
non-­‐transformed  cells.  Additionally,  disrupting  the  HP1-­‐INCENP  interaction  in  non-­‐
transformed   cells   leads   to   a   reduction   of   Aurora   B   activity   and   increased   the  
frequency   of   chromosome   segregation   errors.   However,   the   reverse   experiment,  
namely  to  reduce  the  frequency  of  chromosome  mis-­‐segregation  in  cancer-­‐derived  
cells  by  increasing  the  general  HP1a  level,  was  not  successful.  HP1α  overexpression  
in  cancer-­‐derived  cells  that  have  reduced  levels  of  HP1  at  mitotic  centromeres  does  
not  result  in  an  overall  increased  amount  of  HP1  bound  CPC  and,  importantly,  does  




1.9   Aims  of  this  work  
In  this  project,  I  examined  whether  centromeric  HP1  has  a  positive  effect  on  
the   frequency   of   chromosome   segregation   errors.   As   described   above,   a   simple  
overexpression  of  HP1a  has  no  positive  effect  on  chromosome  mis-­‐segregation  rates  
in  cells  with  a  decreased  level  of  centromeric  HP1.  Therefore,  I  chose  an  approach  to  
actively  tether  HP1a  to  centromeres  and  used  for  this  a  simplified  system  in  which  
HP1a  localisation  does  not  depend  on  chromatin  marks,  but  is  rather  determined  by  
the  DNA-­‐binding  domain  of  CENP-­‐B.  Furthermore,  based  on  recent  work  suggesting  
that  HP1  is  an  essential  CPC  component  (Abe  et  al.,  2016),  I  examined  the  interaction  
between  HP1   and   the   CPC   and   focused   on   the   role   of  HP1   in   CPC   clustering   and  




2   Materials  and  Methods  
  
2.1   Solutions,  buffers  and  reagents  
  
All  listed  buffers  and  solutions  were  prepared  with  double-­‐distilled  water  and  
chemicals  from  Sigma-­‐Aldrich  unless  otherwise  stated.    
  
Table  1  –  General  solutions  and  buffers  
Name   Composition  
2x  Laemmli  sample  
buffer    
120  mM  Tris-­‐HCl  pH  6.8,  4%  SDS,  20%  Glycerol;    
1x  reducing  SB:  100  µl  2x  SB,  90  µl  ddH2O,  10  µl  2-­‐
Mercaptoethanol  
1x   reducing   sample  
buffer  
100  µl  2x  sample  buffer,  10  µl  2-­‐Mercaptoethanol,  90  µl  ddH2O  
SDS   Electrophoresis  
buffer  
25  mM  Tris,  192  mM  glycine,  0.1%  SDS;  (pH  8.8)  
Transfer  Buffer   25  mM  Tris,  192  mM  glycine,  0.1%  SDS,  20%  methanol;   (pH  
8.8)  
TAE   40  mM  Tris-­‐acetate,  1  mM  EDTA;  (pH  8.0)  
PBS     137  mM  NaCl,  2.7  mM  KCl,  10  mM  Na2HPO4,  2mM  KH2PO4  
PHEM   60mM  PIPES,  25mM  HEPES,  10mM  EGTA,  2mM  MgCl2  
Lower  gel  buffer     1.5  M  Tris-­‐HCl;  (pH  8.8)  
Upper  gel  buffer     0.5  M  Tris-­‐HCl;  (pH  6.8)  
LB   1%  tryptone,  0.5%  yeast  extract,  10mM  NaCl;  (pH  7.4)  
Lysis  buffer   10mM  Tris  (pH  7.0),  100mM  EDTA,  0.5%  SDS  
TE   10  mM  Tris,  1mM  EDTA;  (pH  8.0)  
  
Table  2  -­‐  Drugs  
Drug   Diluent   Used  Concentration   Source  
ZM447439     DMSO   indicated   Tocris  Bioscience    
RO-­‐3306     DMSO   9  µM   Tocris  Bioscience    





2.2   Oligonucleotides  
  
All  oligonucleotides  were  purchased   from  Sigma-­‐Aldrich  and   resuspended   in  
double-­‐distilled  water.  
  
Table  3  -­‐  Oligonucleotides  used  for  cloning  and  sequencing  
Description   Sequence  (5’  –  3’)  
Cloning     
HP1a_Fwd   CACCATGGGAAAGAAAACCAAGCGGACAGC  
HP1a_Rev   GCTCTTTGCTGTTTCTTTCTCTTTGTTTTCC    
HP1_Stop-­‐codon_Fwd   GGTCGGCGCGCGCACCCTAGCTCTTTGCTG    
HP1_Stop-­‐codon_Rev   CAGCAAAGAGCTAGGGTGCGCGCGCCGACC    
HP1_V22M_Fwd     AGAGGATGAGGAGGAGTATGTTATGGAGAAGGTGC    
HP1_V22M_Rev     GCACCTTCTCCATAACATACTCCTCCTCATCCTCT    
HP1_I165E_Fwd     GCTAATGTGAAATGTCCACAAATTGTGGAGGCATTTTATGAA
GAGAGACTGACATGG    
HP1_  I165E_Rev     CCATGTCAGTCTCTCTTCATAAAATGCCTCCACAATTTGTGGAC
ATTTCACATTAGC    




CDK1_Fwd   GCCGTGGGAGGATCCCCTGAGCCCAGGAGG  
CDK1_Rev   GTGCGGCATTCTCAACTACCAAAAATAGGG  
Sequencing     
T7  Promoter     TAATACGACTCACTATAGGG  
tYIP_SEQ2     CTCTGGCTAACTAGAGAACCC    
tYIP_SEQ4     CTGGAGTACAACTACAACAGCC    
  
Table  4  -­‐  siRNA  oligonucleotides  
Description   Sequence   Reference  
Mad2   ACCUUUACUCGAGUGCAGATTdTdT     (Nitta  et  al.,  2004)  





2.3   Commercial  kits  
  
Table  5  -­‐  Commercial  kits  
Description  (catalogue  number)   Manufacturer  
QIAfilter  Plasmid  Midi  Kit  (12243)   Qiagen  
QIAprep  Spin  Miniprep  Kit  (27106)     Qiagen  
QIAquick  Gel  Extraction  Kit  (28704)     Qiagen    
QIAquick  PCR  Purification  Kit  (28104)     Qiagen  
QuikChange  II  kit  (200523)   Stratagene  
Neon  Transfection  System  100  µL  Kit  (MPK10096)   Thermo  Fisher  Scientific  
Zero  Blunt  TOPO  PCR  Cloning  Kit  (K280020)   Thermo  Fisher  Scientific  
Quick  Ligation  Kit  (M2200S)     New  England  Biolabs  
BigDye  Terminator  v3.1  Cycle  sequencing  Kit  (4337455)   Applied  Biosystems  
  
  
2.4   Molecular  biology  techniques  
  
2.4.1   Restriction  digestion  of  DNA  plasmids  and  fragments  
  
All   plasmid   DNA   or   DNA   fragments   synthesised   by   GeneArt   (Thermo   Fisher  
Scientific)  were  digested  with  appropriate  endonuclease   restriction  enzymes   from  
New  England  Biolabs.  A  typical  50  µl  reaction  contained  the  desired  amount  of  DNA,  
10  units  of  the  relevant  endonuclease  per  µg  of  DNA,  and  the  recommended  reaction  
buffer.  The  digestion  was  performed  for  two  hours  at  the  appropriate  temperature.  
When  required,  the  re-­‐ligation  of  the  digested  plasmids  was  limited  by  removal  of  
the  5’  phosphate  group  using  Calf  Intestine  Phosphatase  (CIP)  (New  England  Biolabs)  
after  restriction  digestion.  One  unit  of  CIP  was  used  per  µg  of  DNA  and  incubated  for  
30   min   at   37   °C.   Digested   plasmids   were   recovered   and   purified   by   agarose   gel  
electrophoresis,  whereas  digested  GeneArt  DNA  fragments  were  purified  using  the  




2.4.2   Agarose  gel  electrophoresis  and  purification  of  DNA  
A   gel   solution   containing   between   1%   and   2%   agarose   (Sigma-­‐Aldrich)   was  
prepared  with   TAE   buffer   and   0.5   µg/ml   ethidium   bromide   (Sigma-­‐Aldrich).   DNA  
samples  in  a  final  1x  dilution  of  6x  gel  loading  dye  (New  England  Biolabs)  were  loaded  
on  the  gel  and  gel  electrophoresis  was  performed  in  TAE  buffer  at  a  constant  voltage  
of  100  V.  DNA  fragments  were  visualised  under  UV  light  and  excised  from  the  agarose  
gel.  Purification  of  the  desired  DNA  fragment  was  performed  using  the  QIAquick  gel  
extraction  kit  (Qiagen)  according  to  the  manufacturer’s  instructions.    
  
2.4.3   DNA  ligation    
The  ligation  of  DNA  fragments  was  performed  using  the  Quick  Ligation  kit  (New  
England  Biolabs).  A  reaction  volume  of  20  µl  contained  10  µl  2x  Quick  Ligase  reaction  
buffer  and  a  molar  ratio  of  1:3  (vector  to  insert)  was  used.  1  µl  of  the  Quick  Ligase  
was  added  last  and  the  reaction  incubated  at  room  temperature  for  5  min.  The  entire  
reaction  volume  was  used  for  transformation  of  competent  E.  coli.    
  
2.4.4   Transformation  
Chemically  competent  TOP10  E.  coli  cells  were  thawed  on  ice  and  50  –  100  µl  
were  mixed  with  the  freshly  ligated  plasmid  DNA.  After  30  min  incubation  on  ice,  the  
cells  were  heat-­‐shocked  for  90  seconds  at  42  °C  and  allowed  to  recover  for  2  min  on  
ice.  Next,  500  µl  LB  medium  was  added  to  the  cells,  followed  by  an  incubation  at  37  
°C  for  1  hour.  Cells  were  plated  onto  LB-­‐agar  plates  containing  100  µg/ml  ampicillin  
and  plates  were  incubated  at  37  °C  over-­‐night.  
  
2.4.5   Recovery  of  plasmid  DNA  from  E.  Coli  
LB  medium   supplemented  with   the   appropriate   antibiotic   at   concentrations  
described   above   were   inoculated   with   a   single   colony   from   an   LB-­‐agar   plate.  
Depending  on  the  volume  of  the  bacterial  over-­‐night  culture,  either  the  Qiagen  mini-­‐




~  50  ml  bacterial  culture)  was  used  according  to  the  manufacturer’s  instructions.  If  
the  plasmid  DNA  was  used   for   transfection  of  mammalian  cells,   a   step  of  30  min  
incubation  with  endotoxin  removal  buffer  (Qiagen)  was  included  into  the  process  of  
plasmid  DNA  isolation,  as  advised  by  the  manufacturer.    
  
2.4.6   Sequencing  of  plasmids  
Plasmids  were  sequenced  based  on  the  Sanger  dideoxynucleotide  method.  The  
BigDye  Terminator  v3.1  Cycle  sequencing  Kit  (Applied  Biosystems)  was  used  and  a  10  
µl   reaction   contained:   ~   200   ng   plasmid  DNA  prepared  with   a  mini-­‐prep   kit,   4   µl  
BigDye  mix,  2  µl  of  5  µM  primer.    
After  an  initial  denaturation  for  two  minutes  at  96  °C,  a  cycle  with  the  following  
parameters   was   repeated   25x:   30   seconds   denaturation   at   96   °C,   15   seconds  
annealing  at  50  °C  and  four  minutes  extension  at  60  °C.  The  subsequent  sequencing  
steps  were  performed  at  the  Edinburgh  Genomics  Facility  (University  of  Edinburgh,  
King’s  Buildings)  and  the  resulting  sequencing  files  were  analysed  using  the  Lasergene  
software  or  the  Benchling  online  platform.  
  
2.4.7   Genomic  DNA  extraction  
Cells  were  harvested  and  lysed  in  1  ml  lysis  buffer  (see  Table  1)  per  5  x  106  cells.  
RNase  A  was  added  (20  µg/ml  final  concentration)  and   lysates  were   incubated  for  
two  hours   at   37   °C.   Proteinase   K  was   added   (100  µg/ml   final   concentration)   and  
lysates  were  incubated  over-­‐night  at  37  °C.  The  genomic  DNA  was  isolated  following  
a  standard  phenol/chloroform  extraction  procedure,  precipitated  with  ethanol,  and  
resuspended  in  TE  buffer  (see  Table  1).  Purity  and  concentration  of  the  genomic  DNA  





2.4.8   PCR  to  amplify  the  CRISPR/Cas9  target  site  in  the  CDK1  gene  
To  characterise  the  CRISPR/Cas9  cut  site,  the  sequence  within  the  CDK1  gene  
was   amplified   using   PCR.   This   was   performed   with   Phusion   High-­‐Fidelity   DNA  
Polymerase,   suitable   primer   (see   Table   3),   and   the   genomic   DNA   as   a   reaction  
template.  The  PCR  reactions  were  prepared  in  a  total  volume  of  50  µl  and  contained  
200  µM  of  each  dNTP,  500  nM  of  forward  and  reverse  primer,  250  ng  genomic  DNA  
and  0.5  µl  of  Phusion  polymerase  in  1x  dilution  of  the  provided  reaction  buffer.  After  
an  initial  denaturation  for  30  seconds  at  98  °C,  30  cycles  of  following  parameters  were  
performed:  10  seconds  denaturation  at  98  °C  and  60  seconds  extension  at  72  °C.  A  
final  extension  was  performed  for  10  minutes  at  72  °C.  Yield  and  specificity  of  the  PCR  
reaction  was   determined   by   agarose   gel   electrophoresis   and   the   desired   500   bp  
fragment  was  excised  from  the  agarose  gel  and  purified.  Next,  the  DNA  fragment  was  
cloned  into  the  pCRII-­‐Blunt-­‐TOPO  vector  (Thermo  Fisher  Scientific)  according  to  the  
manufacturer’s  instructions.  This  allowed  the  sequencing  of  the  PCR  fragment  using  
a  standard  T7  promoter  primer  (see  Table  3).    
  
  
2.4.9   Generation  of  expression  constructs  
  
CENP-­‐BDBD-­‐EYFP-­‐HP1a  
The  initial  vector  expressing  the  CENP-­‐BDBD-­‐EYFP-­‐HP1a  construct  was  cloned  by  
Oscar  Molina,  Nuno  M.  C.  Martins  and  Stephen  Barrass.  The  sequence  coding  for  the  
DNA-­‐binding  domain  (DBD)  of  human  CENP-­‐B  (aa  1–159)  was  codon-­‐optimised  for  
expression  in  human  cell  lines  and  synthesised  by  GeneArt  (Thermo  Fisher  Scientific).  
The  synthesised  DNA  was  cloned  into  the  NheI  and  AgeI  restrictions  sites  of  the  pYIP-­‐
EYFP  vector,  containing  attL  and  attR  sites  for  Gateway  cloning.  The  HP1α  sequence  
was  amplified  from  a  HeLa  cells  cDNA  library  using  the  primers  described  in  Table  3.  
The  DNA   fragment   corresponding   to  HP1α  was  cloned   into   the  pENTR  vector  and  
Gateway   cloning   was   performed   according   to   the   manufacturer’s   instructions  




under   a   CMV   promoter.   This   construct   was   lacking   a   stop   codon   after   the   HP1α  
sequence,  allowing  the  fusion  of  additional  proteins  to  the  tethering  construct.  For  
the  final  vector,  I   introduced  a  stop  codon  after  the  codon  coding  for  serine191  of  
HP1α   by   performing   site-­‐directed   mutagenesis   using   the   QuikChange   II   kit  
(Stratagene)  (see  Table  3  for  the  used  oligonucleotides).  
  
CENP-­‐BDBD-­‐mut-­‐EYFP-­‐HP1a  
To   generate   the   vector   expressing   CENP-­‐BDBD-­‐mut-­‐EYFP-­‐HP1α,   the   DNA  
fragment  corresponding  to  the  human  CENP-­‐B  DNA-­‐binding  domain  (1–159aa),  but  
coding   for   the   substitutions   S40A,   N120A,   R125A,   was   synthesised   by   GeneArt  
(Thermo  Fisher  Scientific)  and  cloned  into  the  NheI  and  AgeI  restriction  sites  of  the  
pYIP  CENP-­‐BDBD-­‐EYFP-­‐HP1a  vector,   replacing  the  sequence  of  the  wildtype  CENP-­‐B  
DNA-­‐binding  domain.    
  
EYFP-­‐HP1a  
To   generate   the   vector   expressing   EYFP-­‐HP1α,   the   CENP-­‐BDBD-­‐EYFP-­‐HP1a  
vector  was   digested  with   ClaI   and  AgeI,  which   removed   the   CENP-­‐B  DNA-­‐binding  
domain   sequence   between   those   restriction   sites.   The   single   stranded   DNA   ends  
were   blunted   by   using   1   unit   of   T4   DNA   polymerase   (New   England   Biolabs)   and  
500  µM  of  each  dNTP.  The  reaction  was  incubated  for  10  minutes  at  12  °C  prior  to  
heat  inactivation  for  10  minutes  at  75  °C,  followed  by  the  above-­‐described  ligation  
protocol.    
  
HP1  mutations  in  the  CENP-­‐BDBD-­‐EYFP-­‐HP1a  vector  
The   three   HP1α   mutants   CENP-­‐BDBD-­‐EYFP-­‐HP1aV22M,   CENP-­‐BDBD-­‐EYFP-­‐
HP1aI165E,   and   CENP-­‐BDBD-­‐EYFP-­‐HP1aW174A   were   generated   using   site-­‐directed  
mutagenesis.   The   oligonucleotides   described   in   Table   3   were   used   with   the  




2.5     Immunoblotting  
Whole-­‐cell  lysates  were  prepared  from  HeLa  cells  that  were  transfected  either  
with  the  indicated  siRNAs  or  the  indicated  constructs  24  h  before  harvesting.  Cells  
were   lysed   in  reducing  sample  buffer   (see  Table  1),  boiled  at  95  °C   for  5  min  and  
sonicated  for  20  min  (settings:  30  s  on,  30  s  off,  high  intensity)  using  the  Bioruptor  
sonication   device   (Diagenode).   Proteins   were   resolved   using   sodium   dodecyl  
sulphate  polyacrylamide  gel  electrophoresis   (SDS-­‐PAGE).  Polyacrylamide  gels  were  
prepared   using   a   30%   acrylamide/bis-­‐acrylamide   solution   (Ratio   37.5:1)   (Severn  
Biotech)  and  the  upper  or  lower  gel  solutions  (see  Table  1).    
After  proteins  were  transferred  to  a  nitrocellulose  membrane  (GE  Healthcare)  
in  transfer  buffer  (see  Table  1),  the  membrane  was  blocked  with  5  %  (w/v)  milk  in  
PBS   with   0.05%   Tween20   (VWR)   (PBS-­‐Tween)   or   with   SuperBlock   (PBS)   blocking  
buffer   (Thermo   Fisher   Scientific)   for   1   hour   and   subsequently   incubated  with   the  
appropriate  primary  antibodies   (Table  6).  The  membrane  was  washed  three  times  
with  PBS-­‐Tween  for  5  min  and  incubated  with  the  appropriate  secondary  antibodies  
(Table  7)   for  45  min.  When  determining   the   fluorescence   intensities  by  using   the  
imaging   systems   Odyssey   or   Odyssey   CLx   (LI-­‐COR   Biosciences),   two   PBS-­‐Tween  
washes  and  a  final  PBS  wash  were  performed  before  detection.  When  determining  
the  HRP   activity   after   incubation  with   ECL   substrate   (Thermo   Fisher   Scientific)   by  
using   the   ChemiDoc  MP   imaging   system   (BioRad),   three   PBS-­‐Tween  washes  were  




Table  6  –  Primary  antibodies  -­‐  Immunoblotting  
Antibody   Dilution   Source   Lot  no.  
HP1a   1:750   Merck  Millipore;  15.19s2  05-­‐689   2908595  
GAPDH   1:2,500   Abcam;  ab9485     
a-­‐tubulin   1:3,000   Sigma-­‐Aldrich;  B512     
Mad2   1:5,000   Bethyl;  A300-­‐301A   2  
GFP   1:1,500   Thermo  Fisher  Scientific;  A-­‐11122   1828014  




Table  7  –  Secondary  antibodies  -­‐  Immunoblotting  
Antibody   Dilution   Source  
IRDye  680rd     1:10,000   LI-­‐COR  Biosciences    
IRDye  800cw     1:10,000   LI-­‐COR  Biosciences    
ECL  horseradish  
peroxidase-­‐linked    




2.6   Cell  culture  
Cells  were  grown  in  Dulbecco’s  modified  Eagle  medium  (DMEM;  Thermo  Fisher  
Scientific)  supplemented  with  10  %  foetal  bovine  serum  (FBS),  penicillin  (100  U/ml)  
and  streptomycin  (100  µg/ml)  at  37  °C  /  5%  CO2  in  a  humidified  atmosphere.  Cells  
were   washed   with   Dulbecco’s   phosphate   buffered   saline   (DPBS;   Thermo   Fisher  
Scientific)   and   incubated   with   TrypLE   (Thermo   Fisher   Scientific)   at   37   °C   for   five  
minutes.   Cells   were   diluted  with  media   to   an   appropriate   concentration   and   the  





2.7   Transient  transfection  
Transient  transfection  for  fixed  cell  experiments  was  performed  using  jetPRIME  
according   to   the   manufacturer’s   instructions   (Polyplus   Transfection).   Cells   were  
seeded  in  12-­‐well  plates  for  indirect  immunofluorescence  experiments  or  in  6-­‐well  
plates   for   immunoblotting   experiments.   125   to   500   ng   plasmid   DNA   and,   where  
indicated,  siRNA  oligonucleotides  (50  nM  final  concentration)  were  added  to  100  µl  
of   jetPRIME  buffer.  Additionally,  125  ng  of  UltraPure  Salmon  Sperm  DNA  (Thermo  
Fisher   Scientific)   or   40   nM   of   the   21mer   oligonucleotide   CGUACGCGGAAUACUU-­‐
CGAdTdT  (Elbashir  et  al.,  2001)  was  added  to  the  transfection  mixture,  serving  as  a  
carrier  to   improve  the  transfection  efficiency  as  previously  reported  (Pradhan  and  
Gadgil,  2012).  After  vortexing,  2  µl  of  jetPRIME  were  added,  followed  by  an  additional  
vortexing  step  and  10  minutes  incubation.  The  final  mixture  was  added  dropwise  to  
the  cells.    
Transient  transfection  for  live  cell  imaging  experiments  was  performed  with  the  
Neon  transfection  system  (Thermo  Fisher  Scientific).  2  –  4  x  105  cells  were  diluted  in  
100  µl  buffer  R  of  the  Neon  transfection  kit  and  1.5  –  4  µg  of  plasmid  DNA  was  added.  
The  electroporation  parameter  used  are  described  in  Table  8.  
  
  
Table  8  –  Neon  transfection  parameter  
Cell  Line   Pulse  Voltage   Pulse  Width   Pulse  Number  
  
HeLa   1,035  V   35  ms   2  
U2OS   1,230  V   10  ms   4  
  
  
2.8     Indirect  immunofluorescence  microscopy    
Cells  were  grown  on  16  mm  polylysine-­‐coated  coverslips  in  12  well  plates.  Cells  
were  fixed  for  10  min  using  pre-­‐warmed  4%  formaldehyde  (Thermo  Fisher  Scientific)  




for  1  hour  with  10  %  donkey  serum  (Jackson   ImmunoResearch)   in  PBS.  Cells  were  
incubated  for  1  hour  with  primary  antibodies  diluted  in  PBS  with  0.05  %  Tween20  and  
5  %  donkey  serum  as  indicated  in  Table  9.  Cells  were  washed  three  times  with  PBS,  
prior  to  the  incubation  with  suitable  Alexa  Fluor  488,  594,  or  647  labelled  secondary  
antibodies   (Thermo   Fisher   Scientific).   DNA   was   stained   using   Hoechst   33342,  
coverslips  were  mounted  on  glass  slides  using  ProLong  Diamond  Antifade  (Thermo  
Fisher  Scientific)  and  cured  for  at  least  24  h  before  imaging.  For  experiments  in  which  
pre-­‐extraction  was  performed,  cells  were  incubated  for  1  min  in  pre-­‐warmed  PHEM  
buffer  with  0.1%  Triton  X-­‐100  prior  to  fixation.  In  experiments  staining  for  Dsn1ph,  
the  pre-­‐extraction  buffer  contained  1x  PhosSTOP  (Roche).    
Cold-­‐stable  microtubule   assays  were   performed   24   h   after   transfection   and  
cells  were  incubated  in  ice-­‐cold  Leibovitz’s  L-­‐15  medium  (Thermo  Fisher  Scientific)  
supplemented  with  20  mM  HEPES  for  10  minutes  on  ice.  Subsequently,  cells  were  
fixed   in   4%   formaldehyde   in   PBS   containing   0.2%   Triton   X-­‐100.   Staining   was  
performed  as  described  above.    
Imaging  of  fixed  cells  was  performed  using  the  widefield  DeltaVision  Spectris  
microscope   (Applied  Precision)  with  a  60×  NA  1.4  PlanApo  or  a   100×  NA  1.4  Plan  
Apochromat  objective.  Optical  sections  were  acquired  every  0.2  µm  with  a  CoolSNAP  
HQ  CCD  camera  (Photometrics).  Deconvolution  was  performed  using  the  softWoRx  
software   (Applied   Precision)   and   images   were   adjusted   for   display   using  






Table  9  –  Primary  antibodies  -­‐  Immunofluorescence  microscopy  
Antibody   Dilution   Source   Lot  no.  
a-­‐tubulin   1:500   Sigma-­‐Aldrich;  DM1A   074M4789V  
Aurora  B   1:600   Abcam;  ab2254   GR171000-­‐1  
Aurora  B   1:500   BD  Transduction  Laboratories;  611082       
CENP-­‐C   1:500   Earnshaw  lab.;  R554;  (Saitoh  et  al.,  1992)     
cyclin  A2     1:100   Abcam;  6E6;  ab16726   GR236737-­‐14  





Iain  Cheeseman;   (Welburn  et  al.,  2010)  
phosphorylated  Ser100/Ser109  
  
H2AT120ph   1:500   Active  Motif;  61195   31511001  
H3S10ph     1:400   Merck  Millipore;  06-­‐570;     L1003  
H3S10ph     1:500   Hiroshi  Kimura;  313     
H3T3ph     1:500   Hiroshi  Kimura;  16B2     
Hec1     1:500   Abcam;  9G3;  ab3613       GR260581-­‐30  
HP1a   1:200   Merck  Millipore;  MAB3584   2726144  
MPM2   1:400   Abcam;  ab14581     
 
2.9     Live  cell  imaging    
For  live  cell  imaging  experiments  determining  the  mitotic  timing  and  frequency  
of  abnormalities,  cells  were  grown  on  imaging  chambers  CG  with  a  glass  bottom  and  
DIC   lid   (Zell-­‐Kontakt).   The   medium   was   exchanged   to   Leibovitz’s   L-­‐15   medium  
(phenol  red  free)  with  10  %  FBS.  Live  cell   imaging  movies  were  captured  with  the  
Eclipse  Ti  wide-­‐field  microscope  (Nikon)  using  a  Plan  Apo  60×  NA  1.4  objective  and  in  
an  environmental  chamber  at  37°C.    
Optical  sections  were  collected  with  a  spacing  of  2  µm  using  the  ORCA-­‐Flash  
4.0  CMOS  camera  C11440-­‐22CU   (Hamamatsu),  with  2  ×  2  binning   to  enhance   the  
signal  intensity.  Expression  levels  of  the  HP1a  tethering  constructs  were  determined  




values  of  EYFP  were  measured   in   the   frame   in  which  NEB  occurred   by  applying  a  
region  of   interest   (ROI)   to   chromatin.  The  measured  value  was   subtracted   by   the  
mean  value  of  three  ROIs  applied  to  the  cytoplasm  of  the  same  cell.  
Values  from  300  –  1000  were  assigned  as  low  expression,  from  >  1000  –  3000  
as  medium  expression,  and  from  >  3000  to  6000  as  high  expression.  Cells  with  EYFP  
values  below  300  and  above  6000  were  excluded,  since  weak  expression  meant  that  
lagging   chromosomes   could   not   be   identified   reliably   and   very   high   expression  




2.10   Live  cell  imaging  with  labelled  Fab  fragments  
For  live  cell  imaging  experiments  with  labelled  Fab  fragments,  cells  were  grown  
in  35  mm  glass  bottom  dishes  (ibidi),  which  were  covered  with  DIC  lids  (ibidi).  Bead  
loading  of  the  Fab  fragments  (Table  10)  was  performed  as  following:    
Culture  medium  was   aspirated   and   2   µl   of   the   Fab   fragment   solution  were  
pipetted  in  the  centre  of  the  glass  part.  A  single  layer  of  glass  beads  (106  µm,  Sigma-­‐
Aldrich)   was   sprinkled   onto   the   cells.   Next,   the   dish   was   firmly   struck   ten   times  
against   the   hood   table   top   and   immediately   2   ml   of   pre-­‐warmed   antibiotic-­‐free  
medium  were  added.  Cells  were  repeatedly  washed  with  medium  to  remove  the  glass  
beads  and  left  in  Leibovitz’s  L-­‐15  medium  (phenol  red  free)  with  10  %  FBS  at  37°C  and  
5%  CO2   in  air   for  2  to  4  hours  prior  to   imaging.  Imaging  was  performed  using  the  
earlier  described  Eclipse  Ti  widefield  microscope  (Nikon)  with  either  a  Plan  Apo  100×  
NA   1.40   or   Plan   Apo   60×   NA   1.4   objective.   Movies   were   deconvolved   using  
AutoQuant  X3  (version  X3.1.2)  and  maximum  intensity  projected.    
  
Table  10  –  Fab  fragments  
Fab  Fragment   Source   Reference  
H3S10ph  (Fab313)   Hiroshi  Kimura   (Hayashi-­‐Takanaka  et  al.,  2009)  




2.11   Automated  quantification  of  histone  H3S10ph-­‐positive  G1  cells  
Fixed  cells  were  captured  using   the  Eclipse  Ti  wide-­‐field  microscope   (Nikon)  
with  a  Plan  Fluor  40×  NA  1.3  objective  and  optical   sections  were  collected  with  a  
spacing   of   0.7   µm   using   the   CMOS   camera   ORCA-­‐Flash   4.0   C11440-­‐22CU  
(Hamamatsu).   The   software   CellProfiler   (Kamentsky   et   al.,   2011)   was   used   to  
determine   the  number  of  histone  H3S10ph-­‐positive  nuclei   in   transfected  G1   cells.  
Image   stacks  were  maximum   intensity  projected  and   saved  as  TIFF   files  using   the  
CellProfiler   modules   “MakeProjection”   and   “SaveImages”.   The   quantification   was  
performed  as  following:    
In   an   initial   step,   the   modules   “IdentifyPrimaryObjects”,  
“MeasureObjectIntensity”,   “ClassifyObjects”,   and   “FilterObjects”   were   used   to  
identify   interphase  nuclei  and  to  distinguish  them  from  mitotic  cells  based  on  the  
Hoechst   33342   staining.   Next,   “MeasureObjectIntensity”,   “ClassifyObjects”,   and  
“FilterObjects”  were  used  to  identify  transfected  cells  based  on  the  EYFP  signal.  The  
modules  “MeasureObjectIntensity”,  “ClassifyObjects”,  and  “FilterObjects”  were  also  
used  to  identify  G1  cells  based  on  cyclin  A2-­‐negative  nuclei  (Alexa  647  fluorescence  
signal).  Finally,  “MeasureObjectIntensity”  and  “ClassifyObjects”  were  used  to  identify  
cells  positive  for  histone  H3S10ph  (Alexa  594  fluorescence  signal).    
	  
2.12   Automated  quantification  of  Dsn1ph  signal  
The  DeltaVision  widefield  micro  scope  (details  described  above)  were  used  to  
capture   fixed   cells   that   were   transfected.   Images   were   deconvolved   and   sum  
intensity  projected  using  the  SoftWoRx  software  (Applied  Precision).  Image  analysis  
was  performed  using  a  modified  standard  CellProfiler  pipeline.  Chromosomes  were  
identified  using  the  “IdentifyPrimaryObjects”  module  based  on  the  Hoechst  33342  
staining.   Next,   the   Hec1   signal   (Alexa   594)   was   identified   using   the  
“IdentifyPrimaryObjects”,   “EnhanceOrSuppressFeatures”,   and   “MaskImage”  
modules.   The   Hec1   segmentation   was   expanded   by   1   pixel   using   the  




overlap  with  that  of  Dsn1ph.  The  quantification  of  the  Dsn1ph  signal  (Alexa  647)  was  
performed  using  the  “MeasureObjectIntensity”  module.    
Some  of  the  analysed  cells  exhibited  Dsn1ph  intensity  values  with  up  to  600  
times  the  intensity  of  the  median.  To  ensure  that  the  results  of  the  analysis  were  not  
distorted  by  these  extreme  values,  I  applied  a  general  cut-­‐off  value  of  10  in  the  same  
way  in  all  experiments  and  repeats  and  cells  were  excluded  if  they  exhibited  values  
above  this  cut-­‐off.  This  resulted   in  the  exclusion  of   following  cell  numbers:  CB-­‐EY-­‐
HP1α:  four  cells;  CB-­‐EY-­‐HP1α  W174A:  none;  untransfected  cells:  three  cells.    
  
  
2.13   Microtubule  quantification  after  cold  treatment  
The   overall   microtubule   intensity   after   cold   treatment   was   determined  
manually   using   the   Fiji   software   (Schindelin  et   al.,   2012).   Image   stacks  were   sum  
intensity   projected   and   an   ROI  was   applied   to   the  mitotic   spindle.   The  measured  




2.14   Flow  cytometry  
Hela   cells   grown   in   6-­‐well   plates   were   transfected   with   the   appropriate  
constructs  or  left  untransfected.  24  hours  after  transfection,  the  cells  were  treated  3  
µM  ZM447439  or  an  equivalent  amount  of  DMSO  for  5  h,  harvested  and  resuspended  
in   ice-­‐cold   70%   ethanol   for   fixation.   Ethanol-­‐fixed   cells   were   washed   in   0.05%  
Tween20/PBS   containing   1%   BSA.   Indirect   immunofluorescence   staining   was  
performed  using  the  MPM2  antibody  (see  Table  9)  and  subsequently   incubated   in  
PBS  containing  5  µg/ml  Hoechst  33342  over-­‐night.  Detection  was  performed  using  an  
LSRII   flow   cytometer   (BD   Biosciences).   The   FlowJo   8.7   software   was   used   to   set  
appropriate  gates  and  the  percentage  of  cells  positive  for  the  MPM2  staining  was  




As   a   side   note,   the   mitotic   index   upon   CB-­‐EY-­‐HP1α   expression   in   this   flow  
cytometry  experiment  (Fig.  17C)  varied  from  the  mitotic  index  shown  in  Figure  5B.  
This   is  most   likely   because   of   the   different   detection  methods   used,   which  were  
fluorescence  microscopy  for  Fig.  5B  and  flow  cytometry  for  Fig.  17C.  Based  on  the  
flow  cytometry  results,  the  transfection  efficiency  was  over  99%.  However,  analysis  
by  eye,  using  a  fluorescence  microscope,  suggested  a  transfection  efficiency  of  ~  70%.  
The  difference  might  be  due  to  the  ability  of  the  flow  cytometer  to  detect  cells  with  
very   low   levels   of   expression.   This   assumption   is   supported   by   the   fact   that   an  
adjustment   of   the   gates   in   the   flow   cytometry   experiment   to   ~   70%  CB-­‐EY-­‐HP1α  
transfection   efficiency   increased   the   mitotic   index   to   10.3%   for   CB-­‐EY-­‐HP1α  
expressing  cells  treated  with  DMSO  and  was,  therefore,  more  similar  to  the  mitotic  
index   shown   in   Figure   5B.   At   the   same   time,   the   mitotic   index   of   CB-­‐EY-­‐HP1α  
expressing   cells   treated  with   ZM447439   increased   only   from  3.9%   to   4.2%   after   I  
altered  the  gating.  
  
  
2.15   Fluorescence  Recovery  After  Photobleaching  (FRAP)  
FRAP  experiments  were  performed  using  a  Leica  SP5  confocal  microscope  with  
a  63×,  1.4  NA  objective  and  an  argon  laser  (laser  line  488  nm).  HeLa  cells  were  grown  
on  25  mm  round  polylysine-­‐coated  coverslips  and  transfected  with  the  appropriate  
constructs  24  h  prior   to   the  FRAP  measurements.  The  medium  was  exchanged   to  
FluoroBrite  DMEM  (phenol  red  free;  Thermo  Fisher  Scientific)  with  10  %  FBS  and  cells  
were  kept  at  37   °C  and  5%  CO2   in  air   in  an  environmental   chamber   (Life   Imaging  
Services)  during  imaging.  For  the  FRAP  experiment,  first  five  pre-­‐bleach  images  were  
captured  followed  by  bleaching  a  ROI  of  1.6  µm  diameter  for  1  s  at  full  laser  power,  
choosing   a   region   where   the   individual   HP1α-­‐fusion   constructs   clustered   in  
interphase  cells.  The  subsequent  images  were  captured  in  three  different  phases.  The  
initial  phase  consisted  of  20  frames  every  0.65  seconds  to  capture  a  rapid  recovery.  




stages  of  recovery.  The  final  phase  consisted  of  45  frames  every  5  s  to  capture  the  
complete  recovery  of  all  constructs.    
Image  processing  was  performed  using  the  Image-­‐Pro  Premier  software  (Media  
Cybernetics).   The   intensity  measurements  were  corrected   for  photobleaching  and  
the  values  were  normalised  according  to  (Phair  and  Misteli,  2001),  by  applying  an  ROI  
to  the  bleach  spot,  to  the  background  and  to  a  non-­‐bleached  area  of  an  adjacent  cell.  
Normalisation  was  performed  based  on  the  five  pre-­‐bleach  images.  The  halftime  of  




3   Results  chapter  1:  Tethering  HP1α  to  centromeres  results  in  
a  mitotic  delay  and  increased  segregation  errors  
  
3.1   Tethering  HP1α  to  the  centromere  via  fusion  to  a  CENP-­‐B  DNA-­‐binding  domain  
results  in  a  mitotic  delay  
To  investigate  the  effect  of  tethering  HP1α  at  mitotic  centromeres  in  HeLa  cells,  
I  used  a   fusion  construct   linking  HP1α  to  the  DNA-­‐binding  domain  of  CENP-­‐B  (CB)  
(Pluta  et  al.,  1992)  and  enhanced  yellow  fluorescent  protein  (EYFP  /  EY).  I  will  refer  
to   this   construct   as   CB-­‐EY-­‐HP1α   and   also   apply   this   nomenclature   to   the   control  
constructs  consisting  of  only  yellow  fluorescent  protein  (EY)  or  untethered  HP1α  (EY-­‐
HP1α)  (Fig.  5A).  The  transient  expression  of  CB-­‐EY-­‐HP1α  resulted  in  a  clear  increase  
in  the  number  of  mitotic  cells  (Fig.  5B).  Importantly,  cells  expressing  the  untethered  
HP1α  (EY-­‐HP1α)  lacking  the  CENP-­‐B  DNA-­‐binding  domain,  did  not  show  an  altered  
mitotic  index  compared  to  control  cells  expressing  only  yellow  fluorescent  protein  
(EY).    
In   a   more   detailed   analysis,   I   determined   the   distribution   of   the   individual  
mitotic  stages  in  cells  expressing  the  CB-­‐EY-­‐HP1α  construct  (Fig.  5C).  This  tethering  
of   HP1α   to   centromeres   led   to   an   altered   mitotic   distribution   with   a   clear  
accumulation  of  metaphase  cells  and  a  concomitant  decrease  in  the  number  of  cells  
in  anaphase  and  telophase.  Cells  expressing  the  untethered  HP1α  construct  EY-­‐HP1α  
also  showed  no  altered  behaviour  compared  to  control  cells  expressing  only  EYFP  in  
this   experiment.   Both   exhibited   a   similar   mitotic   progression   profile   with   no  






Figure  5:  Tethering  HP1α  to  the  centromere  via  fusion  to  a  CENP-­‐B  DNA-­‐binding  domain  
results  in  a  mitotic  delay.  
(A)  Schematic  representation  of  the  HP1α  tethering  constructs  and  different  controls.  HP1α  (blue)  is  fused  
to  EYFP  (EY  -­‐  green)  and  the  DNA-­‐binding  domain  of  CENP-­‐B  (CB  -­‐  grey),  resulting  in  CB-­‐EY-­‐HP1α.  
(B)  Frequency  of  mitotic  HeLa  cells  24  h  after  transfection  with  the  indicated  constructs.  Graphs  represent  
the  mean   and   standard   deviation   of   three   independent   experiments,   with   n=500   cells   per   experiment.  
Statistical  analysis:  Fisher's  exact  test  followed  by  the  Benjamini–Hochberg  multiple  comparison  test.  ****,  
P  <  0.0001;  n.s.,  not  significant.  
(C)   Frequency   of   the   different   mitotic   phases   in   HeLa   cells   24   h   after   transfection   with   the   indicated  
constructs.  Graphs   represent   the  mean   and   standard  deviation  of   three   independent   experiments,  with  
n=60   mitotic   cells   per   experiment.   Statistical   analysis:   Fisher's   exact   test   followed   by   the   Benjamini–






To   analyse   whether   the   chimeric   CB-­‐EY-­‐HP1α   specifically   localises   to  
centromeres,   I   transiently   expressed   this   construct   in   HeLa   cells   and   performed  
immunofluorescence   staining   for   the   centromere   protein   CENP-­‐C   (Fig.  6).  
Additionally,  I  stained  for  tubulin  which  facilitates  the  identification  of  the  individual  
mitotic   stages.   The   fluorescence   microscopy   analysis   revealed   that   CB-­‐EY-­‐HP1α  
localises  throughout  the  centromeric  region  beneath  the  kinetochore  in  mitotic  cells,  
which  is  consistent  with  the  normal  localization  of  the  CENP-­‐B  protein  in  HeLa  cells  
(Cooke   et   al.,   1990).   These   results   confirm   that   specific   tethering   of  HP1α   to   the  
centromere  is  possible  using  the  CB-­‐EY-­‐HP1α  construct.  
  
  
3.2   Modulating  the  binding  dynamics  of  the  CENP-­‐B  tethering  construct  rescues  
the  mitotic  delay  
To  test  whether  the  strength  of  HP1α  tethering  affects  the  metaphase  delay  
phenotype,  I  mutated  the  CENP-­‐B  DNA-­‐binding  domain  to  perturb  its  DNA  binding  
properties.  I  substituted  the  amino  acid  residues  S40,  N120  and  R125  with  alanine,  
resulting   in   the   construct   CBmut-­‐EY-­‐HP1α.   These   residues   were   selected   in  
consultation  with  A.  Jeyaprakash  Arulanandam  based  on  their  specific  contacts  with  
the   DNA   of   the   CENP-­‐B   boxes   in   the   crystal   structure   of   Tanaka   and   colleagues  
(Tanaka   et   al.,   2001)   and   their   high   degree   of   conservation   among   the   following  
species:   Homo   sapiens,   Mus   musculus,   Cricetulus   griseus,   Rattus   norvegicus,  
Schizosaccharomyces   pombe   (CENP-­‐B   homolog   protein1   and   2),   Ornithorhynchus  
anatinus,  Bos  taurus,  Cavia  porcellus,  Macaca  mulatta,  and  Pediculus  humanus.  The  
sequence  alignment  and  the  diagram  of  the  crystal  structure  (PDB:  1HLV)  highlighting  
the  mutated  residues  in  “stick”  were  made  by  A.  Jeyaprakash  Arulanandam  (Fig.  7).    
Importantly,   the   mutant   construct   CBmut-­‐EY-­‐HP1α   did   not   cause   cells   to  
accumulate  in  mitosis  compared  to  EYFP  or  EY-­‐HP1α  expressing  cells  and  also  did  not  

















Figure  6:  CB-­‐EY-­‐HP1α  localises  specifically  to  centromeres  throughout  the  cell  cycle.  
Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  a  construct  expressing  CB-­‐EY-­‐HP1α  
(shown   in   green).   Cells   were   stained   with   Hoechst   33342   (blue)   and   immunostained   with   antibodies  





Figure  7:  Selected  amino  acid  residues  of  the  CENP-­‐B  DNA-­‐binding  domain  were  mutated  
to  perturb  its  DNA  binding  properties.  
(A)   Protein   sequence   alignment   of   the   CENP-­‐B  DNA-­‐binding   from   different   species.  Multiple   sequence  
alignment  was  performed  by  A.  Jeyaprakash  Arulanandam  using  Clustal  Omega  and  was  edited  with  Aline  
for   display.   Asterisks   indicate   the   residues   selected   for  mutation.  The  protein   sequence   from   following  
species  were  used  for  the  alignment:  Homo  sapiens,  Mus  musculus,  Cricetulus  griseus,  Rattus  norvegicus,  
Schizosaccharomyces   pombe   (CENP-­‐B   homolog   protein1   and   2),   Ornithorhynchus   anatinus,   Bos   taurus,  
Cavia  porcellus,  Macaca  mulatta,  and  Pediculus  humanus.  
(B)  Structure  of  the  DNA-­‐binding  domain  of  CENP-­‐B  (grey)  is  shown  as  a  ribbon  diagram  interacting  with  
DNA   (coloured)   (PDB  code  1HLV)  and  was  made  by  A.   Jeyaprakash  Arulanandam.  Residues  selected   for  
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Next,  I  sought  to  determine  the  exact  centromeric  localisation  of  the  various  
HP1α   constructs   by   use   of   line   scan   profiles   at   different   stages   of  mitosis.   HP1α  
tethered  via  the  wildtype,  or  mutated  CENP-­‐B  DBD  showed  the  same  localisation  as  
untethered  EY-­‐HP1α  at  the  inner  centromere  of  prometaphase  cells,  judged  by  the  
staining  for  CENP-­‐C  (Fig.  8A).  At  this  stage  of  mitosis,  centromeres  are  not  yet  under  
tension.   However,   in   metaphase   cells,   when   chromosomes   biorientate   and  
centromeres  are  stretched,  both  HP1α  tethering  constructs  divided  into  two  peaks  
that  moved  together  with  the  separating  CENP-­‐C  staining,  whereas  the  untethered  
EY-­‐HP1α   remained   concentrated   as   one   slightly   broader   peak   at   the   inner  
centromere   (Fig.   8B).   Importantly,   the   tethered   CB-­‐EY-­‐HP1α   remained   ~   0.2   µm  
internal   to  the  CENP-­‐C  signal,   indicating  that   it  occupies  the  kinetochore-­‐proximal  
region  of  the  inner  centromere,  as  previously  shown  for  tethering  experiments  using  
the  CENP-­‐B  DNA-­‐binding  domain  fused  to  the  CPC  subunit  INCENP  (Liu  et  al.,  2009;  
Wang  et  al.,  2011a;  Hengeveld  et  al.,  2017).  
Comparing  the  three  HP1α  constructs  by  Western  blot  analysis  demonstrated  
that  they  are  all  expressed  correctly,  judged  by  the  bands  running  at  the  expected  
size   (Fig.   8C).   Furthermore,   the   EYFP   tagged   HP1α   was   expressed   at   a   level  
comparable  to  endogenous  HP1α  in  the  entire  culture,  and  both  CENP-­‐B  DBD  tagged  































































































































Figure   8:   Localisation   and   expression   level   of   chimeric   HP1α   tethering   constructs  
compared  to  untethered  HP1α.  
(A,  B)  Immunofluorescence  analysis  of  early  prometaphase  (A)  or  metaphase  (B)  Hela  cells  24  h  after  
transfection  with   constructs   expressing   CB-­‐EY-­‐HP1α   (1),   the   tethering   mutant   CBmut-­‐EY-­‐HP1α   (2),   or  
untethered  EY-­‐HP1α  (3)  (shown  in  green).  Cells  were  stained  with  Hoechst  33342  and  immunostained  
with  an  antibody  recognising  CENP-­‐C  (magenta)  after  pre-­‐extraction  with  0.1%  Triton  X-­‐100/PHEM  buffer  
for  1  min.  Line  scans  are  showing  the  HP1α  construct  and  CENP-­‐C  (i);  the  HP1α  construct  alone  (ii);  or  
CENP-­‐C  alone  (iii).  Scale  bar,  5  µm.  
(C)  Western  blot  analysis  of  Hela  whole  cell  lysates  24  h  after  transfection  with  the  indicated  HP1α  fusion  
constructs.  Endogenous  HP1α  and  HP1α  fusion  constructs  were  detected  using  an  anti-­‐HP1α  antibody.  




   To  analyse  the  effect  of  the  introduced  point  mutations  on  the  DNA-­‐binding  
properties   of   the   CENP-­‐B   DBD,   I   determined   the   dynamics   of   the   different   EYFP-­‐
tagged   HP1α   constructs   using   the   Fluorescence   Recovery   After   Photobleaching  
(FRAP)  method  (Fig.  9).  I  selected  an  area  where  HP1α  was  clustered  in  transiently  
transfected  interphase  cells,  bleached  a  spot  of  1.6  µm  diameter,  and  measured  the  
EYFP  fluorescence  recovery   in  three  different  phases  (20  frames  every  0.648  s,  30  
frames  every  2  s  and  45  frames  every  5  s)  to  capture  both  the  dynamic  recovery  range  
and  the  complete  steady-­‐state  recovery  of  the  various  HP1α  fusion  proteins.    
In  line  with  previous  published  observations,  untethered  EY-­‐HP1α  had  a  mean  
halftime  of  recovery  (t1/2)  of  3.1  s  (Schmiedeberg  et  al.,  2004).  In  contrast,  tethering  
HP1α  to  the  centromere  via  the  DNA-­‐binding  domain  of  CENP-­‐B  had  a  substantial  
influence   on   its   dynamics.   The   recovery   halftime   of   CB-­‐EY-­‐HP1α   was   ~   49  s,   an  
increase  by  more  than  15-­‐fold  compared  to  EY-­‐HP1α.  Introducing  the  three  above-­‐
mentioned   point   mutations   into   the   DNA-­‐binding   domain   of   the   HP1α   tethering  
construct  resulted  in  nearly  three-­‐fold  faster  dynamics  with  a  t1/2  for  CBmut-­‐EY-­‐HP1α  
of   18  s.   Together,   these   results   suggest   that   decreasing   HP1α   dynamics   at  

























CB-EY-HP1αI165E  8.0 s
CB-EY  6.8 s
EY-HP1α 3.1 s








Figure  9:  Binding  dynamics  of  various  HP1α  tethering  constructs  determined  by  FRAP.  
Quantitative   fluorescence   recovery   after   photobleaching   (FRAP)   analyses   of   the   indicated   EYFP  
containing  constructs  in  interphase  HeLa  cells  24  h  after  transfection.  Measurements  were  made  in  three  





3.3   Preventing  HP1  interaction  with  PxVxL/I  motif-­‐containing  proteins  eliminates  
the  mitotic  delay  caused  by  centromeric  HP1α  tethering  
HP1   interacts   with   a   large   number   of   client   proteins   as   demonstrated   by   a  
previous  mass  spectrometry  screen  (Nozawa  et  al.,  2010).  Therefore,  I  hypothesised  
that  the  mitotic  delay  caused  by  HP1α  tethering  to  centromeres  could  be  due  to  the  
centromeric  retention  of  one  or  more  of  these  mitotic  regulators  that  interact  with  
HP1α.  In  order  to  test  my  hypothesis,  I  introduced  several  point  mutations  into  the  
HP1α   domain   of   the   CB-­‐EY-­‐HP1α   construct   that   have   been   previously   shown   to  
perturb  different  HP1α   functions  (Fig.  10A).  The  V22M  substitution   in  the  chromo  
domain  prevents  HP1α  binding  to  H3K9me2/3  (Bannister  et  al.,  2001;  Lachner  et  al.,  
2001;  Nielsen  et  al.,  2001).  The  chromoshadow  domain  mutation  I165E  disrupts  HP1  
dimer   formation,   while   W174A   disrupts   the   formation   of   a   hydrophobic   pocket  
required   to   bind   client   proteins.   Importantly,   both  mutations,   I165E   and  W174A,  
perturb   HP1   association   with   binding   partners   containing   the   PxVxL/I   motif,   but  
W174A  does  not  interfere  with  the  dimerization  of  HP1α  (Brasher  et  al.,  2000;  Thiru  
et  al.,  2004;  Nozawa  et  al.,  2010).  
Figure  10:  Preventing  HP1  interaction  with  PxVxL/I  motif-­‐containing  proteins  eliminates  
the  mitotic  delay  caused  by  centromeric  HP1α  tethering.  
(A)  Schematic  representation  of  the  tethered  HP1α  mutants,  indicating  their  perturbed  functions.  
(B)   Frequency  of   the   different  mitotic   phases   in  HeLa   cells   24   h   after   transfection  with   the   indicated  
constructs.  Graphs  represent  the  mean  and  standard  deviation  of  three  independent  experiments,  with  
n=60  mitotic   cells   per   experiment.   Statistical   analysis:   Fisher's   exact   test   followed   by   the   Benjamini–




Western  blot  analysis  confirmed  that  all  HP1α  mutants,  when  fused  to  the  DBD  of  
CENP-­‐B,  were  expressed  correctly  and  to  a  similar  level  (Fig.  11A).  In  this  experiment,  
I  used  an  antibody  that  detects  the  EYFP  domain  of  the  tethering  constructs,  in  case  
the   introduced   point  mutations   perturb   the   epitope   recognised   by   the   anti-­‐HP1α  
antibody  used  in  the  previous  Western  blot  analysis  (see  Fig.  8C).  
Fluorescence   microscopy   of   transiently   transfected   cells   showed   that   the  
localisation  of   the  mutants  was   similar   to   that  of  CB-­‐EY-­‐HP1α  containing  wildtype  
HP1α,  except   for  CB-­‐EY-­‐HP1αI165E,  which  showed  a  higher  diffuse  background   (Fig.  
11B).  
To  investigate  the  reason  for  the  more  diffuse  appearance  of  CB-­‐EY-­‐HP1αI165E,  
I  performed  further  FRAP  experiments  to  determine  the  binding  dynamics  of  the  CB-­‐
EY-­‐HP1αI165E  construct  (Fig.  9).  Interestingly,  introducing  the  I165E  mutation  into  CB-­‐
EY-­‐HP1α,  which  prevents  dimer  formation  in  full-­‐length  HP1,  resulted  in  a  t1/2  of  ~  8  s,  
which   is   more   than   6-­‐fold   faster   than   the   t1/2   of   the   tethered   wildtype   HP1α.  
Moreover,  for  CB-­‐EY,  which  consists  of  only  the  CENP-­‐B  DNA  binding  domain  fused  
to   EYFP   without   any   further   attached   protein,   I   measured   a   similar   halftime   of  
recovery   in   FRAP   experiments   of   6.8   seconds.   This   suggests   that   CENP-­‐B   might  
require  to  dimerise  for  stable  DNA  binding.  This  suggestion  is  further  supported  by  
the  FRAP  result  of  the  CSD  mutant  CB-­‐EY-­‐HP1αW174A,  which  is  able  to  dimerise,  unlike  
CB-­‐EY-­‐HP1αI165E.   The   halftime  of   recovery   for   CB-­‐EY-­‐HP1αW174A  was   ~   42   seconds,  
similar   to   the   result   of   wildtype   CB-­‐EY-­‐HP1α   (~   49   s)   and   a   more   than   five-­‐fold  
increase  compared  to  the  I165E  CSD  mutant  construct.  Together,  these  results  reveal  
that  the  dimerisation  mediated  by  HP1α  results  in  stronger  binding  properties  of  the  
































Figure   11:   Expression   level   and   localisation   of   different   HP1α  mutants  
fused  to  the  CENP-­‐B  DBD.  
(A)  Western   blot   analysis   of   Hela  whole   cell   lysates   24   h   after   transfection  with   the  
indicated  HP1α  fusion  constructs.  The  HP1α  constructs  were  detected  using  an  anti-­‐GFP  
antibody.  α-­‐tubulin  served  as  a  loading  control.  
(B)   Immunofluorescence   analysis   of  Hela  cells   24   h   after   transfection  with  constructs  
expressing   CB-­‐EY-­‐HP1α   (1),   or   the   tethered   HP1  mutants   CB-­‐EY-­‐HP1αV22M   (2),   CB-­‐EY-­‐
HP1αI165E  (3),  and  CB-­‐EY-­‐HP1αW174A  (4)  (shown  in  green).  Cells  were  stained  with  Hoechst  
33342  (blue)  and  immunostained  with  an  antibody  recognising  CENP-­‐C  (magenta).  Scale  





Introducing   the   V22M   mutation   into   CB-­‐EY-­‐HP1α   had   no   effect   on   the  
metaphase  delay  phenotype,  and  its  mitotic  progression  profile  resembled  that  for  
wildtype   CB-­‐EY-­‐HP1α   (Fig.   10B).   This  was   expected   because   the   chimeric  HP1α   is  
tethered   to   centromeres   via   the   DBD   of   CENP-­‐B   and   therefore   its   localisation   is  
unlikely  to  depend  on  the  chromo  domain  binding  to  H3K9me3.  Remarkably,  both  
chromoshadow  domain  mutants   I165E   or  W174A   abolished   the  metaphase   delay  
caused  by  centromeric  tethering  of  HP1α:  Cells  expressing  CB-­‐EY-­‐HP1αI165E  and  CB-­‐
EY-­‐HP1αW174A   exhibited   mitotic   progression   profiles   similar   to   cells   expressing  
untethered  EY-­‐HP1α,  which  was  shown  to  have  no  effect  on  mitotic  progression  (see  
Fig.  5).  
These  results  suggest  that  the  mitotic  delay  may  be  caused  by  proteins  that  
bind  to  the  chromoshadow  domain  of  tethered  HP1α  at  centromeres  and  most  likely  
contain  a  PxVxL/I  motif.  
  
Due  to  the  results  described  here,  I  used  CB-­‐EY-­‐HP1αW174A  as  a  control  construct  
for  all  following  experiments.  CB-­‐EY-­‐HP1αW174A  behaves  very  similarly  to  the  wildtype  
CB-­‐EY-­‐HP1α   construct   regarding   its   expression   level,   specific   localisation   to   the  
centromere   region,   and   binding   dynamics,   however,   it   does   not   cause   an   altered  




3.4   Live  cell  imaging  analysis  of  mitotic  progression  and  chromosome  segregation  
defects  upon  HP1α  centromere  tethering  
I   performed   live   cell   imaging   experiments   to   analyse   the   mitotic   delay  
phenotype   in   greater   detail   and   to   determine   the   effect   of   HP1α   centromere  
tethering  on  chromosome  segregation  errors.  
  
3.4.1   The  mitotic  delay  caused  by  centromeric  tethering  of  HP1α  is  not  a  cell  line  
specific  effect  
Imaging  with  Differential  Interference  Contrast  (DIC)  microscopy  allowed  me  to  
determine  precisely  the  times  of  nuclear  envelope  breakdown  (NEB)   (Fig.  12A  –  0  
min)  and  onset  of  anaphase  (Fig.  12A  –  84  min).  Based  on  the  identification  of  these  
two  specific  mitotic   landmarks,   I  could  accurately  determine  the  timing  of  mitotic  
progression.  Additionally,  the  live  cell  imaging  indicated  that  cells  with  tethered  HP1α  
at   centromeres   had   no   difficulties   with   chromosome   congression.   An   example   is  
shown   in   Figure   12A,   where   a   well-­‐organised   metaphase   plate   forms   within   12  
minutes  after  NEB.  
I  grouped  the  imaged  cells  into  categories  of  low  (L),  medium  (M),  and  high  (H)  
expression,  depending  on  the  level  of  the  transiently  transfected  tethering  construct  
(see  the  Materials  and  Methods  chapter  for  a  detailed  explanation)  (Fig.  12B).  The  
live   cell   imaging   experiments   using   HeLa   cells   confirmed   the   metaphase   delay  
phenotype   observed   after   wildtype   HP1α   tethering   to   centromeres   in   fixed   cell  
samples   (see  Figs.  5C  and  10B).  The  median  (x#)  duration  from  NEB  until  anaphase  
onset   in   the   three   categories   was   66   min   (L),   120   min   (M),   and   111   (H)   min,  
respectively.  Remarkably,   I  could  observe  cells  remaining  over  38  hours   in  mitosis  
before  anaphase  onset.  A  robust  mitotic  delay  was  particularly  present  among  cells  
expressing  CB-­‐EY-­‐HP1α  at  a  high  level,  shown  by  an  upper  quartile  value  of  1692  min.  
In   contrast,   cells   expressing   the   control   construct   CB-­‐EY-­‐HP1αW174A   showed   a  
progression  through  mitosis  resembling  that  of  untransfected  cells,  with  a  median  of  
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Figure   12:   Live   cell   imaging   experiments   reveal   the   robustness   of   the  mitotic   delay  
caused  by  centromeric  tethering  of  HP1α  in  different  cell  lines.  
(A)  Stills  from  a  live  cell  imaging  video  using  Differential  Interference  Contrast  (DIC)  microscopy.  A  U2OS  
cell  from  category  “high  level  of  CB-­‐EY-­‐HP1α  expression”  is  shown.  Arrow  indicates  lagging  chromosome.  
Scale  bar,  5  µm.  
(B)  Quantification  of  the  timing  from  nuclear  envelope  breakdown  (NEB)  until  anaphase  onset  analysed  
from  live  cell  imaging  movies  of  Hela  or  U2OS  cell  expressing  either  CB-­‐EY-­‐HP1α  (red),  CB-­‐EY-­‐HP1αW174A  
(blue),  or  of  untransfected  cells  (grey).  Cells  were  grouped  into  categories  of   low  (L),  medium  (M),  or  
high   (H)   levels  of  protein  expression   (see  Materials  and  Methods  section   for  further  details).  Crosses  
represent  cell  death  before  the  onset  of  anaphase,  and  empty  squares  represent  the  end  of  the  movie  
before  the  onset  of  anaphase.  Graphs  indicate  the  median  and  interquartile  range.  Statistical  analysis:  
Kolmogorov-­‐Smirnov   test   followed   by   the   Benjamini-­‐Hochberg   multiple   comparison   test.   ****,   P   <  






Tethering  HP1α  to  centromeres  in  U2OS  osteosarcoma  cells  also  produced  a  
delayed  mitotic  progression  in  cells  with  a  medium  (x#  =  60  min)  or  high  (x#  =  90  min)  
expression   of   CB-­‐EY-­‐HP1α   compared   to   untransfected   U2OS   cells   (x#   =   30   min)  
(Fig.  12B).  In  contrast  to  Hela  cells,  a  low  expression  of  CB-­‐EY-­‐HP1α  did  not  result  in  
an   overall   delayed   mitotic   progression   (x#   =   30   min).   U2OS   cells   expressing   the  
mutated   HP1αW174A   tethering   construct   also   showed   no   significant   difference  
compared  to  untransfected  cells  (x#  =  42  min  (L),  30  min  (M),  36  min  (H)).  
Overall,  the  live  cell  imaging  experiments  confirmed  the  mitotic  delay  observed  
in  fixed  cell  cultures  upon  tethering  of  wildtype  HP1α  to  centromeres.  Furthermore,  
the  live  cell  imaging  method  indicates  that  it  is  not  chromosome  congression  that  is  
affected,   but   rather   the   mitotic   progression   after   a   metaphase   plate   is   formed,  
revealing  that  CB-­‐EY-­‐HP1α  can  cause  an  extensive  metaphase  delay,  whereas  CB-­‐EY-­‐
HP1αW174A  does  not  affect  mitotic  progression.  
  
3.4.2   Centromere   tethering  of  HP1α   is  accompanied   by  an   increased  number  of  
cells  with  lagging  chromosomes  and  micronuclei  
  
The   live   cell   imaging  with   the   tethering   constructs   allowed  me   not   only   to  
define   the   exact   duration   of   individual   cells   in  mitosis   but   also   to   quantitate   the  
frequency   of   chromosome   segregation   defects   by   monitoring   the   behaviour   of  
fluorescently  labelled  centromeres.  This  analysis  revealed  that  the  tethering  of  HP1α  
to  centromeres  using  the  CENP-­‐B  DBD  resulted  in  a  substantial  increase  of  lagging  
chromosomes:  While  HeLa  cells  expressing   the  control   construct  CB-­‐EY-­‐HP1αW174A  
showed  lagging  chromosomes  with  a  frequency  up  to  18  percent,  the  tethering  of  
wildtype  HP1α  resulted  in  an  increase  to  42%  (L),  66%  (M),  and  78%  (H)  (Fig.  13A).  
In  U2OS  cells,  I  observed  lagging  chromosomes  in  27%  of  cells  expressing  the  
control   construct   CB-­‐EY-­‐HP1αW174A   at   low   and  medium   levels   Fig.   13A).   This   high  
frequency  of  lagging  chromosomes  appeared  to  reflect  an  elevated  baseline  value  in  




cells   with   a   high   expression   of   CB-­‐EY-­‐HP1αW174A   showed   a   slightly   increased  
frequency   of   lagging   chromosomes   (41%),   however   this   frequency  was   still   lower  
than  in  cells  with  wildtype  HP1α  tethered  to  centromeres:  In  CB-­‐EY-­‐HP1α  expressing  
U2OS  cells  I  observed  a  frequency  of  lagging  chromosomes  from  44%  (L),  86%  (M),  
up  to  100%  (H).  
Lagging   chromosomes   often   result   in   the   formation   of   micronuclei   after  
mitosis.  Therefore,   I  next  analysed  the  frequency  of  micronuclei   formation   in  cells  
expressing  the  HP1α  tethering  constructs.  This  analysis  confirmed  that  a  high  rate  of  
lagging  chromosomes  resulted   indeed   in  an   increased  frequency  of  micronuclei   in  
both  cell  lines  (Fig.  13B).    
  
Thus,   tethering  HP1α   to   centromeres   by   use   of   the   CENP-­‐B  DBD   causes   an  
increase   in  the  frequency  of  chromosome  segregation  errors  rather  than  having  a  
positive  effect  on  chromosome  mis-­‐segregation  as  might  have  been  predicted  based  
on  one  published  study  (Abe  et  al.,  2016).  





Figure  13:  Centromere  tethering  of  HP1α  is  accompanied  by  an  increased  number  of  
cells  with  lagging  chromosomes  and  micronuclei.  
(A,  B)  Graphs  represent  the  frequency  of  lagging  chromosomes  (A)  or  micronuclei  (B)  observed  in  live  
cell  imaging  movies  of  Hela  or  U2OS  cell  expressing  either  CB-­‐EY-­‐HP1α  (red)  or  CB-­‐EY-­‐HP1αW174A  (blue).  
Dark-­‐coloured  sections  indicate  frequencies  of  cells  with  lagging  chromosomes  (A)  or  with  micronuclei  
(B).   Pale-­‐coloured   sections   indicate   frequencies   of   cells   without   lagging   chromosomes   (A)   or  
micronuclei  (B).  Statistical  analysis:  Fisher's  exact  test  followed  by  the  Benjamini-­‐Hochberg  multiple  
comparison  test.  *,  P  <  0.05;  **,  P  <  0.01;  ***,  P  <  0.001;  ****,  P  <  0.0001;  n.s.,  not  significant.  
(C)  The  number  of  cells  used  to  quantify  the  mitotic  timing  (Fig.  12B)  and  defects  (Figure  13A,  B)  from  
live  cell  imaging  videos.  Each  cell  line  is  shown  either  untransfected  or  expressing  CB-­‐EY-­‐HP1α  or  CB-­‐





4   Results  chapter  2:  Centromere  tethering  of  HP1  affects  the  
CPC    
  
4.1   The   delay   mechanism   caused   by   centromeric   HP1α   tethering   suggests   an  
involvement  of  the  CPC  
  
To  understand  why  CB-­‐EY-­‐HP1α  expression  leads  to  a  mitotic  delay  instead  of  
improving   the   rate   of   chromosome   mis-­‐segregation,   I   further   investigated   the  
molecular  consequences  of  HP1  centromere  tethering.  
  
4.1.1   The  mitotic  delay  caused  by  centromere  tethering  of  HP1α  is  due  to  spindle  
assembly  checkpoint  activity  
  
The  live  cell  imaging  experiments  revealed  that  the  cells  expressing  CB-­‐EY-­‐HP1α  
form  a  metaphase  plate  in  a  timely  manner,  but  the  onset  of  anaphase  is  delayed.  
Therefore,   I  hypothesised  that  the  mitotic  accumulation  of  cells  expressing  CB-­‐EY-­‐
HP1α  might  be  caused  by  an  active  spindle  assembly  checkpoint  (SAC).  To  test  this  
hypothesis,  I  used  published  siRNA  oligonucleotides  (Gorbsky  et  al.,  1998;  Nitta  et  al.,  
2004)  to  deplete  the  essential  SAC  component  Mad2  in  cells  expressing  either  CB-­‐EY-­‐
HP1α  or,  as  a  control,  CB-­‐EY-­‐HP1αW174A.    
Immunoblot  analysis  confirmed  that  extracts  from  cells  transfected  with  this  
specific   siRNA   showed   reduced   levels   of   Mad2   protein   compared   to   the   levels  
observed   in  cells   transfected  with  a  control  siRNA,  which  exhibited  similar  protein  
levels  of  Mad2  as  untransfected  cells  (Fig.  14A).  
Cells   expressing   CB-­‐EY-­‐HP1α   and   treated   with   control   siRNA   showed   a  
metaphase  delay  similar  to  that  seen  in  Figures  5C  and  10B  (Fig.  14B).  On  the  other  
hand,   depletion   of   Mad2   in   those   cells   resulted   in   a   decreased   frequency   of  
metaphase  cells  and  an  increase  of  cells  in  anaphase  and  telophase  to  levels  similar  




imaging  experiments  (see  Fig.  12B),  cell  expressing  CB-­‐EY-­‐HP1αW174A  did  not  show  a  
mitotic   delay.   However,   as   expected,   cells   progressed   more   quickly   through  
metaphase   upon   Mad2   depletion,   demonstrated   by   the   decreased   frequency   of  
metaphase  cells  (Fig.  14B).  
Overall,  this  experiment  confirms  that  the  mitotic  delay  induced  by  tethering  























































Figure  14:  The  mitotic  delay  caused  by  centromere  tethering  of  HP1α  is  due  to  spindle  
assembly  checkpoint  activity.  
(A)   Western   blot   analysis   of   Hela   whole   cell   lysates   transfected   with   the   indicated   siRNA.   Mad2   was  
detected  using  an  anti-­‐Mad2  antibody  and  demonstrates  depletion  of   the  Mad2  protein  in   the  culture  
transfected  with  siRNA  that  targets  Mad2  mRNA.  α-­‐tubulin  served  as  a  loading  control.  
(B)  Frequency  of  the  different  mitotic  phases  in  HeLa  cells  24  h  after  transfection  with  the  indicated  HP1  
tethering   constructs   and   co-­‐transfection  with   control   siRNA   (solid   bars)   or   with  Mad2   targeting   siRNA  
(striped  bars).  Graphs  represent  the  mean  and  standard  deviation  of  three  independent  experiments,  with  
n=60   mitotic   cells   per   experiment.   Statistical   analysis:   Fisher's   exact   test   followed   by   the   Benjamini–




4.1.2   Centromere  tethering  of  HP1α  results  in  impaired  microtubule  attachments  
to  kinetochores  
The  SAC  is  active  when  kinetochores  lack  proper  microtubule  attachments.  To  
test   whether   HP1α   tethering   leads   to   impaired   microtubule   attachment   to  
kinetochores,  I  performed  a  cold-­‐stable  microtubule  assay.  This  assay  is  based  on  the  
observation  that  microtubules  that  are  end-­‐on  attached  to  kinetochores  (so-­‐called  K-­‐
fibres),  are  more  stable  at  low  temperatures  than  unattached  microtubules  (Rieder,  
1981).  Therefore,  the  cold-­‐stable  microtubule  assay  can  be  used  as  a  readout  for  the  
kinetochore-­‐microtubule  attachment  status.  
Immunofluorescence   microscopy   detecting   microtubules   and   the   inner  
kinetochore  protein  CENP-­‐C  revealed  that  CB-­‐EY-­‐HP1α  expressing  cells  showed  either  
a  reduced  microtubule  density   (Fig.  15A-­‐2i)  or  even  no  microtubules   (Fig.  15A-­‐2ii)  
close   to   the   CENP-­‐C   signal   in   metaphase   cells   after   cold   treatment.   In   contrast,  
untransfected  cells  or  cells  expressing  the  control  construct  CB-­‐EY-­‐HP1αW174A  showed  
robust  microtubules  close  to  the  CENP-­‐C  signal  in  metaphase  cells,  indicating  stable  
microtubule  attachments  even  after  cold  treatment  (Fig.  15A-­‐1  and  15A-­‐3).  
To  quantify  this  observation,  I  measured  the  overall  microtubule   intensity   in  
metaphase  cells  after  cold  treatment  (Fig.  15B).  While  CB-­‐EY-­‐HP1αW174A  expressing  
cells   showed   a   microtubule   intensity   similar   to   untransfected   cells,   an   apparent  
decrease   of   the   overall   microtubule   intensity   was   detectable   in   CB-­‐EY-­‐HP1α  
expressing  cells  after  cold  treatment.  
In   summary,   this   cold-­‐stable   microtubule   experiment   indicates   that  
microtubule  attachments  to  kinetochores  are  impaired  upon  CB-­‐EY-­‐HP1α  tethering  
to  centromeres.    




     
Figure   15:   Centromere   tethering   of   HP1α   results   in   impaired   microtubule  
attachments  to  kinetochores.  
(A)  Immunofluorescence  analysis  of  untransfected  Hela  cells  (1)  or  of  HeLa  cells  24  h  after  transfection  
with  constructs  expressing  CB-­‐EY-­‐HP1α  (2),  or  CB-­‐EY-­‐HP1αW174A  (3)  (shown  in  green)  and  subjected  to  
cold   treatment.   Cells   were   stained   with   Hoechst   33342   and   immunostained   with   antibodies  
recognising  α-­‐tubulin  (cyan)  and  CENP-­‐C  (magenta).  The  merge  is  a  maximum  intensity  projection  of  5  
z-­‐planes.  Zooms  are  showing  α-­‐tubulin  and  CENP-­‐C  (i,  ii),  the  HP1α  tethering  construct  and  CENP-­‐C  (iii  
and  iv),  or  the  HP1α  tethering  construct  alone  (v,  vi).  Scale  bar,  5  µm.  
(B)  Quantification  of  the  overall  microtubule  intensity  after  cold  treatment  of  untransfected  HeLa  cells  
(grey)   or   cells   transfected  with   constructs   expressing   CB-­‐EY-­‐HP1α   (red),   or   CB-­‐EY-­‐HP1αW174A   (blue).  
Graphs   indicate   the   mean   and   standard   deviation   of   normalised   values   from   three   independent  
experiments  with  the  following  numbers  of  cells  analysed:  n=33  for  untransfected  cells,  n=36  for  cells  





































































4.1.3   Centromere   tethering   of   HP1α   leads   to   altered   Aurora   B   distribution   and  
results  in  increased  levels  of  phosphorylated  Dsn1    
Because   HP1   localisation   to   centromeres   during   mitosis   depends   on   its  
interaction  with  the  CPC  core  subunit  INCENP  (Kang  et  al.,  2011),  I  hypothesised  that  
HP1α  tethering  by  use  of  the  CENP-­‐B  DBD  might  result  in  ectopic  recruitment  of  the  
CPC,  thereby  causing  the  metaphase  delay  phenotype.  This  idea  of  a  CPC  contribution  
was  supported  by  my  previous  experiments,  demonstrating  in  Figure  15  that  wildtype  
HP1α  tethering  to  centromeres  impaired  kinetochore-­‐microtubule  attachments,  but  
tethering  the  CSD  mutant  HP1αW174A  did  not  have  an  effect:  The  CPC  is  well-­‐known  
to  regulate  microtubule  attachments  to  the  kinetochore  and  interacts  with  HP1  via  
its  CSD.  
  
In  order  to  investigate  the  role  of  the  CPC  in  the  mitotic  delay  observed  after  
HP1α  tethering  to  centromeres,  I  first  used  indirect  immunofluorescence  to  localise  
endogenous  Aurora  B,  the  kinase  component  of  the  CPC,  in  cells  expressing  CB-­‐EY-­‐
HP1α.   In  control  experiments,   I  also   identified  the   localisation  of  Aurora  B   in  cells  
expressing  the  HP1α  CSD  mutant  construct  (CB-­‐EY-­‐HP1αW174A)  and  in  untransfected  
cells  (Fig.  16A).  
Aurora   B   co-­‐localised   almost   perfectly   with   the   CB-­‐EY-­‐HP1α   construct   at  
centromeres  in  prometaphase  cells  (Fig.  16A2).  In  contrast,  in  cells  expressing  CB-­‐EY-­‐
HP1αW174A,  Aurora  B  showed  a  localisation  similar  to  that  observed  in  untransfected  
cells,  consisting  of  a  centromeric  pool  plus  diffuse  staining  along  the  chromosome  
arms  (Fig.  16A1,  A3).  Remarkably,  this  Aurora  B  localisation  to  chromosome  arms  was  
seen  to  a  much  lesser  extent  in  cells  expressing  CB-­‐EY-­‐HP1α  (Figure  16A2).    
To   examine   whether   this   altered   Aurora   B   distribution   had   functional  
consequences,  I  analysed  the  phosphorylation  level  of  the  known  Aurora  B  substrate  
Dsn1   (Yang   et   al.,   2008;   Welburn   et   al.,   2010).   Indeed,   immunofluorescence  






























































Figure  16:  Centromere  tethering  of  HP1α  leads  to  altered  Aurora  B  distribution  and  
results  in  increased  levels  of  phosphorylated  Dsn1.  
(A)  Immunofluorescence  analysis  of  untransfected  Hela  cells  (1)  or  of  HeLa  cells  24  h  after  transfection  
with   constructs   expressing   CB-­‐EY-­‐HP1α   (2),   or   CB-­‐EY-­‐HP1αW174A   (3)   (shown   in   green).   Cells   were  
stained  with  Hoechst  33342  (blue)  and  immunostained  with  an  antibody  recognising  Aurora  B  (red).  
The  gamma  value  was  reduced  by  the  same  ratio  for  all  images  showing  Aurora  B  staining  (Aurora  B  -­‐  
g  adjusted)  to  highlight  the  chromosome  arm  distribution  of  Aurora  B.  Scale  bar,  5  µm.    
(B)  Immunofluorescence  analysis  of  untransfected  Hela  cells  (1)  or  of  HeLa  cells  24  h  after  transfection  
with  constructs  expressing  CB-­‐EY-­‐HP1α  (2),  or  CB-­‐EY-­‐HP1αW174A  (3).  Cells  were  stained  with  Hoechst  
33342  and  immunostained  with  antibodies  recognising  phosphorylated  Dsn1  (Dsn1ph)  and  Hec1  after  
pre-­‐extraction.  
(C)  Quantification  of  the  mean  Dsn1ph  value  per  individual  kinetochore  in  metaphase  cells.  Graphs  
indicate   the  median  and   interquartile   range  of   three  independent  experiments.  Kinetochores  were  
individually   analysed   and   compared,  with   n=60  cells   for   CB-­‐EY-­‐HP1α  expressing   and  untransfected  




expressing  CB-­‐EY-­‐HP1α  compared  to  the  two  control  conditions,  untransfected  and  
CB-­‐EY-­‐HP1αW174A  expressing  cells  (Fig.  16B).  
Quantification   of   the   Dsn1ph   signal   by   measuring   the   signal   of   individual  
kinetochores   confirmed   a   minor   but   statistically   significant   increase   in   Dsn1  
phosphorylation  when  wildtype  HP1α  was  tethered  to  centromeres  compared  to  the  
two   control   conditions,  HP1αW174A   tethering   or   untransfected   cells   (Fig.   16C).   This  
result   is   in   line   with   a   previous   study   that   reported   an   increased   level   of   Dsn1  
phosphorylation  when  the  CPC  subunit  INCENP  is  tethered  to  centromeres  via  the  
CENP-­‐B  DBD  (Wang  et  al.,  2011a).    
Together,   these   observations   further   support   the   hypothesis   of   a   CPC  
contribution  to  the  metaphase  delay  phenotype  upon  centromere  tethering  of  HP1α.    
  
4.1.4   The  mitotic  delay  caused  by  centromere  tethering  of  HP1α  is  sensitive  to  the  
Aurora  B  inhibitor  ZM447439  
  
To  further  determine  whether  Aurora  B  activity  could  be  responsible  for  the  
observed  metaphase  delay  following  the  tethering  of  HP1α  to  centromeres,  I  made  
use  of  the  Aurora  B  inhibitor  ZM447439.    
In  an  initial  experiment,  I  treated  cells  expressing  CB-­‐EY-­‐HP1α  with  ZM447439  
for   30   min   before   fixation   and   performed   immunofluorescence   microscopy   to  
analyse   these   samples   (Fig.  17A,B).   The  mitotic   phase  distribution  of   control   cells  
expressing   CB-­‐EY-­‐HP1α   and   treated   with   DMSO   resembled   the   result   of   earlier  
experiments  in  which  cells  expressed  CB-­‐EY-­‐HP1α  without  drug  treatment  (see  Figs.  
5C  and  10B).  However,  after  Aurora  B  inhibition,  the  proportion  of  cells  in  metaphase  
decreased   substantially,   and   that   of   cells   in   anaphase   and   telophase   increased  
(Fig.  17A).   This   shift   in   the   mitotic   phase   distribution   presumably   represents   the  
mitotic  progression  of  cells  that  had  previously  accumulated  in  metaphase  but  now  
proceeded  towards  the  mitotic  exit.  Interestingly,  this  change  in  cell  cycle  dynamics  





Next,   I   assessed   the   effect   of   ZM447439   on   cells   expressing   the   control  
construct   CB-­‐EY-­‐HP1αW174A   and   on   untransfected   cells   (Fig.   17C).   Flow   cytometry  
analysis   demonstrated   that   ZM447439   treatment   led   to   a   minor   increase   in   the  
mitotic  indices  of  control  cells.  Importantly,  the  mitotic  index  of  cells  expressing  CB-­‐
EY-­‐HP1α  decreased  when  cultures  were  treated  with  ZM447439,  resulting  in  a  similar  
mitotic  index  for  all  three  experimental  conditions  after  treatment  with  ZM447439  
(Fig.  17C).    
Together,   these   results   indicate   that   the   mitotic   delay   caused   by   tethering  
HP1α  to  centromeres  is  sensitive  to  the  Aurora  B  inhibitor  ZM447439,  suggesting  that  
recruitment  of  the  CPC  might  be  responsible  for  the  mitotic  delay  phenotype.    
  
In   summary,  my   results   suggest   that  HP1α   tethering   using   the  DNA-­‐binding  
domain  of  CENP-­‐B  phenocopies  the  effects  observed  following  CENP-­‐B  tethering  of  
the   core   CPC   subunit   INCENP,   including   a   metaphase   delay,   activity   of   the   SAC,  
impaired   kinetochore-­‐microtubule   attachments,   increased   Aurora   B   activity   at  
kinetochores,  and  ZM447439  sensitivity  (Liu  et  al.,  2009).  
























































































4ACB-EY-HP1α 30 min DMSO
CB-EY-HP1α 30 min ZM447439
Figure  17:  The  mitotic  delay  caused  by  centromere  tethering  of  HP1α  is  sensitive  to  the  
Aurora  B  inhibitor  ZM447439.  
(A)   Frequency   of   the   different   mitotic   phases   in   HeLa   cells   24   h   after   transfection   with   a   construct  
expressing  CB-­‐EY-­‐HP1α  and  treatment  with  either  DMSO  (filled  bars)  or  the  Aurora  B  inhibitor  ZM447439  
(striped  bars)  for  30  min  before  fixing  the  cells.  Graphs  represent  the  mean  and  standard  deviation  of  three  
independent  experiments,  with  n=60  mitotic  cells  per  experiment.  Statistical  analysis:  Fisher's  exact  test  
followed  by  the  Benjamini–Hochberg  multiple  comparison  test.  ****,  P  <  0.0001;  n.s.,  not  significant.  
(B)   Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  a  construct  expressing  CB-­‐EY-­‐
HP1α  (shown  in  green)  and  treated  with  the  Aurora  B  inhibitor  ZM447439  for  30  min  before  fixing  the  cells.  
Cells  were  stained  with  Hoechst  33342  (blue)  and  immunostained  with  an  antibody  recognising  Aurora  B  
(red).  Scale  bar,  5  µm.  
(C)   Flow   cytometry   analysis   of   HeLa   cells   that   were   treated  with   DMSO   or   3  µM  ZM447439   24   h   after  
transfection  with  the  indicated  constructs.  Mitotic   indices  were  determined  by  use  of  a   flow  cytometer  
after  cells  were  stained  with  Hoechst  33342  and  immunostained  with  an  antibody  recognising  MPM2.  A  
minimum  of  40,000  singlets  were  analysed  per  condition  and  individual  experiment.  Graphs  represent  the  




4.2   Tethering  HP1α  highlights  a  strong  interaction  between  the  CPC  and  HP1  in  vivo  
When  analysing  the  mitotic  phase  distribution  following  ZM447439  treatment,  
I  detected  a  robust  co-­‐localisation  of  Aurora  B  with  CB-­‐EY-­‐HP1α  at  centromeres  in  
anaphase  and  telophase  cells  (see  Figure  17B).  This  was  unexpected  as  the  CPC  does  
not  normally  localise  to  the  centromere  at  these  stages  of  the  cell  cycle  but  instead  
shifts  to  the  spindle  midzone  and  midbody  region  (Earnshaw  and  Cooke,  1991).  This  
observation   suggests   the   existence   of   a   strong   interaction   between   the   CPC   and  
tethered  HP1α.  
  
4.2.1   Centromere  tethering  of  HP1α   leads  to  abnormal  centromeric   retention  of  
Aurora  B    
I  next  tested  whether  the  chromatin  retention  of  Aurora  B  described  in  Figure  
17B  was  an  effect  of  the  Aurora  B  inhibition,  which  is  known  to  perturb  CPC  transfer  
to  the  spindle  midzone  (Xu  et  al.,  2009),  or  whether  CB-­‐EY-­‐HP1α  is  also  able  to  retain  
Aurora  B  at  centromeres  under  physiological  conditions.  Therefore,  I   repeated  the  
immunofluorescence  experiment  without  drug  treatment.  Remarkably,  even  without  
perturbing   Aurora   B   activity,   a   substantial   amount   of   Aurora   B   continued   to   co-­‐
localise  with  CB-­‐EY-­‐HP1α  at  centromeres  in  telophase  cells  and  only  a  fraction  of  the  
kinase   localised   to   the   midbody   (Fig.   18-­‐1).   Importantly,   I   did   not   observe   this  
abnormal   retention   of   Aurora   B   at   centromeres   in   telophase   cells   expressing   the  
mutated  CB-­‐EY-­‐HP1αW174A  construct,  but  rather  detected  the  entire  pool  of  Aurora  B  
localised  at  the  midbody,  which  is  its  physiological  localisation  at  this  stage  of  mitosis  
(Fig.  18-­‐2).  
The  CBmut-­‐EY-­‐HP1α  construct,  which  shows  faster  binding  dynamics  than  CB-­‐
EY-­‐HP1α   and   does   not   cause   a   mitotic   delay,   also   failed   to   retain   Aurora   B   at  
centromeres   in   telophase   (Fig.   18-­‐3).   Instead,   I   observed   an   EYFP   signal   at   the  
midbody  region  in  CBmut-­‐EY-­‐HP1α  expressing  cells.  Therefore,  it  appears  that  the  CPC  
was  dominant  over  CBmut-­‐EY-­‐HP1α  and   instead  determined  the   localisation  of  this  














Figure  18:  Centromere  tethering  of  HP1α  leads  to  abnormal  centromeric  retention  of  
Aurora  B  in  telophase.  
Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  constructs  expressing  CB-­‐EY-­‐HP1α  
(1),  CB-­‐EY-­‐HP1αW174A   (2),  CBmut-­‐EY-­‐HP1α  (3),  or  EY-­‐HP1α  (4)   (shown   in  green).  Cells  were  stained  with  
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Figure  19:  Tethering  of  HP1α  to  centromeres  leads  to  abnormal  centromeric  retention  
of  Aurora  B  in  anaphase  and  after  chromosome  decondensation.  
(A)  Fluorescence  microscopy  analysis  of  Hela  cells  24  h  after  transfection  with  a  construct  expressing  EY-­‐
HP1α   (shown   in   green).   Cells  were   stained  with  Hoechst   33342   (blue)   after   pre-­‐extraction  with   0.1%  
Triton  X-­‐100/PHEM  buffer  for  1  min.  Scale  bar,  5  µm.  
(B,  C)  Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  constructs  expressing  CB-­‐
EY-­‐HP1α   (1)   or   CB-­‐EY-­‐HP1αW174A   (2)   (shown   in   green).   Cells   were   stained   with   Hoechst   33342   and  
immunostained  with  an  antibody  recognising  Aurora  B  (red)  and  α-­‐tubulin.  The  brightness  of  the  channel  
showing  the  EYFP  signal  was  scaled  individually  to  optimise  the  clarity  of  the  tethering,  however,  in  both  




observed   a   similar   EYFP   signal   at   the   midbody   region   in   cells   expressing   the  
untethered  EY-­‐HP1α  (Fig.  18-­‐4),  which  has  been  previously  reported  to  localise  to  the  
midbody  in  telophase  (Hayakawa  et  al.,  2003).  The  recruitment  of  EY-­‐HP1α  to  sites  
of  CPC  localisation  in  anaphase  and  telophase  became  even  clearer  when  I  performed  
pre-­‐extraction  before  fixing  the  cells  with  PFA  (Fig.  19A).  
Additionally,  the  retention  of  Aurora  B  at  centromeres  was  also  visible  in  CB-­‐
EY-­‐HP1α   expressing   cells   at   anaphase   and   even   at   much   later   stages   when  
chromosomes  began  to  decondense  (Fig.  19B,C).  By  contrast,  cells  expressing  the  CB-­‐
EY-­‐HP1αW174A  construct  did  not  exhibit  this  clear  Aurora  B  retention  at  any  of  these  
stages  (Fig.  19B,C).    
  
4.2.2   Retention  of  HP1-­‐bound  CPC  leads  to  H3S10  phosphorylation  in  G1  cells  
When   investigating   the   consequences   of   retaining  Aurora   B   at   centromeres  
during   mitotic   exit,   I   discovered   a   robust   H3S10ph   signal   in   interphase   cells  
expressing  CB-­‐EY-­‐HP1α  (Fig.  20A-­‐1).  Importantly,  co-­‐staining  with  an  anti-­‐cyclin  A2  
antibody  allowed  me  to  identify  cells  in  G1  phase,  indicated  by  the  absence  of  a  cyclin  
A2   signal.   Thus,   this   histone   H3S10   phosphorylation   was   independent   of   the  
physiological  H3S10ph  that  occurs  during  G2  phase  (Hendzel  et  al.,  1997;  Crosio  et  al.,  
2002;  Monier  et  al.,  2007;  Hayashi-­‐Takanaka  et  al.,  2009).  The  H3S10ph  observed  in  
G1   phase   was   not   detectable   in   cells   expressing   the   construct   CB-­‐EY-­‐HP1αW174A  
(Fig.  20A-­‐2),  which  did  not  retain  Aurora  B  at  telophase  centromeres  (see  Fig.  18-­‐2).  
To   quantify   this   observation,   I   used   the   automated   image   analysis   software  
CellProfiler,  which  automatically  quantified  the  number  of  histone  H3S10ph-­‐positive  
G1  cells  (Fig.  20B).  In  HeLa  cells,  the  specific  H3S10ph  signal  was  detectable  24  h  after  
transfection   in   54%  of   CB-­‐EY-­‐HP1α   expressing  G1   cells.   However,  when  using   the  
same  detection  parameters,  I  detected  few,  if  any,  G1  cells  positive  for  H3S10ph  in  
cultures  expressing  CB-­‐EY-­‐HP1αW174A,  CBmut-­‐EY-­‐HP1α,  EY-­‐HP1α,  or  in  untransfected  
cells,  which  all  did  not  retain  Aurora  B  at  centromeres  in  telophase.  Analysing  U2OS  
cells,  I  obtained  a  comparable  result:  CB-­‐EY-­‐HP1α  expression  led  to  H3S10ph-­‐positive  


















































Figure  20:  Retention  of  HP1-­‐bound  CPC  leads  to  H3S10  phosphorylation  in  G1  cells.  
(A)  Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  constructs  expressing  CB-­‐
EY-­‐HP1α   (1)   or   CB-­‐EY-­‐HP1αW174A   (2)   (shown   in   green).   Cells  were   stained  with  Hoechst   33342   and  
immunostained  with  antibodies  recognising  histone  H3S10  phosphorylation  (red)  and  cyclin  A2.  The  
latter  was  used  to  identify  cells  at  the  G1  stage  of  the  cell  cycle  (indicated  by  the  absence  of  cyclin  A2).  
Scale  bar,  5  µm.  
(B)  Quantification  of  G1  cells  positive  for  histone  H3S10  phosphorylation  24  h  after  transfection  with  
the   indicated  HP1α  fusion  constructs  or   in  untransfected  cells  using   the  automated  image  analysis  
software   CellProfiler.   Graphs   represent   the   mean   and   standard   deviation   of   three   independent  
experiments.  The  overall  numbers  of  analysed  cells  which  met  the  criteria  of  being  transfected  and  




signal   was   observed   with   the   automated   image   analysis   (frequencies   below   1%)  
following  the  expression  of  the  above-­‐mentioned  controls.    
The  automated  image  analysis  allowed  me  to  quantify  a  large  number  of  cells,  
emphasising   the   utility   of   an   automated   approach   when   analysing   a   distinct  
subpopulation,  such  as  transfected  cells   that  are   in  the  G1  phase,  and  detecting  a  
specific  phenotype,  which  in  my  experimental  setup  was  H3S10ph-­‐positive  nuclei.  
Together,  these  results  reveal  that  Aurora  B  retained  at  centromeres  in  cells  
expressing  CB-­‐EY-­‐HP1α  remains  active  following  mitotic  exit,   indicating  that  stably  
tethered  HP1α  can  localise  a  functional  CPC  in  G1  cells,  a  cell  cycle  stage  at  which  the  
CPC  is  typically  inactive.  
  
4.2.2.1   Live   cell   imaging   highlights   the   robustness   of   the   induced   H3S10  
phosphorylation  throughout  interphase    
To  determine  the  robustness  of  the  induced  H3S10ph  interphase  signal,  I  made  
use  of  a  specific  imaging  technique,  with  which  chromatin  marks  are  traceable  in  live  
cell  experiments.  The  imaging  approach  is  based  on  fluorescently  labelled  antigen-­‐
binding  fragments  (Fabs),  which  I  loaded  into  living  transfected  cells  using  glass  beads  
(McNeil  and  Warder,  1987;  Hayashi-­‐Takanaka  et  al.,  2011).  To  ensure  that  the  Fab  
recognises  the  H3S10ph  mark  at  tethered  HP1α  clusters  during   interphase,   I  used  
Fab313,   which   can   also   react   with   H3S10ph   next   to   a   H3K9me3   mark,   as  
demonstrated  in  a  previous  study  (Hayashi-­‐Takanaka  et  al.,  2009).  
Using   this   experimental   setup,   I   could   track   the   specific   H3S10ph   signal  
localised   at   sites   of   the   tethered   CB-­‐EY-­‐HP1α   foci   for  more   than   8   h   hours   after  
mitotic  exit  (Fig.  21A;  Movie  1).  In  control  cells  expressing  CB-­‐EY-­‐HP1αW174A,  no  such  
H3S10ph  signal  was  detectable  after  cells  left  mitosis  (Fig.  21B),  which  is  in  line  with  
the  fixed  cell  experiment  (see  Fig.  20A-­‐2).  
Reducing  the  frequency  of   image  acquisition  to  every  30  min  allowed  me  to  
track   cells  across  an  entire   cell   cycle.  This  experiment   revealed   that   the  H3S10ph  
signal  was  detectable  continuously  between  two  consecutive  mitoses  and  therefore  




   Together,  the  live  cell  imaging  experiments  using  fluorescently  labelled  Fabs  
revealed  that  the  H3S10  phosphorylation  induced  by  tethering  of  wildtype  HP1α  is  
stable  throughout  interphase.     
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Figure   21:   Live   cell   imaging   highlights   the   robustness   of   the   induced   H3S10  
phosphorylation  throughout  interphase.  
(A,  B)  Stills  of  live  cell  imaging  movies  analysing  HeLa  cells  expressing  CB-­‐EY-­‐HP1α  (A)  or  CB-­‐EY-­‐HP1αW174A  
(B).   Live   cell   imaging   was   performed   using   CF640R-­‐labelled   Fab   fragments   that   recognise   H3S10  
phosphorylation,   together   with   differential   interference   contrast   (DIC)   microscopy.   Movies   were  
acquired  with  a  100×  objective  every  10  min  and  five  z-­‐sections  every  2  μm.  Scale  bar,  5  μm.  
(C)  Stills  of  a  live  cell  imaging  movie  analysing  HeLa  cells  expressing  CB-­‐EY-­‐HP1α.  Live  cell  imaging  was  
performed  using  CF640R-­‐labelled  Fabs  that  recognise  H3S10  phosphorylation,  together  with  differential  
interference  contrast  (DIC)  microscopy.  Movies  were  acquired  with  a  60×  objective  every  30  min  and  five  




4.2.2.2   The  induced  interphase  H3S10  phosphorylation  is  sensitive  to  a  low  dosage  
of  the  Aurora  B  inhibitor  ZM447439  
Use   of   the   Aurora   B   inhibitor   ZM447439   allowed   me   to   test   whether   the  
persistence   of   the   H3S10ph   signal   co-­‐localising  with   the   CB-­‐EY-­‐HP1α   construct   in  
interphase   required   continuous   Aurora   B   activity   (Fig.   22A).   Interestingly,   the  
H3S10ph   signal   in   interphase   cells   vanished   after   treatment   with   a   low   dosage  
(0.5µM)  of  ZM447439,  a  concentration  that  has  no  apparent  effect  on  H3S10ph  in  
mitotic  cells  (Fig.  22A2).  
The   disappearance   of   the   H3S10ph   signal   occurred   even   though   Aurora   B  
remained   localised   at   the   CB-­‐EY-­‐HP1α   foci   (Fig.   22B2).   Therefore,   the   addition   of  
ZM447439   did   not   disrupt   the   CPC-­‐HP1α   interaction,   but   this   experiment   instead  
indicates   that   Aurora   B   activity   might   be   more   sensitive   to   inhibition   during  
interphase  than  it  is  during  mitosis.    
  








































 aurora B localization does not depend on its kinase activity (Girdler et al., 2006)
FROM KIMURAS LIVE CELL PAPER
Figure  22:  The  induced  interphase  H3S10  phosphorylation  is  sensitive  to  a  low  dose  of  
the  Aurora  B  inhibitor  ZM447439.  
(A)  Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  a  construct  expressing  CB-­‐EY-­‐
HP1α  (shown  in  green)  treated  with  either  DMSO  (1)  or  with  0.5  µM  ZM447439  (2)  for  60  minutes  before  
fixing  the  cells.  Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  
histone  H3S10  phosphorylation  (red)  and  α-­‐tubulin.  Scale  bar,  10  μm.  
(B)  Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  a  construct  expressing  CB-­‐EY-­‐
HP1α  (shown  in  green)  treated  with  either  DMSO  (1)  or  with  0.5  µM  ZM447439  (2)  for  60  minutes  before  
fixing  the  cells.  Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  






5   Results  chapter  3:  Investigating  the  molecular  mechanism  of  
endogenous  H3S10ph  foci  in  G2  cells  
  
5.1   Analysing  endogenous  H3S10ph  foci  in  G2  cells  
The  results  I  described  so  far  have  revealed  a  strong  interaction  between  HP1α  
and   the  CPC   in   vivo.   Furthermore,   tethered  HP1α   is  able  to   concentrate  Aurora  B  
resulting  in  H3S10ph  foci  at  CB-­‐EY-­‐HP1α  clusters  in  interphase.  Therefore,  I  decided  
to  examine  the  possible  contribution  of  HP1α  to  the  CPC-­‐dependent  emergence  of  
endogenous  H3S10ph  in  interphase  cells  during  G2.    
  
5.1.1   H3S10ph  foci  co-­‐localise  with  untethered  EY-­‐HP1α  in  G2  cells  
As  shown  earlier  in  Figures  20,  21,  and  22,  clear  H3S10ph  foci  co-­‐localised  with  
CB-­‐EY-­‐HP1α   in   interphase   cells   (Fig.   23-­‐1).   Furthermore,   I   also   detected   distinct  
H3S10ph   foci   in   untransfected   cells   in   the  G2   stage   of   the   cell   cycle,   indicated   by  
positive   staining   for   cyclin   B   (Fig.   23-­‐2,   see   asterisk).   Various   studies   previously  
described  this  observed  emergence  of  H3S10ph  foci  in  G2  cells  (Hendzel  et  al.,  1997;  
Crosio  et  al.,  2002;  Monier  et  al.,  2007;  Hayashi-­‐Takanaka  et  al.,  2009).  Interestingly,  
the  H3S10ph  signal  in  G2  cells  co-­‐localised  with  foci  of  untethered  EY-­‐HP1α  (Fig.  23-­‐
2).  This  H3S10ph  signal  was  most  likely  not  artificially  induced  by  the  expression  of  
EY-­‐HP1α,  as  a  similar  signal  was  detectable  in  the  untransfected  G2  cells  of  the  same  
culture  (Fig.  23-­‐2,  see  asterisk).  Moreover,  EY-­‐HP1α  was  not,   in  contrast  to  CB-­‐EY-­‐
HP1α,  able  to  induce  H3S10ph  in  G1  cells,  as  described  earlier  (see  Fig.  20B).  














Figure  23:  H3S10ph  foci  co-­‐localise  with  untethered  EY-­‐HP1α  in  G2  cells.  
Immunofluorescence  analysis  of  Hela  cells  24  h  after  transfection  with  constructs  expressing  CB-­‐EY-­‐HP1α  
(1)   or  EY-­‐HP1α   (2)   (shown   in  green).   Cells  were   stained  with  Hoechst   33342   and   immunostained  with  
antibodies  recognising  histone  H3S10  phosphorylation  (red)  and  cyclin  B.  The  latter  was  used  to  identify  





5.1.2   Characteristic  endogenous  H3S10ph  foci  at  the  CDK1  arrest  point  in  G2  
The  H3S10ph  chromatin  mark  typically  emerges  in  G2  cells  at  heterochromatin  
foci   and   spreads   across   the   entire   nucleus   with   progression   towards   the   G2/M  
transition.   Therefore,   I   detected   a   broad   spectrum   of   different   H3S10ph   staining  
patterns   in   unsynchronised   cultures   (Fig.   24A).   These   included   cells   with   a   few  
isolated   H3S10ph   foci   in   the   nucleus   (1),   cells   with   larger   and   more   abundant  
H3S10ph   foci   (2),   and   nuclei   that   showed   a  more   general   H3S10ph   staining   that  
started  to  spread  through  the  nucleus  (3),  eventually  leading  to  a  H3S10ph  labelling  
of  the  entire  chromatin  in  mitosis  (4).  
The   rapid   progression   of   the   H3S10ph   chromatin   labelling   in   the   G2   phase,  
resulting  in  those  various  H3S10ph  staining  patterns,  made  it  challenging  to  precisely  
analyse  the  emergence  of  the  H3S10ph  foci.  Therefore,  I  used  Hela  cells  whose  cell  
cycle  progression  is  driven  by  a  CDK1-­‐analogue  sensitive  (-­‐as)  kinase  (Fig.  24B).  The  
ATP-­‐binding  pocket  of  Xenopus   laevis  CDK1  was  modified  using  chemical  genetics,  
allowing  a  reversible  inhibition  with  the  bulky  ATP  analogue  1NM-­‐PP1  (Hochegger  et  
al.,  2007).  Incubation  with  1NM-­‐PP1  synchronised  cells  at  the  CDK1  arrest  point  in  
the   G2   phase   and   cells   entered   mitosis   in   less   than   60   minutes   after   1NM-­‐PP1  
removal.  This  allowed  me  to  analyse  the  H3S10ph  foci  in  a  highly  synchronous  culture  
of  G2  cells  and  therefore  with  high  temporal  accuracy.    
Analysing  the  pattern  of  H3S10ph  foci  in  cells  after  incubation  with  1NM-­‐PP1  
for  20  h   revealed  a   striking   consistency   throughout   the  culture,  as  nearly  all   cells  
exhibited  3  to  6  distinct  H3S10ph  foci  (Fig.  24C).  Therefore,  the  CDK1-­‐as  approach  
allowed  me  to  study  precisely  the  formation  of  H3S10ph  foci  in  G2  cells  and  further  
revealed  that  this  H3S10  phosphorylation  is  independent  of  CDK1  activity.  























Figure  24:  Characteristic  endogenous  H3S10ph  foci  at  the  CDK1  arrest  point  in  G2.  
(A)   Immunofluorescence  analysis  of  unsynchronised  Hela  CDK1-­‐as  (analogue  sensitive)  cells  stained  
with   Hoechst   33342   (blue)   and   immunostained   with   an   antibody   recognising   histone   H3S10  
phosphorylation  (green).  Numbers  indicate  different  levels  of  H3S10  phosphorylation  (see  main  text  
for  detailed  description).  Scale  bar,  10  µm.  
(B)   Schematic   representation   of   the   cell   cycle   and   the   effect   of   1NM-­‐PP1   treatment   on   cell   cycle  
progression  in  HeLa  CDK1-­‐as  cells.    
(C)  Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  synchronised  with  10  µM  1NM-­‐PP1  for  20  h.  
Cells  were  stained  with  Hoechst  33342  (blue)  and  immunostained  with  antibodies  recognising  histone  




5.1.2.1   Live  cell  imaging  highlights  the  robustness  of  the  H3S10ph  foci  at  the  CDK1  
arrest  point  
To  characterise  the  dynamics  of  the  H3S10ph  foci  at  the  CDK1  arrest  point  in  
more  detail,   I  used  the  fluorescently   labelled  Fab  fragments  recognising  H3S10ph,  
that  I  described  in  section  4.2.2.1.  The  H3S10ph  foci  appeared  to  be  very  stable  and  
hardly  changed  over  a  recorded  period  of  12  h  when  monitored  with  Fab  fragments  
in  living  CDK1-­‐as  cells  synchronised  with  1NM-­‐PP1  (Fig.  25;  Movie  3).  The  decreasing  
intensity  of  the  H3S10ph  foci  over  the  duration  of  the  movie  was  most  likely  due  to  
photobleaching,  as  images  were  acquired  every  6  min,  the  overall  fluorescent  signal  
decreased,  and  in  contrast  to  fluorescent  proteins  like  GFP,  which  are  continuously  
expressed,   the   amount   of   fluorescent   probe  within   the   cell   is   not   renewed  when  
using  labelled  Fab  fragments.  
Together,   the   live   cell   imaging   revealed   that   the   H3S10ph   foci   remain   at   a  
distinct   chromatin   localisation   when   cells   are   kept   at   the   CDK1   arrest   point.  
Additionally,  CDK1  inhibition  appeared  to  not  only  prevent  cell  cycle  progression  but  
also  spreading  of  the  H3S10ph  signal  throughout  the  nucleus.    

















Figure  25:   Live   cell   imaging  highlights   the   robustness  of   the  
H3S10ph  foci  at  the  CDK1  arrest  point.  
Stills  of  a   live  cell   imaging  movie  analysing  HeLa  CDK1-­‐as  cells   that  were  
synchronised  with  10  μM  1NM-­‐PP1.  Live  cell  imaging  was  performed  using  
Cy5-­‐labelled   Fab   fragments   that   recognise   H3S10   phosphorylation,  
together  with  differential  interference  contrast  (DIC)  microscopy.  Movies  
were  acquired  with  a  100×  objective  every  6  min  and  five  z-­‐sections  every  




5.1.2.2   Endogenous  interphase  H3S10ph  foci  are  sensitive  to  a  low  dosage  of  the  
Aurora  B  inhibitor  ZM447439    
I  next  tested  the  sensitivity  of  the  endogenous  G2  H3S10ph  foci  to  inhibition  
with  a  low  concentration  of  the  Aurora  B  inhibitor  ZM447439  (Fig.  26).  Similar  to  the  
induced   H3S10ph   signal   in   CB-­‐EY-­‐HP1α-­‐expressing   interphase   cells,   0.5   µM   of  
ZM447439  entirely  abolished  the  H3S10ph  signal  in  1NM-­‐PP1  synchronised  CDK1-­‐as  
cells.  The  H3S10ph  signal  was  not  detectable  upon  ZM447439  treatment,  although  
Aurora  B  kinase  continued  to  co-­‐localise  with  EY-­‐HP1α  foci  (Fig.  26-­‐1).  
I  also  observed  this  co-­‐localisation  between  EY-­‐HP1α  and  Aurora  B  in  cultures  
that  were  not   synchronised  with  1NM-­‐PP1   (   -­‐1NM-­‐PP1)   (Fig.  26-­‐2).   Similar   to   the  
synchronised   cells,   0.5   µM   ZM447439   abolished   H3S10ph   in   interphase   of   the  
unsynchronised  culture.  However,  a  clear  signal  of  H3S10ph  remained  detectable  in  
mitotic   cells,   overall   confirming   the   results   obtained   from   experiments   analysing  
interphase  H3S10ph  foci  induced  by  CB-­‐EY-­‐HP1α  (see  Fig.  22).  Together,  these  results  
indicate  that  endogenous  interphase  H3S10ph  requires  continuous  Aurora  B  activity  
and  is  more  sensitive  to  low  dosage  Aurora  B  inhibition  than  H3S10ph  in  mitosis.    
  
The   results  presented   in   this  section   suggest   that  endogenous  H3S10ph   foci  
that  emerge  at  the  G2  stage  of  the  cell  cycle  co-­‐localise  with  EY-­‐HP1α  clusters,  occur  
before  CDK1  activation,  and  require  continuous  Aurora  B  activation.  







5.2   H3S10ph  foci  in  G2  precede  histone  modifications  that  cause  CPC  clustering  in  
mitosis  
The   centromere   localisation   of   the   CPC   during   mitosis   is   reported   to   be  
determined   by   two   histone   tail   post-­‐translational   modification,   H3T3ph   and  
H2AT120ph.  Thus,   targeting  of  the  CPC  to  centromeres   is  achieved  through  direct  
binding   of   survivin   to   H3T3ph   and   via   Shugoshin,   which   binds   H2AT120ph   and  
interacts  with  borealin  (Kelly  et  al.,  2010;  Wang  et  al.,  2010;  Yamagishi  et  al.,  2010).  
I  therefore  next  investigated  whether  these  mechanisms  of  CPC  clustering  also  apply  
in  the  G2  phase  and  lead  to  the  observed  H3S10ph  foci.  
  
5.2.1   H3S10ph  foci  precede  emergence  of  H3T3  phosphorylation    
To  determine  a  potential  connection  between  H3T3ph  and  the  occurrence  of  
H3S10ph   foci   in   G2   cells,   I   performed   immunofluorescence   experiments   and   co-­‐
stained  for  these  two  histone  marks.  The  entire  culture  of  CDK1-­‐as  cells  synchronised  
Figure  26:  Endogenous  interphase  H3S10ph  foci  are  sensitive  to  a  low  dose  of  the  Aurora  
B  inhibitor  ZM447439.  
Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  24  h  after  transfection  with  a  construct  expressing  EY-­‐
HP1α  (shown  in  green)  and  treated  with  0.5  µM  ZM447439  for  60  minutes  before  fixing  cells.  Cells  were  
synchronised   for   20h  with   10  μM  1NM-­‐PP1   (+1NM-­‐PP1)   (1)   or   left   unsynchronised  by   addition   of   only  
DMSO   (-­‐1NM-­‐PP1)   (2).   Cells   were   stained   with   Hoechst   33342   and   immunostained   with   antibodies  







































with  1NM-­‐PP1  was  negative  for  the  H3T3ph  staining.  However,  the  above  described  
H3S10ph  foci  that  occur  at  the  CDK1  arrest  point  were  detectable  in  almost  every  cell  
(Fig.  27A1).    
To  take  into  account  the  possibility  that  the  inhibition  of  the  CDK1  kinase  had  
an  effect  on  Haspin  activity  in  these  1NM-­‐PP1  synchronised  G2  cells,  I  also  analysed  
cells  that  were  not  synchronised  (-­‐1NM-­‐PP1)  (Fig.  27A2).  The  unsynchronised  culture  
showed  the  same  trend:  H3S10ph  foci  emerged  in  nuclei  before  I  could  detect  any  
H3T3ph   signal   (Fig.   27A2).   Increasing   the   image   intensities   highlights   the   state   in  
which   the   H3S10ph   foci   started   to   emerge  while   the   H3T3ph   signal   was   still   not  
present   (Fig.  27A3   -­‐  outlined  cells).   The  H3T3ph  mark  only  appeared  when  nuclei  
already  showed  a  general  H3S10ph  signal  all  over  chromatin  (Fig.  27A2).  
In   an   additional   control,   I   stained   for   the   two   histone   marks   H3S10ph   and  
H3T3ph  in  wildtype  HeLa  cells  to  exclude  the  possibility  of  a  specific  effect  in  Hela  
CDK1-­‐as  cells  due  to  the  modified  CDK1  kinase.  Staining  of  the  wildtype  HeLa  cells  led  
to  the  same  result  (Fig.  27B):  I  observed  clear  H3S10ph  foci  in  cells  that  were  negative  
for  H3T3ph  staining.  Moreover,   chromatin   labelling  with  H3T3ph  occurred   only   in  
cells  that  exhibited  strong  H3S10ph  staining  throughout  the  nucleus.    
  
I  further  resolved  the  temporal  relationship  between  the  H3T3ph  and  H3S10ph  
marks  in  cells  normally  passing  through  the  cell  cycle  by  using  fluorescently  labelled  
Fab  fragments  and  live  cell  imaging.  To  allow  a  simultaneous  detection  of  two  histone  
marks,   I   used   CF640R-­‐labelled   Fab   fragments   detecting   H3T3ph   and   Alexa488-­‐
labelled  Fab  fragments  detecting  H3S10ph.  This  experimental  setup  allowed  me  to  
study  the  formation  of  these  two  histone  marks  in  living  cells  with  a  very  accurate  
temporal  resolution  (Fig.  28;  Movie  4).  
The  live  cell  analysis  revealed  that  the  typical  H3S10ph  foci  seen  in  the  G2  phase  
are  present  in  interphase  cells  long  before  the  H3T3ph  mark  emerges  (Fig.  28  -­‐  6.0  
h/8.7  h).  It  was  only  with  the  breakdown  of  the  nuclear  envelope  that  a  simultaneous  
signal  for  both  chromatin  marks  was  detectable  and  appeared  all  over  chromatin  (Fig.  







































Figure  27:  H3S10ph  foci  precede  emergence  of  H3T3  phosphorylation.  
(A)  Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  synchronised  with  10  µM  1NM-­‐
PP1  for  20  h  (+1NM-­‐PP1)  (1)  or  left  unsynchronised  (-­‐1NM-­‐PP1)  (2).  Cells  were  stained  
with   Hoechst   33342   and   immunostained  with   antibodies   recognising   histone   H3T3  
phosphorylation  and  histone  H3S10  phosphorylation.  Scale  bar,  5  µm.  
Panel  3  shows  the  same  cells  as  those  in  panel  2,  but  with  increased  image  intensities  
of  the  channels  representing  the  H3T3ph  and  H3S10ph  staining.  The  outlined  nuclei  
show  the  stage  at  which  H3S10ph  foci  are  already  present  while  a  H3T3ph  signal  is  not  
yet  detectable.  
(B)  Immunofluorescence  analysis  of  Hela  cells  with  a  wildtype  CDK1  kinase.  Cells  were  
stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  histone  




Besides   the   emergence   of   H3T3ph   and   H3S10ph,   the   live   cell   imaging   also  
provided  insight  into  the  removal  of  those  marks.  Remarkably,  H3T3ph  disappeared  
quickly  after  the  onset  of  anaphase,  whereas  the  chromatin  remained  positive  for  the  
H3S10ph  mark  for  a  longer  time  (Fig.  28  -­‐  10.8  h).  
     Together,   the   formation   of   the   H3S10ph   foci   in   G2   cells   appears   to   be  
independent  of  H3T3ph,  as  the  H3T3ph  mark  only  emerges  after  foci  of  H3S10ph  had  














Figure   28:   Live   cell   imaging   reveals   the   relative   timing   of   the  H3S10ph   and  H3T3ph  
marks.  
Stills   of   a   live   cell   imaging  movie   analysing   HeLa   cells   with   two   different   fluorescently   labelled   Fab  
fragments.   Alexa488-­‐labelled   Fab   fragments   recognise   histone   H3S10   phosphorylation   and   CF640R-­‐
labelled  Fabs   recognise  H3T3  phosphorylation.  Movies  were  acquired  with  a  100×  objective  every  10  
min,  with   five  z-­‐sections  every   1.2  μm  and  using  Differential   Interference  Contrast   (DIC)  microscopy.  




5.2.2   H3S10ph  foci  precede  clustering  of  the  H2AT120  phosphorylation  mark  
Besides  the  H3T3ph  mark,  H2AT120ph  also  contributes  to  CPC  clustering  at  the  
centromere  region  of  mitotic  chromosomes  (Yamagishi  et  al.,  2010).  Therefore,  I  next  
examined  a  possible  role  of  H2AT120ph  in  H3S10ph  focus  formation  in  G2  cells.    
  
Similar  to  the  experiments  investigating  a  contribution  of  H3T3ph  in  H3S10ph  
focus  formation  in  G2,  I  performed  immunofluorescence  experiments  and  co-­‐stained  
for  H3S10ph  and  H2AT120ph  in  1NM-­‐PP1  synchronised  HeLa  CDK1-­‐as  cells  (Fig.  29-­‐
1).   In  contrast  to  the  H3T3ph  signal,  which  was  absent  at  the  CDK1  arrest  point,   I  
observed  a  diffuse  labelling  of  the  entire  nucleoplasm  in  the  channel  detecting  the  
H2AT120ph  staining.  Because  the  whole  culture  was  synchronised  and  exhibited  the  
same  staining  pattern,  I  could  not  determine  whether  the  staining  represented  the  
correct  H2AT120ph  detection  or  was  an  unspecific  background  labelling.  
Therefore,   I  next  analysed  cells   that  were  not  synchronised  (-­‐1NM-­‐PP1)   (Fig.  
29-­‐2).  In  the  unsynchronised  culture,  I  also  observed  nuclei  with  a  staining  pattern  
similar  to  that  present  in  the  synchronised  culture,  with  individual  H3S10ph  foci  and  
a  diffuse  H2AT120ph  labelling.  However,  in  cells  that  were  in  early  mitosis,  judged  by  
the  condensed  chromatin  and  strong  H3S10ph  signal  throughout  the  nucleus,  clear  
foci   of   H2AT120ph   were   visible,   representing   the   typical   H2AT120ph   staining   at  
mitotic  centromeres.  
These  observations  suggest  that  the  anti-­‐H2AT120ph  antibody  recognises  the  
correct  epitope  and  that  H3S10ph  foci  appear  at  centromeres  at  a  time  when  the  
H2AT120ph  mark  still  localises  diffusely  throughout  the  nucleus.    
  
Next,  I  planned  to  investigate  the  temporal  relationship  between  H2AT120ph  
and  H3S10ph  in  more  detail,  but  I  did  not  have  access  to  Fab  fragments  that  recognise  
H2AT120ph.  However,  my  knowledge  about  H3S10ph  progression  from  previous  live  
cell   imaging  experiments  using  Fab  fragments  allowed  me  to  arrange   imaged  cells  




The  diffuse  labelling  of  H2AT120ph  throughout  nuclei  was  present  in  cells  that  
were   negative   for   the   H3S10ph   staining   (Fig.30-­‐1).   Note   that   the   smaller   cell,  
presumably   representing   the  G1   stage,  was   negative   for   the  H2AT120ph   staining,  
indicating  that  diffuse  staining  of  the  H2AT120ph  mark  through  nuclei  emerges  after  
the  G1  phase  and  before  H3S10ph  foci  are  established  in  G2.  When  the  H3S10ph  foci  
emerged,  the  H2AT120ph  labelling  did  not  change  (Fig.  30-­‐2).  Even  as  the  H3S10ph  
became  more   prominent   and  more   abundant,   I   did   not   observe   a   change   in   the  
H2AT120ph  staining  pattern   (Fig.  30-­‐3).  Only  when   the  H3S10ph  signal   started   to  
spread  through  the  nucleus  did  the  H2AT120ph  signal  begin  to  concentrate  in  small  
foci  (Fig.  30-­‐4).  Once  the  entire  chromatin  was  positive  for  the  H3S10ph  mark,  the  
H2AT120ph  foci  became  clearer,  increasing  in  size  and  brightness  (Fig.  30-­‐5).  After  
the  H3S10ph  labelling  became  abundant,  the  increasing  chromosome  condensation  
allowed  me  to  determine  the  stage  of  individual  cells  in  mitotic  progression  further.  
At  the  stage  in  which  condensed  chromosomes  became  apparent,  strong  H2AT120ph  
foci  were  present  (Fig.  30-­‐6).    















Figure  29:  Diffuse  nuclear  labelling  of  H2AT120  phosphorylation  at  the  CDK1  arrest  point.  
Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  synchronised  with  10  µM  1NM-­‐PP1  for  20  h  (+1NM-­‐
PP1)   (1)   or   left   unsynchronised   (-­‐1NM-­‐PP1)   (2).   Cells   were   stained   with   Hoechst   33342   (blue)   and  
immunostained  with  antibodies  recognising  histone  H3S10  phosphorylation  (green)  and  histone  H2AT120  












Figure  30:  H3S10ph  foci  precede  clustering  of  the  H2AT120  phosphorylation  mark.  
Immunofluorescence  analysis  of  unsynchronised  Hela  CDK1-­‐as  cells  that  are  arranged  in  a  sequence  
from  the  early  G2  stage  (1)  towards  prophase  (6)  based  on  the  H3S10  phosphorylation  staining  and  
the   chromosome   condensation   state.   Cells   were   stained   with   Hoechst   33342   (blue)   and  
immunostained   with   antibodies   recognising   histone   H3S10   phosphorylation   (green)   and   histone  




Together,   these   results   indicate   that   H3S10ph   foci   form   independently   of  
H2AT120ph  clustering,  which  begins  only  once  the  H3S10ph  mark  starts  to  spread  
through  the  nucleus.    
  
Overall,  the  investigation  of  the  histone  marks  H3T3ph  and  H2AT120ph,  which  
are   reported   to   be   responsible   for   CPC   localisation   at   centromeres   in   mitosis,  
revealed  that  they  only  begin  to  concentrate  at  centromeres  at  the  G2/M  transition.  
Therefore,   this   suggests   that   these   marks   do   not   contribute   to   H3S10ph   focus  
formation  during  G2,  and   instead  other  molecular  mechanisms  are  responsible   for  
CPC  clustering  and  activation  in  the  G2  phase  of  the  cell  cycle.  




5.3   H3S10ph  foci  in  G2  depend  on  HP1    
In  light  of  my  previous  results,  including  the  independence  of  H3S10ph  focus  
formation   in  G2   cells   from  H3T3ph  and  H2AT120ph   (see  Figs.  27   -­‐  30),   the   strong  
interaction  between  the  CPC  and  CB-­‐EY-­‐HP1α  in  mitosis  (see  Figs.  18  and  19),  and  the  
clear  co-­‐localisation  between  H3S10ph  foci  and  clusters  of  EY-­‐HP1α  (see  Fig.  23),  I  
hypothesized  that  HP1α  might  contribute  to  Aurora  B  clustering  and  activation  in  G2  
cells.    
  
5.3.1   H3S10ph  foci  appear  at  clusters  of  endogenous  HP1α  
To  determine  whether  HP1α  is  responsible  for  H3S10ph  focus  formation  in  G2  
cells,   I   first  performed   immunofluorescence  experiments  and  stained  for  H3S10ph  
and  endogenous  HP1α  in  1NM-­‐PP1  synchronised  CDK1-­‐as  cells.  As  was  the  case  for  
clusters  of  expressed  EY-­‐HP1α  (see  Fig.  23),  the  H3S10ph  foci  co-­‐localised  precisely  
with   clusters   of   endogenous   HP1α   (Fig.   31A).   Furthermore,   endogenous   HP1α  
clusters   showed   a   clear   co-­‐localisation   with   Aurora   B   in   the   entire   synchronised  
culture  (Fig.  31B).  These  results  indicate  that  Aurora  B  clustering  and  the  formation  
of  H3S10ph  foci  occur  at  sites  of  endogenous  HP1α  clusters  in  G2  cells.  
  
     
Figure  31:  Aurora  B  concentration  and  H3S10ph  foci  appear  at  clusters  of  endogenous  
HP1α.  
(A)  Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  synchronised  with  10  µM  1NM-­‐PP1  for  20  h.  
Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  HP1α  (green)  
and  histone  H3S10  phosphorylation  (red).  Scale  bar,  5  μm.  
(B)  Immunofluorescence  analysis  of  Hela  CDK1-­‐as  cells  synchronised  with  10  µM  1NM-­‐PP1  for  20  h.  
Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  HP1α  (green)  
and  Aurora  B  (red).  Scale  bar,  5  μm.  
A
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5.3.2   Loss  of  HP1α  +  HP1γ  eliminates  H3S10ph  foci  at  the  G2  stage  
To  analyse  the  role  of  the  three  HP1  isoforms  in  H3S10ph  focus  formation  in  G2  
cells,  I  used  various  single  and  double  knockouts  of  HP1α,  HP1β,  and  HP1γ  in  HeLa  
cells.  The  individual  knockout  cells  were  generated  using  the  CRISPR/Cas9  system  in  
the  laboratory  of  Shinya  Ohta  at  Kochi  University,  Japan  and  a  Western  blot  analysis  
provided  by  him  demonstrates  the  successful  depletion  of  the  indicated  HP1  isoforms  
(Fig.  32A).  The  HP1  knockout  cell  lines  were  generated  based  on  cells  with  a  wildtype  
CDK1  kinase.  Therefore,  I  used  RO-­‐3306,  a  CDK1  inhibitor,  to  synchronise  cells  at  the  
CDK1   arrest   point   in   G2.   However,   RO-­‐3306   does   not   work   as   reliably   as   the  
CDK1-­‐as/1NM-­‐PP1  system  in  terms  of  synchronisation,  and  hence,  I  stained  for  cyclin  
B  to  evaluate  the  cell  cycle  stage  of  the  analysed  cells  more  precisely.  
In  line  with  previous  experiments,  I  detected  evident  H3S10ph  foci  in  wildtype  
G2  cells,  which  expressed  all  three  HP1  isoforms  (Fig.  32B1).  In  HP1α  KO  cells,  I  still  
identified  H3S10ph  foci  in  cyclin  B-­‐positive  G2  cell,  but  with  a  reduced  frequency  (in  
67%  of  HP1α  KO  cell  versus  in  93%  of  wildtype  cells)  and  a  somewhat  decreased  signal  
intensity  (Fig.  32B2).  A  further  analysis  of  various  HP1  single  and  double  knockout  cell  
lines  revealed  that  only  the  simultaneous  knockout  of  HP1α  and  HP1γ  led  to  the  loss  
of  H3S10ph  foci  in  almost  all  G2  cells  (Fig.  32B3):  Instead  of  H3S10ph  foci,  a  diffuse  
H3S10ph  staining  evenly  labelled  the  nuclei  of  HP1α  +  HP1γ  double  KO  cells.  In  a  few  
cases  (<  5%),  I  observed  cells  with  H3S10ph  foci  in  the  HP1α  +  HP1γ  double  knockout  
culture  (Fig.  32B4).  However,   the  staining  for  cyclin  B  was  much  stronger   in  these  
cells,  suggesting  that  they  were  approaching  the  G2/M  transition.    


























































































Figure  32:  Loss  of  HP1α  +  HP1γ  eliminates  H3S10ph  foci  at  the  G2  stage.  
(A)  Western  blot  analysis  of  Hela  whole  cell  lysates  using  the  indicated  HP1  single  or  double  knockout  
cell  (KO)  lines.  The  individual  HP1  isoforms  were  detected  using  anti-­‐HP1α,  anti-­‐HP1β  or  anti-­‐HP1γ  
antibodies.  GAPDH  served  as  a  loading  control.  Western  blot  figure  was  provided  by  Shinya  Ohta  who  
generated  the  various  HP1  KO  cell  lines.  
(B)  Immunofluorescence  analysis  of  Hela  wildtype  (1),  HP1α  knockout  (2),  or  HP1α  +  HP1γ  double  
knockout  (DKO)  cells  (3,4).  Cells  were  synchronised  for  18  h  with  9  μM  of  RO-­‐3306  and  stained  with  
Hoechst  33342  and  immunostained  with  antibodies  recognising  histone  H3S10  phosphorylation  and  
cyclin  B.  Image  processing  was  performed  without  deconvolution  to  preserve  the  actual  appearance  
of  the  cyclin  B  staining.  The  numbers  indicate  the  frequency  of  cells  with  the  phenotype  shown  (n  =  




Indeed,   I   could   confirm   this  assumption  by  use  of   live   cell   imaging  with  Fab  
fragments   (Fig.  33;  Movie  5).  Detecting  H3S10ph   in  cycling   cells  revealed   that  the  
H3S10ph  foci  were  present  long  before  the  onset  of  mitosis  in  wildtype  cells,  whereas  
weak  H3S10ph  foci  typically  appeared  just  four  frames  (which  equals  24  min)  before  
NEB  in  the  HP1α  +  HP1γ  double  knockout  cells  (Fig.  33  1.6h).  Similar  to  wildtype  cells,  
the  entry  into  mitosis  was  accompanied  by  a  H3S10ph  signal  all  over  chromatin  also  
in  the  HP1α  +  HP1γ  double  knockout  cells  (Fig.  33  2.0h).  
Together,  these  results  indicate  that  HP1α  and  HP1γ  contribute  to  the  initial  



































































Figure   33:   Live   cell   imaging   reveals   the   delayed   appearance   of   H3S10ph   foci   in  
HP1α  +  HP1γ  double  KO  cells.  
Stills  of  live  cell  imaging  movies  analysing  wildtype  HeLa  cells  and  HP1α  +  HP1γ  double  knockout  (DKO)  
HeLa  cells.  Live  cell  imaging  was  performed  using  Cy5-­‐labelled  Fab  fragments  that  recognise  H3S10  
phosphorylation,  together  with  differential  interference  contrast  (DIC)  microscopy.  The  brightness  of  
the  channels  representing  the  Cy5  signal  was  adjusted  individually  between  the  movies  of  wildtype  
cells  and  HP1α  +  HP1γ  DKO  cells  (0.65%  difference),  to  compensate  for  the  slightly  larger  amount  of  
loaded  Fabs  in  the  wildtype  HeLa  cell.  Movies  were  acquired  with  a  100x  objective  every  6  min,  five  z-­‐




5.3.3   Loss  of  HP1α  +  HP1γ  abolishes  Aurora  B  clusters  in  G2  cells.  
Given   the  diffuse  H3S10ph  staining   in  HP1α  +  HP1γ  double  KO  G2   cells   (Fig.  
32B3),   I   also   investigated   the   localisation   of   Aurora   B,   the   kinase   catalysing   the  
H3S10ph   signal.   Similar   to   the   diffuse   H3S10ph,   Aurora   B   showed   a   diffuse  
distribution  in  synchronised  HP1α  +  HP1γ  double  KO  G2  cells  (Fig.  34-­‐2).  By  contrast,  
Aurora  B  formed  clusters  that  co-­‐localised  with  endogenous  HP1α  foci   in  wildtype  
cells  (Fig.  34-­‐1),  as  earlier  shown  in  CDK1-­‐as  cells  synchronised  with  1NM-­‐PP1  (see  
Fig.  31B).  Therefore,  a  double  knockout  of  HP1α  +  HP1γ  eliminates  the  clustering  of  
Aurora  B  kinase  in  G2  cells.    
Together,   these   results   indicate   that   HP1α   and   HP1γ   contribute   to   the  





     

















Figure  34:  Loss  of  HP1α  +  HP1γ  abolishes  Aurora  B  clusters  in  G2  cells.  
Immunofluorescence  analysis  of  Hela  wildtype  (1)  or  HP1α  +  HP1γ  double  knockout  (DKO)  cells  (2).  Cells  
were  synchronised  for  18  h  with  9  μM  of  RO-­‐3306  and  stained  with  Hoechst  33342  and  immunostained  





5.3.4   Time  difference  between  the  emergence  of  H3S10ph  foci  and  histone  marks  
that  cluster  the  CPC  in  mitosis  appears  smaller  in  HP1α  +  HP1γ  double  KO  cell  
  
Next,   I   investigated  whether   the  H3S10ph   foci   that   appear   in  HP1α   +  HP1γ  
double  KO  cells  close  to  the  G2/M  transition,  could  be  mediated  by  CPC  clustering  
through  histone  marks  that  are  responsible  for  CPC  localisation  during  early  mitosis.    
Co-­‐staining   for  H3S10ph   and  H3T3ph   in   fixed  HP1α   +  HP1γ   double   KO   cells  
suggested  that  H3S10ph  foci  appear  in  cells  with  emerging  H3T3ph  (Fig.  35A2).  By  
contrast,   the   H3S10ph  mark   labelled   the  whole   nucleus  when   the   H3T3ph   signal  
started  to  emerge   in  wildtype  cells   (Fig.  35A1),  as   I  previously  described   in  earlier  
experiments  (see  Fig.  27).  However,  in  some  cases  of  the  HP1α  +  HP1γ  double  KO  
culture,  I  observed  cells  that  did  not  exhibit  any  H3T3ph  signal  but  showed  individual  
H3S10ph  foci  (Fig.  35A2).    
  
I  observed  a   similar   trend  when  co-­‐staining   for  H3S10ph  and  H2AT120ph   in  
fixed  cells:  H3S10ph  foci  appeared  when  the  H2AT120ph  signal  became  somewhat  
more  granular,  but  no  specific  clusters  of  H2AT120ph  were  yet  detectable  in  those  
HP1α  +  HP1γ  double  KO  cells  (Fig.  35B2).  Evident  H2AT120ph  foci  started  to  emerge  
only  in  cells  with  a  strong  H3S10ph  labelling  of  the  nucleus.  Similar  to  previous  results  
(see  Figs.  29  and  30),  H3S10ph  foci  were  present  in  wildtype  cells  when  the  nuclei  
still  showed  diffuse  H2AT120ph  labelling  (Fig.  35B1).    
  
Together,   these   results   indicate   that   the   time   difference   between   the  
formation  of  H3S10ph  foci  and  the  appearance  of  chromatin  marks  that  cluster  the  
CPC  in  mitosis  is  much  smaller  in  HP1α  +  HP1γ  double  KO  cells  compared  to  wildtype  
cells.    











































Figure  35:  Time  difference  between  the  emergence  of  H3S10ph  foci  and  histone  marks  
that  cluster  the  CPC  in  mitosis  appears  smaller  in  HP1α  +  HP1γ  double  KO  cells.  
(A)  Immunofluorescence  analysis  of  Hela  wildtype  (1)  and  HP1α  +  HP1γ  double  knockout  (DKO)  cells  (2).  
Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  histone  H3S10  
phosphorylation  (green)  and  histone  H3T3  phosphorylation  (red).  Scale  bar,  5  μm.  
(B)  Immunofluorescence  analysis  of  Hela  wildtype  (1)  and  HP1α  +  HP1γ  double  knockout  (DKO)  cells  (2).  
Cells  were  stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  histone  H3S10  




5.3.4.1   Live  cell  imaging  reveals  the  timing  of  H3S10ph  focus  formation  and  H3T3ph  
emergence  in  HP1α  +  HP1γ  double  KO  cell  
I  wanted  to   investigate  the  emergence  of  the  H3S10ph   foci  and  the  H3T3ph  
mark   in   HP1α   +   HP1γ   double   KO   cells   with   a   more   precise   temporal   resolution.  
Therefore,   I   made   use   of   the   dual   labelling   approach   with   two   fluorescent   Fab  
fragments,  recognising  H3S10ph  and  H3T3ph  simultaneously  in  live  cell  imaging  (Fig.  
36;  Movie  6).    
These  experiments  confirmed  that  the  time  difference  between  the  emergence  
of  H3S10ph  foci  and  the  appearance  of  the  H3T3ph  mark  was  indeed  very  short  in  
HP1α  +  HP1γ  double  KO  cells.  However,  H3S10ph  foci  still  seemed  to  appear  shortly  
before  the  H3T3ph  labelling  became  visible  (Fig.  36  1.5h).  Again,  this  contrasts  with  
the  results  obtained  in  wildtype  cells,  in  which  I  observed  clear  H3S10ph  foci  a  long  
time  before  the  H3T3ph  mark  could  be  detected.    
  
5.3.5   Expression  of  EYFP-­‐HP1α  in  HP1α  +  HP1γ  double  KO  cells  restores  H3S10ph  
focus  formation  in  G2  cells    
To   confirm   that   HP1   contributes   to   CPC   clustering,   which   in   turn   leads   to  
H3S10ph  focus  formation  in  G2  cells,  I  expressed  EY-­‐HP1α  in  the  HP1α  +  HP1γ  double  
KO  cells  (Fig.  37).  Indeed,  the  presence  of  EY-­‐HP1α  in  these  double  KO  cells  resulted  
in  the  appearance  of  H3S10ph  foci,  co-­‐localising  with  EY-­‐HP1α  clusters  in  cyclin  B-­‐
positive   cells.   Importantly,   cells   that   did   not   express   EY-­‐HP1α   showed   a   diffuse  
H3S10ph  labelling  even  when  their  cell  cycle  stage  was  closer  to  the  G2/M  transition,  
as  indicated  by  a  stronger  cyclin  B  signal  (Fig.  37).    
  
Overall,  these  results  suggest  that  HP1α  and  HP1γ  contribute  to  the  clustering  
and  activation  of  the  CPC  in  the  G2  phase  of  the  cell  cycle.  This  is  a  novel  mode  of  CPC  
recruitment  that  occurs  before  the  CPC  concentration  takes  place  via  histone  marks  
at  mitotic  centromeres.    
  















































































Figure  36:  Live  cell  imaging  reveals  the  delayed  appearance  of  H3S10ph  foci  in  HP1α  +  
HP1γ  double  KO  cells.  
Stills  of  live  cell  imaging  movies  analysing  wildtype  HeLa  cells  and  HP1α  +  HP1γ  double  knockout  (DKO)  
HeLa   cells.   Live   cell   imaging  was   performed  using   Cy5-­‐labelled   Fab   fragments   that   recognise  H3S10  
phosphorylation,  together  with  differential   interference  contrast  (DIC)  microscopy.  The  brightness  of  
the  channels  representing  the  Cy5  signal  was  adjusted  individually  between  the  movies  of  wildtype  cells  
and  HP1α  +  HP1γ  DKO  cells  (0.65%  difference),  to  compensate  for  the  slightly  larger  amount  of  loaded  
Fabs  in  the  wildtype  HeLa  cell.  Movies  were  acquired  with  a  100x  objective  every  6  min,  five  z-­‐sections  










     











Figure  37:  Expression  of  EYFP-­‐HP1α  in  HP1α  +  HP1γ  double  KO  cells  restores  H3S10ph  focus  
formation  in  G2  cells.  
Immunofluorescence  analysis  of  HP1α  +  HP1γ  double  knockout  (DKO)  HeLa  cells  24  h  after  transfection  with  a  
construct   expressing  EY-­‐HP1α   (shown   in  green).   Cells  were   synchronised   for   12   h  with   9  μM  RO-­‐3306   and  
stained  with  Hoechst  33342  and  immunostained  with  antibodies  recognising  histone  H3S10  phosphorylation  
(red)  and  cyclin  B.  The  percentage  of  cyclin  B  positive  EY-­‐HP1α  expressing  cells  that  showed  H3S10ph  foci  is  




6   Results  chapter  4:  HeLa  CDK1-­‐as  characterisation  
  
Chemical  genetics  can  be  used  to  modify  the  ATP-­‐binding  site  in  kinases  so  that  
they   become   sensitive   to   selective   inhibitors.   1NM-­‐PP1   is   an   ATP   analogue   that  
contains  a   large  hydrophobic  group  and   therefore   fits  only   in  an  engineered  ATP-­‐
binding   site   removing   the  bulky   “gatekeeper”   residue   (Shokat  and  Velleca,  2002),  
allowing  a  specific   inhibition  of  the  modified  kinase.  This  approach  was  previously  
made  mainly  in  yeast  cells,  but  also  in  vertebrate  cells  (Weiss  et  al.,  2000;  Grzegorz  
et  al.,  2004;  Hochegger  et  al.,  2007).  Hochegger  and  colleagues  described   in  their  
work  that  selective  inhibition  of  the  CDK1  kinase  leads  to  an  arrest  in  the  G2  stage  of  
the   cell   cycle   (Hochegger   et   al.,   2007).   This   arrest   is   reversible   upon   1NM-­‐PP1  
washout  and  results  in  a  rapid  entry  into  mitosis  of  the  entire  synchronised  culture.  
Therefore,   the   CDK1-­‐as/1NM-­‐PP1   system   allows   a   specific   synchronisation   at   the  
CDK1  arrest  point  and  a  strong  enrichment  of  mitotic  cells.  Because  of  the  various  
applications   of   the   CDK1-­‐as/1NM-­‐PP1   system,   our   research   group   decided   to  
generate  a  HeLa  CDK1-­‐as  cell  line.  HeLa  cells  are  one  of  the  most  widely  used  human  
cell  lines  in  cell  biology  research  and  have  good  imaging  properties  because  of  being  
adherent  and  relatively  non-­‐motile.    
  
6.1   Cloning  of  HeLa  CDK1-­‐as  cells  
The  original  transfection  and  cloning  to  generate  the  HeLa  CDK1-­‐as  cells  was  
done   by   Kumiko   Samejima   and   Melpomeni   Platani   according   to   the   following  
strategy.  The  cell  line  HeLa  MKF1  was  used  to  create  the  HeLa  CDK1-­‐as  cells  (Klebig  
et  al.,  2009).  First,  cells  were  transfected  with  Xenopus  CDK1as  cDNA  that  was  linked  
to   a   puromycin   resistance   gene   via   a   sequence   coding   for   the   T2A   peptide   (see  
Appendix   for   the   plasmid   map).   Puromycin-­‐resistant   clones   were   analysed   by  
Western  blot  to  determine  the  expression  level  of  the  CDK1-­‐as  protein.  Clones  with  
an   adequate   expression   level   of   CDK1-­‐as   were   subjected   to   inactivation   of   the  
endogenous   CDK1   gene   by   the   CRISPR/Cas9   system.   Cells   were   transiently  




(hCas9;   Addgene   ID41815)   together   with   a   construct   containing   the   guide   RNA  
(gRNA)  (Addgene  ID41824).  Both  constructs  were  previously  described  in  (Mali  et  al.,  
2013)   and   the   insertion   of   the   gRNA   against   the   targeting   sequence  
ATTTCCCGAATTGCAGTACTAGG  within  the  CDK1  gene  into  the  gRNA  cloning  vector  
was  done  in  the  laboratory  of  Masato  Kanemaki  at  the  National  Institute  of  Genetics,  
Japan.  After  geneticin  selection  for  six  days,  colonies  were  grown  in  standard  DMEM  
growth  medium  for  two  weeks.  In  total,  96  colonies  were  picked  and  treated  with  
1NM-­‐PP1  for  two  days.  Colonies  that  showed  mitotic  cells  were  discarded  and  the  
remaining  clones  were  subjected  to  a  1NM-­‐PP1  washout.  Cells  were  examined  for  
the  presence  of  mitotic  cells  1  hour  after  the  washout,  and  18  clones  were  picked  for  
further  characterisation.  This  was  the  point  at  which  my  contribution  to  the  project  
started.  
  
6.2   Characterising  synchronisation  and  release  of  HeLa  CDK1-­‐as  cells  to  identify  a  
suitable  clone  
To  identify  a  suitable  HeLa  CDK1-­‐as  clone,  I  characterised  in  an  initial  step  seven  
different  clones  regarding  their  synchronisation  ability  at  the  CDK1  arrest  point  by  
use  of  1NM-­‐PP1  and  their  behaviour  upon  1NM-­‐PP1  washout  (Fig.  38).  All  clones,  
except  clone  10  and  14,  showed  a  uniform  synchronisation  in  interphase  24  h  after  
1NM-­‐PP1   addition  with   no  mitotic   cells   detectable   (Fig.   38A).   However,   a   strong  
variability  between  the   individual  clones  was  detectable  at  90  min  after  1NM-­‐PP1  
washout,  with  the  mitotic  indices  ranging  from  ~  50%  up  to  over  90%  (Fig.  38A).      
Clones  number  1  and  3  showed  the  highest  mitotic  index  among  those  analysed  
and  were  therefore  used  for  a  more  detailed  examination.  This  included  fixing  cells  
60,  90,  and  120  min  after  1NM-­‐PP1  washout  (Fig.  38B)  and  an  analysis  of  the  mitotic  
phases  (Fig.  38C).  More  than  80%  of  cells  in  both  clones  entered  mitosis  60  min  after  
1NM-­‐PP1  washout.  However,  even  at  120  min  after  1NM-­‐PP1  washout,  some  cells  
remained  in  interphase.  I  did  not  detect  a  difference  in  the  mitotic  index  between  90  
and   120   min   after   1NM-­‐PP1   washout,   suggesting   that   this   small   population   of  
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Figure  38:  Characterising  synchronisation  and  release  of  the  first  set  of  HeLa  CDK1-­‐as  
cells  to  identify  a  suitable  clone.  
Frequency  of  mitotic  cells  (A,  B)  or  of  the  different  mitotic  phases  (C)  in  a  culture  of  HeLa  CDK1-­‐as  cells  
treated  with   1NM-­‐PP1for   24  h.   Cells  were   fixed   after   the  1NM-­‐PP1  washout   at   the   indicated   time  




Next,  I  determined  the  progress  of  the  released  cultures  through  mitosis  (Fig.  
38C).  A  majority  of  cells  had  already  entered  prometaphase  60  min  after  1NM-­‐PP1  
washout,  but  hardly  any  cells  had  reached  the  metaphase  stage  yet.  The  analysis  of  
cells  fixed  90  min  after  1NM-­‐PP1  washout  suggested  that  cells  of  clone  3  progressed  
faster  through  mitosis  than  cells  of  clone  1,  indicated  by  a  higher  ratio  of  cells  being  
in  metaphase  (37%  clone  3  versus.  9%  clone  1).  Analysis  of  cells  fixed  120  min  after  
1NM-­‐PP1  washout   showed   a   similar   trend  with  more   cells   being   at   later  mitotic  
stages  in  the  culture  of  clone  3  than  of  clone  1.    
  
To  identify  a  HeLa  CDK1-­‐as  clone  which  shows  a  more  synchronous  release,  I  
characterised  ten  additional  clones  and  compared  them  to  clones  number  1  and  3  
(Fig.  39A).  Clone  number  11,  16,  and  17  did  not   show  a  complete  cell  cycle  arrest  
after  24  h  of  1NM-­‐PP1  treatment.  Upon  release  from  the  1NM-­‐PP1  block,  only  clone  
21  showed  a  mitotic  index  comparable  to  clone  1  and  3.  Therefore,  I  chose  clone  1,  
3,  and  21  for  a  more  detailed  characterisation.  
First,  I  blocked  with  1NM-­‐PP1  for  24  h  and  characterised  the  mitotic  stages  90  
min  after  1NM-­‐PP1  washout  (Fig.  39B).  At  this  time  point,  77%  of  cells  of  clone  21  
appeared  to  be  in  prometaphase  and  22%  of  cells  in  metaphase.  In  contrast  to  this,  
clone   3   appeared   to   progress   faster   through   mitosis   with   only   26%   of   cells   in  
prometaphase  but  72.7%  in  metaphase.  The  values  for  clone  1  were  between  of  the  
two  other  clones,  with  54.7%  of  cells  in  prometaphase  and  45.3%  in  metaphase.    
During  this  analysis,  I  noticed  a  large  number  of  cells  with  multipolar  spindles,  
with  frequencies  between  2.67%  and  4.67%,  judged  by  the  a-­‐tubulin  staining  (Fig.  
39C)  
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Figure  39:  Characterising  synchronisation  and  release  of  the  second  set  of  HeLa  CDK1-­‐
as  cells  to  identify  a  suitable  clone.  
(A,  B)  Frequency  of  mitotic  cells  (A)  or  of  the  different  mitotic  phases  (B)  in  the  culture  of  HeLa  CDK1-­‐as  
cells  treated  with  1NM-­‐PP1for  24  h.  Cells  were  fixed  after  the  1NM-­‐PP1  washout  at  the  indicated  time  
points  (in  minutes),  with  n=300  cells  analysed  per  clone  and  time  point.    
(C)  Frequency  of  mitotic  cells  with  multipolar  spindles  judged  by  the  immunostaining  with  an  antibody  





6.3   Determining  the  doubling  time  of  CDK1-­‐as  clones  
  
Because   of   the   unusually   large   number   of   cells   with   multipolar   spindles,   I  
determined  the  doubling  time  of  the  different  CDK1-­‐as  clones  and  compared  it  to  the  
cells  with  a  wildtype  CDK1  kinase.  This  served  as  a   further  characterisation  of  the  
individual  clones  but  also  helped  me  to   judge  whether   it   is  possible  to  reduce  the  
duration  of  the  1NM-­‐PP1  treatment  and  at  the  same  time  keep  the  high  synchrony  
of  the  cell  population  released  from  a  1NM-­‐PP1  block.    
First,  I  determined  the  growth  rate  of  these  clones  compared  to  the  wildtype  
cells  containing  an  unmodified  CDK1  kinase  (Fig.  40A).  I  counted  the  number  of  cells  
every  24  h  over  a  period  of  5  days.  All  CDK1-­‐as  clones  showed  a  similar  growth  rate  
like   the  wildtype   cells.   Based   on   the   growth   rate   it  was   possible   to   calculate   the  
doubling  time  using  following  formula:  
  
Doubling	  time =
Duration	  of	  culture ∗ log(2)
log(final	  concentration) − log(initial	  concentration)  
  
Calculating  the  doubling  time  revealed  a  similar  timing  for  all  clones  of  ~  20  h  
(Fig.  40B).  Therefore,  I  reduced  the  duration  of  the  1NM-­‐PP1  treatment  to  20  h,  as  
an  approach  to  minimise  the  number  of  cells  with  multipolar  spindles.  




























Results - Figure 36
Figure  40:  Growth  curve  and  doubling  time  of  selected  HeLa  CDK1-­‐as  clones  compared  
to  wildtype  cells.  
(A)  30,000  cells  were  seeded  per  well  of  a  6-­‐well  plate  and  the  cell  number  was  determined  every  24  h  
in  triplicate.  Graphs  represent  the  mean  and  standard  deviation  using  a  logarithmic  scale.    
(B)  The  doubling  time  of  the  indicated  clones  was  calculated  based  on  the  initial  cell  number  and  the  cell  




6.4   Sequencing  of  the  CDK1  gene  
  
In  parallel  to  the  examination  of  the  doubling  time,  I  sequenced  the  genomic  
region  of  the  CRISPR/Cas9  cut  site  to  determine  the  exact  sequence  of  the  inactivated  
CDK1  gene  (Fig.  41).  Each  of  the  clones  showed  only  two  variants  of  the  repaired  Cas9  
cut   site,   suggesting   that   two   CDK1   alleles   are   present   in   this   HeLa   cell   line.   The  
analysis  revealed  that  clone  1  and  21  contain  frameshift  mutations  in  both  alleles,  
which  led  to  the  inactivation  of  the  endogenous  CDK1  kinase.  Interestingly,  Clone  3  
contained   deletions   which   were   in   frame,   with   21   and   24   base   pairs   deleted,  
respectively.   The   affected   sequence   codes   for   the   CDK   signature   motif   PSTAIRE  
(Jeffrey  et  al.,  1995)  and  the  21  and  24  base  pair  deletions  result  in  a  removal  of  either  
the  amino  acid  residues  47-­‐53  (TAIREIS)  or  45-­‐52  (PSTAIREI).  These  deletions  most  
likely  destroy  the  endogenous  CDK1  activity  of  clone  3,  because  although  this  clone  
has  no  frameshift  mutation,   it  showed  similar  properties   (1NM-­‐PP1  block/release,  
cell  growth  etc.)  to  the  other  two  sequenced  clones,  which  have  frameshift  mutations  
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Figure  41:  Sequencing  of  the  CDK1  gene.  
The  genomic  region  within  the  CDK1  gene  that  was  recognised  by  the  guide  RNA  is  shown  in  green,  with  
the  Cas9  cut  site   in  red.  (A)  displays  the  sequence  of  the  wildtype  cells.  (B)  Hela  CDK1-­‐as  clone  1  shows  
deletions  of  two  and  eight  base  pairs,  respectively.  (C)  Hela  CDK1-­‐as  clone  3  shows  deletions  of  21  and  24  




6.5   Reducing  the  duration  of  the  1NM-­‐PP1  synchronisation  
To  reduce  the  number  of  cells  with  multipolar  spindles  after  the  release  from  
1NM-­‐PP1  synchronisation,  I  shortened  the  duration  of  the  block  from  24  h  to  20  h  
based  on  the  determined  doubling  time  of  ~20  h.  No  mitotic  cells  were  detectable  
after  20  h  of  1NM-­‐PP1  block  (Fig.  42A).  However,  the  decreased  duration  of  the  1NM-­‐
PP1   block   resulted   in   a   reduced   number   of   mitotic   cells   90   min   after   1NM-­‐PP1  
washout,  from  >  90%  to  ~  80%  for  all  three  clones.    
Additionally,  I  determined  the  mitotic  phase  distribution  60  min  after  washout  
of  the  20  h  1NM-­‐PP1  treatment  (Fig.  42B).  Clone  1  and  3  showed  a  similar  distribution  
with  ~  43%  of  cells  in  prometaphase  and  ~  56%  in  metaphase.  Clone  21  exhibited  a  
slower  progression  through  mitosis  compared  to  clone  1  and  3  with  >  60%  of  cells  
scored  as  prometaphase  cells.  The  high  number  of  prometaphase  cells  in  the  clone  
21  culture  could  be  due  to  a  high  frequency  of  cells  with  multipolar  spindles,  which  
may   have   a   negative   impact   on   proper   chromosome   congression   and   therefore  
mitotic  progression.  
For  the  analysis  of  multipolar  spindles,  I  stained  cells  with  an  anti-­‐Pericentrin  
antibody.  Pericentrin  was  identified  as  a  core  component  of  the  centrosome  and  is  
therefore  used  as  a  centrosome  marker  (Doxsey  et  al.,  1994).  This  staining  allowed  a  
much  more  precise  analysis  whether  a  cell  had  a  multipolar  spindle  and  revealed  that  
Clone  1  and  3  both  showed  multipolar  spindles  with  a  frequency  of  8.3%  in  mitotic  
cells  (Fig.  42C).  Remarkably,  the  rate  of  mitotic  cells  with  multipolar  spindles  was  27%  
for  clone  21.  
Because   of   the   persistent   high   number   of   cells   with   multipolar   spindles,   I  
examined  the  effect  of  reducing  the  duration  of  the  1NM-­‐PP1  block  to  4  h  (Fig.  43A).  
This  reduced  duration  was  sufficient  to  eliminate  mitotic  cells  from  the  entire  culture  
(Fig.  43A).  For  clone  1  and  3,  ~  17%  of  cells  entered  mitosis  60  min  after  1NM-­‐PP1  
washout,   and   none   of   them   showed   multipolar   spindles,   judged   by   staining   for  
Pericentrin  (Fig.  43B).  However,  clone  21  showed  cells  with  multipolar  spindles  even  
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Figure  42:  Reducing  the  duration  of  the  1NM-­‐PP1  synchronisation  to  20  h.  
(A,  B)  Frequency  of  mitotic  cells  (A)  or  of  the  different  mitotic  phases  (B)  in  the  culture  of  HeLa  CDK1-­‐as  
cells  treated  with  1NM-­‐PP1  for  20  h.  Data  of  HeLa  CDK1-­‐as  cells  treated  for  24  h  with  1NM-­‐PP1  were  
reproduced  from  Figure  35A  for  comparison.  Cells  were  fixed  after  the  1NM-­‐PP1  washout  at  the  indicated  
time  points  (in  minutes),  with  n=300  cells  analysed  per  clone  and  time  point.    
(C)  Frequency  of  mitotic  cells  with  multipolar  spindles  judged  by  the  immunostaining  with  an  antibody  
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Figure  43:  Reducing  the  duration  of  the  1NM-­‐PP1  synchronisation  to  4  h.  
(A)  Frequency  of  mitotic  cells  in  the  culture  of  HeLa  CDK1-­‐as  cells  treated  with  1NM-­‐PP1  for  4  h.  Cells  were  
fixed  60  minutes  after  the  1NM-­‐PP1  washout,  with  n=300  cells  analysed  per  clone  and  time  point.    
(B)  Total  number  of  mitotic  cells  with  multipolar  spindles  judged  by  the  immunostaining  with  an  antibody  




6.6   Comparing  the  CDK1-­‐as  clones  to  wildtype  cells  
To  complete  the  characterisation  of  clone  1  and  3,  I  examined  their  properties  
compared  to  the  parental  cell  line  which  contains  a  wildtype  CDK1  kinase  (Fig.  44).  
First,  I  determined  the  mitotic  index  in  a  population  which  was  not  treated  with  1NM-­‐
PP1  (Fig.  44A).  Both  CDK1-­‐as  clones  showed  a  mitotic  index  of  ~  4%,  which  was  similar  
to  the  wildtype  cells.  
Next,   I   investigated   the   occurrence   of   mitotic   abnormalities,   such   as  
uncongressed   chromosomes   or   multipolar   spindles,   and   consequences   thereof,  
which  are  anaphase  bridges,  micronuclei  and  multinucleate  cells  (Fig.  44B).  None  of  
these   abnormalities   was   increased   in   the   two   CDK1-­‐as   clones   compared   to   the  
wildtype  cells.  Indeed,  clone  3  showed  a  decreased  frequency  of  anaphase  bridges  
and  micronuclei  compared  to  the  wildtype  cells.  
Figure  44:  Comparison  of  the  CDK1-­‐as  clones  to  wildtype  cells.  
(A)  Frequency  of  mitotic  cells  in  the  culture  of  HeLa  CDK1-­‐as  cells  and  of  HeLa  wildtype  cells  without  
1NM-­‐PP1  treatment,  with  n=1000  cells  analysed.  
(B)  Frequency  of  the  indicated  abnormalities  in  the  entire  culture  of  HeLa  CDK1-­‐as  cells  and  of  HeLa  





























































6.7   Western  blot  analysis  of  the  endogenous  CDK1  and  the  CDK1-­‐as  protein  
In  the  final  characterisation  experiment,  I  determined  the  protein  level  of  the  
exogenous   CDK1-­‐as   compared   to   the   level   of   the   endogenous   CDK1   kinase   by  
Western  blot  analysis  (Fig.  45).  Both  clones  showed  a  CDK1-­‐as  expression  which  was  
similar  to  the  level  of  endogenous  CDK1  in  the  wildtype  cells.  Interestingly,  no  band  
for  the  endogenous  CDK1  was  detectable  in  the  lane  of  clone  3,  although  this  clone  
has   no   frameshift   mutations   and   no   more   than   eight   amino   acid   residues   were  
depleted.  A  possible  explanation  could  be   that   the  protein   is  not   stable  after   the  
signature  motif  PSTAIRE   is  deleted.  Another  possibility  might  be  that  the  antibody  
cannot  recognise  the  altered  CDK1  protein.  However,  this  is  rather  unlikely  because  
a  recombinant  fragment  corresponding  to  amino  acid  residue  50  to  the  C-­‐terminus  
of  Xenopus  laevis  CDK1  was  used  as  an  immunogen  and  the  epitope  is  considered  to  
be  amino  acid  residue  220-­‐227  (LGTPNNEV)  of  mouse  CDK1,  according  to  the  product  
information  of  the  used  anti-­‐CDK1  antibody.  
  
  
Altogether,  this  characterisation  demonstrated  that  CDK1-­‐as  clones  1  and  3  can  
be  effectively  synchronised  at  the  CDK1  arrest  point,  a  mitotic  index  of  >  90%  can  be  
achieved  after   the   release   from  1NM-­‐PP1  and  no  altered  properties  are  apparent  
compared  to  the  parental  CDK1  wildtype  cell  line.  However,  further  optimisation  may  
be  necessary  to  reduce  the  number  of  cells  with  multipolar  spindles  that  occur  after  
extended  treatment  with  1NM-­‐PP1.    
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Figure  45:  Western  blot  analysis  of  the  endogenous  CDK1  and  the  CDK1-­‐as  protein.  
Western  blot  analysis  of  the  indicated  HeLa  CDK1-­‐as  clones  or  of  HeLa  wildtype  cells.  Whole  cell  lysates  
of  either  4  x  105  or  1  x  105  cells  were  loaded  per   lane.  The  endogenous  CDK1  and  the  CDK1-­‐as  protein  




7   Discussion  
  
7.1   Robust  interaction  between  tethered  HP1α  and  the  CPC  
The   CPC   is   a   critical   component   of   the   centromere  machinery   that   ensures  
faithful  chromosome  segregation  during  mitosis.  In  my  work,  I  analysed  the  impact  
of  tethered  HP1α  on  the  mitotic  signalling  network  at  centromeres  and  its  potential  
effect  on  chromosome  segregation.  While  tethering  HP1α  via  the  CENP-­‐B  DBD  did  
not  have  a  beneficial  influence  on  the  rate  of  chromosome  mis-­‐segregation  in  these  
cancer  cell  lines,  these  experiments  highlight  the  tight  association  of  the  CPC  with  the  
chimeric  HP1α  protein.  Thus,  CB-­‐EY-­‐HP1α  can  determine  the  localisation  of  the  CPC  
throughout  mitosis,   resulting   in   a   strong   localisation   of   Aurora   B   at   centromeres,  
even   in   telophase.   Thus,   tethered   HP1α   can   circumvent   the   complex   epigenetic  
signalling  network  that  normally  determines  the  centromeric  CPC  localisation.  
However,  this  strong  interaction  goes  in  both  directions  and  is  robust  enough  
so  that  not  only  can  tethered  HP1α  dictate  the  localisation  of  the  CPC,  but  the  CPC  
can  also  affect  the   localisation  of  HP1α:  When  the  CENP-­‐B  DNA-­‐binding  domain   is  
mutated,  the  CPC  determines  the  localisation  of  CBmut-­‐EY-­‐HP1α  and  carries  it  to  the  
midbody  in  telophase.  This  is  similar  to  the  localisation  of  untethered  EY-­‐HP1α  and  is  
most  likely  due  to  the  perturbed  DNA  binding  properties  of  the  mutated  CENP-­‐B  DNA-­‐
binding   domain   compared   to   the   wildtype   DNA-­‐binding   domain   in   the   chimeric  
protein.  
In   my   experiments,   all   constructs   containing   a   wildtype   HP1α   show   a  
colocalisation  with  the  CPC  in  telophase  cells,  either  at  centromeres  or  the  midbody  
region.   These   interactions   are   all   most   likely   due   to   conventional   HP1α   CSD  
interaction   with   client   proteins,   as   the   single   point   mutation  W174A   in   the   CSD  
eliminates   this   interaction   and   all   phenotypes   resulting   from   the  HP1α   tethering.  
Thus,  when  HP1α  binding  becomes   independent  of   chromatin  marks  and  HP1α   is  






7.2   CB-­‐EY-­‐HP1α  causes  effects  similar  to  those  produced  by  directly  tethering  the  
core  CPC  subunit  INCENP  to  centromeres  via  CENP-­‐B  tethering    
I  present  in  this  study  that  specific  tethering  of  HP1α  to  centromeric  CENP-­‐B  
boxes  by  use  of  the  DBD  of  CENP-­‐B  produces  a  mitotic  delay.  In  controls,  EYFP-­‐HP1α  
expression  did  not  result  in  an  altered  mitotic  progression,  indicating  that  the  specific  
tethering  of  HP1α  to  the  centromere  region  causes  the  metaphase  delay  phenotype.  
In   line   with   the   above-­‐described   robust   interaction   between   the   CPC   and   HP1α,  
tethering  the  CPC  core  subunit   INCENP  via  the  CENP-­‐B  DBD  produces  phenotypes  
similar   to   those   described   in  my   study   using   CB-­‐EY-­‐HP1α.   The   effects   of   INCENP  
tethering  include  an  increase  of  the  mitotic  index  due  to  SAC  activity  and  caused  by  
perturbed   kinetochore-­‐microtubule   interactions   (Liu   et   al.,   2009).   Additionally,  
INCENP  tethering  to  centromeres  results  in  increased  phosphorylation  of  Aurora  B  
substrates  such  as  Dsn1  phosphorylation  (Wang  et  al.,  2011a),  which  I  also  observed  
in  cells  expressing  CB-­‐EY-­‐HP1α.  
Liu  and  colleagues  describe   that  the  Aurora  B   is  spatially   separated   from   its  
kinetochore  substrates  once  chromosomes  bi-­‐orientate  and  kinetochores  stretch  (Liu  
et  al.,  2009).  They  conclude  from  their  experiments  that  placing  Aurora  B  artificially  
closer   to   the   kinetochore   by   using   CENP-­‐B   DBD   tethering   of   INCENP   results   in  
increased  phosphorylation  of  kinetochore  substrates  and  leads  to  destabilisation  of  
kinetochore-­‐microtubule  attachments.  This  idea  is  in  agreement  with  the  “dog  leash”  
model,  which  assumes  that   the  SAH  of   INCENP  can  extend  and  allow  Aurora  B   to  
phosphorylate   outer   kinetochore   substrates   despite   the   binding   of   the   CPC  
localisation  module  to  the  inner  centromere  (Krenn  and  Musacchio,  2015;  Samejima  
et  al.,   2015).  However,  at   the  same   time,   the   range  of  Aurora  B  activity  might  be  
precisely  regulated  through  this  “leash”.  Therefore,   the  tethering  approach,  which  
brings   Aurora   B   closer   to   the   kinetochore,   could   enable   phosphorylation   of  
kinetochore  substrates  that  can  normally  not  be  reached  and  phosphorylated  once  





In  addition  to  the  model  that  the  precise  localisation  of  Aurora  B  is  critical,  my  
results  suggest  that  the  binding  dynamics  could  also  be  important  for  correct  Aurora  
B  activity  at  mitotic  centromeres.  The  CBmut-­‐EY-­‐HP1α  construct  shows  a  similar  shift  
as  CB-­‐EY-­‐HP1α  towards  the  kinetochore  proximal  centromere  when  chromosomes  
bi-­‐orientate   in  metaphase,  whereas  untethered  HP1α   remains   closer   to   the   inner  
centromere.   However,   the   mutated   tethering   construct   does   not   cause   an  
accumulation  of  mitotic  cells,  demonstrating  that  it  does  not  induce  an  activation  of  
the  SAC  that  leads  to  the  metaphase  delay  phenotype.  My  FRAP  analysis  indicates  
that  CBmut-­‐EY-­‐HP1α  has  nearly  three  times  faster  binding  dynamics  than  the  HP1α  
tethering  construct  containing  a  wildtype  CENP-­‐B  DBD.  Additionally,  it  was  previously  
shown  that  the  CPC  component  survivin  exhibits  much  faster  binding  dynamics  at  
prometa-­‐   and  metaphase   compared   to   interphase   centromeres   or   at   the   ana-­‐   or  
telophase   stage   (Beardmore   et   al.,   2004).   Based   on   these   observations   and   my  
results,   I   speculate   that   the   complex   regulation   of   centromeric   CPC   might   be  
necessary   to   ensure   precise   CPC   dynamics   at  mitotic   centromeres.   In   summary,   I  
conclude  that  CENP-­‐B  DBD  driven  HP1α  tethering  to  centromeres  causes  a  mitotic  




7.3   HP1α   tethering   produces   H3S10ph   foci   that   are   persistent   throughout  
interphase  
The  strong  interaction  between  tethered  HP1α  and  the  CPC  described  above  
results  not  only  in  the  retention  of  the  CPC  at  centromeres  in  telophase  cells,  but  the  
CPC  also   remains   trapped  at  CB-­‐EY-­‐HP1α  clusters  even   in  G1.  Remarkably,   a   clear  
H3S10ph  signal  persists  around   the  clusters  of   tethered  HP1α,   indicating   that   the  
Aurora  B  retains  its  catalytic  activity  when  trapped  by  CB-­‐EY-­‐HP1α.  These  H3S10ph  
foci   vanished   when   cells   were   treated   with   0.5   µM   of   the   Aurora   B   inhibitor  
ZM447439,  a  dosage  that  had  no  apparent  impact  on  the  H3S10ph  levels  in  mitosis.  




colocalisation   was   visible   even   in   the   presence   of   ZM447439.   It   was   previously  
described  that  the  general  Aurora  B  localisation  in  interphase  is  independent  of  its  
own  activity  (Hayashi-­‐Takanaka  et  al.,  2009).  Together,  these  results  indicate  that  the  
H3S10ph  signal  in  interphase  requires  continuous  Aurora  B  activity.    
Aurora   B   activity   is   usually   down-­‐regulated   at   the   end   of  mitosis   by   Cdh1  
mediated  proteasomal  degradation  (Nguyen  et  al.,  2005;  Stewart  and  Fang,  2005)  
and  an  increase  in  counteracting  phosphatases  (Murnion  et  al.,  2001;  Vagnarelli  et  
al.,  2011;  Wurzenberger  and  Gerlich,  2011;  Lee  et  al.,  2016).  Therefore,  it  is  surprising  
that  the  activity  of  tethered  Aurora  B  appears  sufficient  to  counteract  any  conflicting  
phosphatase  activity.  This  might  be  achieved  through  continuous  intermolecular  self-­‐
activation,  possibly  through  CB-­‐EY-­‐HP1α  facilitated  concentration.   It   is  indeed  well  
demonstrated  that  clustering  of  the  CPC  leads  to  its  activation,  possibly  through  the  
phosphorylation  of  the  INCENP  C-­‐terminus  by  Aurora  B,  which  stimulates  Aurora  B  
kinase  activity  (Sessa  et  al.,  2005;  Kelly  et  al.,  2007;  Tseng  et  al.,  2010;  Wang  et  al.,  
2011a).  
Overall,  my  results   indicate  that  Aurora  B  activity   itself  does  not  seem  to  be  
subject   to  an   intrinsic   cell   cycle   control.  When   the  CPC   is   retained   in  CB-­‐EY-­‐HP1α  
clusters  at  centromeres,  it  remains  active  throughout  interphase.  Therefore,  I  suggest  
that  Aurora  B  degradation  during  mitotic  exit  may  require  a  relocation  of  the  CPC  
from  centromeres.  This  suggestion  is  supported  by  the  observation  that  depletion  of  
the  ubiquitination  machinery  components  Cul3,  KLHL9,  or  KLHL13  causes  a  failure  in  
inactivating  and  displacing  Aurora  B  from  chromatin  in  ana-­‐  and  telophase,  resulting  
in  an  abnormal  H3S10ph  chromatin  signal  in  late  mitosis  (Sumara  et  al.,  2007).  
  
The  H3S10ph  mark  induced  by  HP1α  tethering  in  the  G1  cells  is  found  only  in  
close  proximity  to  the  CB-­‐EY-­‐HP1α  clusters  and  does  not  spread  all  over  chromatin  as  
is  the  case  in  early  mitosis.  I  speculate  that  the  firm  tethering  of  HP1α  may  prevent  
the  spreading  of  active  Aurora  B  along  chromosomes  because  the  H3S10ph  signal  
does  not  result  in  a  weaker  HP1α  interaction  with  chromatin  as  would  normally  be  




Alternatively,  a  lack  of  sufficient  Aurora  B  activity  could  be  the  reason  why  the  
H3S10ph  signal  does  not  spread  within  the  nucleus  in  G1  cells.  Potential  reasons  for  
low  Aurora  B  activity  during  early  interphase  could  be  that  the  general  protein  level  
of   the  kinase   is  not  sufficient  to  phosphorylate  the  entire  chromatin.  Additionally,  
activating   phosphorylations,   such   as   phosphorylated   threonine   232,  might   not   be  
present  and  Aurora  B  therefore  not  fully  activated.  
I  hypothesise  that  CDK1  activity  perhaps  contributes  to  fully  activate  Aurora  B,  
as  I  did  not  observe  spreading  of  the  H3S10ph  mark  in  synchronised  CDK1-­‐as  cells,  in  
which   CDK1   is   inhibited.   Instead,   the   H3S10ph   foci   remain   highly   stable   without  
showing  any  dynamic  behaviour  in  live  cell  imaging  experiments.    
  
Taken  together,  the  retention  of  Aurora  B  and  the  consequential  H3S10ph  in  
G1  cells  is  an  event  that  does  not  occur  in  wildtype  cells.  This  suggests  that  the  CB-­‐EY-­‐
HP1α-­‐driven  clustering  results  in  Aurora  B  activity  that  can  counteract  the  level  of  
phosphatases  in  G1,  possibly  through  continuous  intermolecular  self-­‐activation  at  the  




7.4   A  novel  HP1-­‐driven  mode  of  CPC  clustering  occurs  prior  to  the  chromatin  marks  
that  determine  CPC  localisation  during  mitosis  
CPC  accumulation  at  mitotic  centromeres  is  widely  believed  to  depend  on  two  
epigenetic  marks:  Haspin  kinase  binds  to  cohesin  and  phosphorylates  histone  H3T3,  
creating  an  interaction  site  for  the  BIR  domain  of  the  CPC  component  survivin  (Dai  et  
al.,  2005;  Kelly  et  al.,  2010;  Wang  et  al.,  2010;  Yamagishi  et  al.,  2010).  Additionally,  
H2AT120  phosphorylated  by  the  Bub1  kinase  in  the  vicinity  of  the  kinetochore  creates  
a   binding   site   for   Shugoshin,   which   recruits   CPC   via   interaction   with   borealin  
(Kawashima  et  al.,  2010;  Yamagishi  et  al.,  2010).    
In  my  experiments,  I  made  use  of  synchronised  fixed  cells  and  live  cell  imaging  




chromatin  marks   at   the   G2   stage.   I   used   this   experimental   setup   to   examine   the  
potential  contribution  of  these  marks  in  CPC  clustering  and  activation  at  the  G2  phase  
of  the  cell  cycle.  Simultaneous  detection  of  H3T3ph  and  H3S10ph  by  live  cell  imaging  
revealed   the   precise   sequential   timing   of   these   marks   and   demonstrates   that  
H3S10ph  foci  appear   long  before  H3T3ph  mark  becomes  detectable,  as  previously  
suggested  by  fixed  cell  experiments  (Polioudaki  et  al.,  2004).  The  H2AT120ph  mark  is  
detectable   before   H3S10ph   foci   form,   however,   H2AT120ph   appears   as   a   diffuse  
labelling  of  the  entire  nucleus  instead  of  concentrated  clusters.  This  diffuse  labelling  
of  H2AT120ph  persists  even  after  H3S10ph  foci  emerge,  and  H2AT120ph  clusters  only  
form   when   cells   enter   prophase.   Together   these   results   demonstrate   that   CPC  
clustering  and  activation  occurs  in  G2  cells  independent  of  the  chromatin  marks  that  
define  CPC  localisation  at  mitotic  centromeres  and  suggest  a  new  mode  responsible  
for  CPC  localisation.    
In  line  with  the  above-­‐described  clusters  of  active  CPC  at  sites  of  CB-­‐EY-­‐HP1α  
tethering,  my  further  results  indicate  that  the  concentration  and  initial  activation  of  
the  CPC  during  the  G2  phase  is  induced  by  the  interactions  with  endogenous  HP1.  For  
a  precise  temporal  resolution,  I  used  CDK1-­‐as  cells  synchronised  by  CDK1  inhibition  
through   the   ATP   analogue   1NM-­‐PP1.   At   the   CDK1   arrest   point,   cells   show   a  
remarkably  reproducible  pattern  of  H3S10ph  foci,  that  co-­‐localise  with  endogenous  
HP1α.   HP1   KO   experiments   revealed   that   HP1α   and   HP1γ   seem   to   redundantly  
mediate  this  CPC  clustering  and  activation,  as  the  individual  knockouts  of  either  did  
not  result  in  a  loss  of  H3S10ph  focus  formation  during  G2,  whereas  focus  formation  
was  lost  in  the  double  knockout.    
An   important   observation   for   the  mode   of   CPC   recruitment   in   G2   cells   was  
reported  by  Perera  and  Taylor   (Perera  and  Taylor,  2010).  They  described   that   the  
clustering  of  shugoshin  is  driven  by  the  Suv39h  /  HP1  pathway  in  G2  cells.  Therefore,  
it  could  be  possible  that  shugoshin,  which  probably  binds  directly  to  HP1  in  G2  cells,  
mediates   the   recruitment   of   the   CPC   through   its   interaction   with   the   borealin  
subunit.  Furthermore,  it  is  conceivable  that  the  isoforms  HP1α  and  HP1γ  might  bind  




stage  specifically  in  HP1α  +  HP1γ  double  KO  cells.  However,  the  interaction  between  
borealin  and  shugoshin  is  promoted  by  CDK1  phosphorylation  of  borealin  (Tsukahara  
et   al.,   2010),   which   should   not   occur   in   1NM-­‐PP1   synchronised   CDK1as   cells.  
Therefore,   an   indirect   CPC   recruitment   to   HP1   clusters   via   shugoshin   in   G2   cells  
appears  less  likely  than  a  direct  HP1-­‐CPC  binding.  
Interestingly,  HP1-­‐driven  clustering  of  the  CPC  appears  to  facilitate  CPC  activity  
even  when  counteracting  phosphatases  are  present.  Indeed,  H3S10ph  is  limited  by  
PP1  activity  in  interphase  cells,  as  it  was  earlier  described  that  selective  inhibition  of  
PP1   promotes   formation   of   interphase   H3S10ph   (Hayashi-­‐Takanaka   et   al.,   2009).  
Therefore,  it  is  tempting  to  speculate  that  HP1  provides  a  microenvironment  which  
protects   either   activating   CPC   phosphorylation   or   the   H3S10ph   itself   against  
counteracting  phosphatases.  The  recently  described  phase  separation  properties  of  
HP1  could  allow  the  formation  of  this  specific  microenvironment  and  are  discussed  




7.5     Functional  implication  of  the  H3S10ph  foci  in  G2  cells    
The  functional  significance  of  the  clustered  CPC  activity  at  sites  of  HP1  foci  is  
not  known.  An  earlier  study  reported  that  the  timing  of  Aurora  B  activation  in  late  
interphase,   which   was   determined   by   H3S10ph   appearance,   correlates   with   the  
frequency  of  chromosome  mis-­‐segregation  events  (Hayashi-­‐Takanaka  et  al.,  2009).  
The  H3S10ph  signal  emerges  much  later,  i.e.  closer  to  the  G2/M  transition,  in  cells  
that  have  a  high  frequency  of  chromosome  segregation  errors  compared  to  cells  with  
a  low  chromosome  mis-­‐segregation  rate.  Additionally,  recent  work  described  that  a  
HP1α   KO   in   mouse   embryonic   fibroblasts   leads   to   an   increased   frequency   of  
merotelic  chromosome  attachments  (Bosch-­‐Presegué  et  al.,  2017),  which  is  reported  





When   analysing   a   general   HP1   KO,   it   is   difficult   to   distinguish   between   the  
effect  of   perturbing   the  early  CPC  clustering   in  G2  phase  and   interfering  with  CPC  
function  in  mitosis,  as  HP1  also  affects  the  level  of  Aurora  B  activity  during  mitosis  
(Abe   et   al.,   2016).   In   general,   the   regulation   of   CPC   function   is   highly   complex,  
involving  numerous  factors  and  extensive  crosstalk.  This  makes  it  challenging  to  draw  
conclusions  from  experiments  that  perturb  individual  processes  of  the  functional  CPC  
network.    
A   previous   study   elegantly   circumvented   this   problem   by   only   transiently  
inhibiting  Aurora  B  function  by  use  of  ZM447439  in  interphase  cells  showing  H3S10ph  
foci   (Hayashi-­‐Takanaka   et   al.,   2009).   This   temporary   Aurora   B   inhibition   during  
interphase  resulted  in  an  increased  frequency  of  chromosome  segregation  errors  in  
the  subsequent  mitosis.  This  observation  indicates  that  Aurora  B  activity  during  late  
interphase  has  a  functional  implication  and  the  exact  molecular  mechanism  should  




7.6   The   dual  mode   of   CPC   concentration   is   possibly   controlled   by  methyl/phos  
switching  
The  general  H3T3ph  labelling  of  nuclei  and  the  concentration  of  the  H2AT120ph  
mark   appear   only   as   the   H3S10ph   signal   spreads   all   over   chromatin.   Therefore,   I  
speculate   that   a   change   in   the  mode   of   CPC   clustering  may   take   place   once   the  
H3S10ph   mark   generally   labels   chromatin   and   as   a   consequence,   methyl/phos  
switching   prevents   the   HP1   interaction   with   nucleosomes.   With   the   entry   into  
mitosis,  the  two  histone  marks  H3T3ph  and  H2AT120ph  start  to  determine  the  CPC  
localisation  and  thus  concentrate  the  CPC  at  mitotic  centromeres,  most  likely  after  
the  methyl/phos  switch  inactivates  the  HP1-­‐driven  mode  of  CPC  clustering.  
The   reason   for   this   dual  mode   of   CPC   concentration   at   centromeres   is   not  
known.  However,  it  is  tempting  to  speculate  that  it  allows  the  transitional  localisation  




signal   is   so   widely   conserved:   The   methyl/phos   switch   disrupts   HP1-­‐chromatin  
binding  and  thus  possibly  ensures  CPC  mobility  during  mitosis,  a  key  feature  of  the  
CPC   that   is   even   included   in   the   name   of   the   complex   (chromosome   passenger  
complex).   Therefore,   H3S10ph   might   be   considered   a   further   histone   mark   that  
determines  CPC  localisation  during  mitosis,  but   instead  of  serving  as  an  additional  
binding  site,  it  rather  disrupts  HP1  binding  to  methylated  H3K9  and  thus  prevents  the  
pathway  that  defines  CPC  localisation  in  interphase.  Indeed,  it  was  previously  shown  
that   ZM447439   treatment,   resulting   in   reduced   levels   of   the   chromatin   marks  
H3S10ph   and   H3T3ph,   leads   to   decreased   localisation   of   HP1   and   INCENP   at  
centromeres  and  a  concomitant  HP1-­‐dependent  increase  of  INCENP  on  chromosome  
arms  (Nozawa  et  al.,  2010).  
Taken  together,  I  propose  that  the  methyl/phos  switch  possibly  ensures  CPC  
mobility   during   mitosis   and   promotes   the   shift   from   HP1-­‐driven   interphase   CPC  




7.7   How  is  H3S10ph  focus  formation  induced  in  the  absence  of  HP1α  and  HP1γ?  
In   HP1α   +   HP1γ   double   KO   cells,   the   H3S10ph   mark   shows   a   weak   diffuse  
labelling   all   over   chromatin   at   the   CDK1   arrest   point   in   G2.   Interestingly,   foci   of  
H3S10ph   still   appear,   but   just   prior   to   the  G2/M   transition,  which   is   close   to   the  
appearance  of  H3T3ph  and  the  beginning  of  H2AT120ph  clustering.  This  suggests  that  
the  late  clustering  of  Aurora  B  activity  in  the  absence  of  HP1α  and  HP1γ  could  depend  
on   these   histone   marks   that   are   well-­‐known   to   concentrate   the   CPC   at   mitotic  
centromeres.    
An  alternative  hypothesis  is  that  HP1β,  the  only  remaining  HP1  isoform,  could  
mediate  the  late  CPC  clustering  in  those  cells.  I  speculate  that  HP1β  may  have  a  lower  
binding  affinity  for  the  CPC  compared  to  HP1α  and  HP1γ,  as  was  previously  shown  
for  other  proteins  interacting  with  the  HP1  CSD  (Bosch-­‐Presegué  et  al.,  2017;  Yi  et  al.,  




a  higher  concentration  before  stable  HP1β-­‐CPC  clusters   form,  whereas  the  tighter  
binding   HP1α   and   HP1γ   isoforms   can   cluster   the   CPC   at   lower   concentrations.  
Perhaps  the  level  of  CPC  components  is  high  enough  at  the  end  of  the  G2  phase  that  





7.8   Persistent  H3S10ph  may  facilitate  the  shift  of  the  CPC  from  chromatin  to  the  
central  spindle    
The   live   cell   imaging   approach   with   fluorescently   labelled   Fab   fragments  
detecting  H3S10ph  and  H3T3ph  allowed  me  to  compare  precisely  the  timing  of  these  
two  marks  in  the  same  cell.  The  analysis  showed  not  only  a  different  timing  in  the  
appearance   of   these   marks,   as   discussed   above,   but   also   revealed   that   H3T3ph  
vanishes  after  the  onset  of  anaphase  as  previously  reported  (Dai  et  al.,  2005;  Kelly  et  
al.,  2010;  Qian  et  al.,  2011),  whereas  the  H3S10ph   labelling  of  chromatin  remains  
present   for   somewhat   longer.   I   speculate   that   the   different   timing   presumably  
facilitates  the  correct  transition  of  the  CPC  from  chromatin  to  the  central  spindle.  
With   the   rapid   disappearance   of   H3T3ph,   survivin   is   no   longer   recruited   to  
centromeres,  and  the  persistent  H3S10ph  labelling  continues  to  inhibit  HP1  binding  
to   chromatin.   This   hypothesis   is   supported   by   my   tethering   experiments,   which  
indicate  that  HP1α’s  binding  to  chromatin  is  regulated  rather  than  its  interaction  with  
the  CPC,  probably  contributing  to  proper  CPC  complex  formation  and  functionality,  
as  suggested  by  Abe  and  colleagues  (Abe  et  al.,  2016).  
Together,   the   prolonged   persistence   of   the   H3S10ph   signal   compared   to  
H3T3ph  serves  as  a  further  example  of  how  H3S10  phosphorylation  might  contribute  
to  CPC  mobility,  in  this  case  supporting  the  shift  away  from  chromatin.    
In  general,  my  results  suggest  that  the  dynamics  of  chromatin  reader  proteins  
have  a  direct  influence  on  the  mobility  and  activity  of  factors  that  attach  to  them.  In  




actively   regulate   the  dynamics  of   these   readers   and  as  a   consequence,   their  own  
dynamics.  In  the  case  of  HP1,  this  can  be  by  either  enhancing  (e.g.  H3K9me2/3  by  




7.9   The   phase   separation   properties   of   HP1α   may   facilitate   H3S10ph   focus  
formation  in  interphase    
Two   recent   studies   report   that   HP1α   forms   liquid-­‐like   droplets   in   vitro   and  
suggest  that  heterochromatin  domain  formation  is  mediated  by  HP1α-­‐driven  phase  
separation  (Larson  et  al.,  2017;  Strom  et  al.,  2017).  These  described  phase  separation  
properties  of  HP1α  might  explain  how  H3S10ph  foci  can  form  at  HP1  clusters  even  in  
the   presence   of   counteracting   phosphatases   in   interphase.   I   speculate   that  HP1α  
forms  liquid-­‐like  domains  at  heterochromatin  clusters  that  allow  CPC  components  to  
be  incorporated  but  might  exclude  phosphatases  from  entering.  This  possibly  forms  
a  microenvironment,  in  which  H3S10ph  is  stable  despite  low  kinase  activity,  as  Aurora  
B   is   not   yet   fully   activated,   and   despite   an   interphase   level   of   counteracting  
phosphatases.  This  hypothesis  is  supported  through  the  results  presented  by  Larson  
and  colleagues  (Larson  et  al.,  2017),  which  demonstrate  that  Aurora  B  can  localise  
inside   of   phase-­‐separated  HP1α  droplets   in   vitro,  whereas   other   proteins   such   as  
Hsp90  are  excluded,  which  may  also  apply  to  phosphatases  or  ubiquitin  ligases  that  




7.10   Why  is  HP1  not  released  from  chromatin  at  H3S10ph  foci  in  G2  cells?  
A  crucial  question  remains  about  the  H3S10ph  foci  at  endogenous  HP1  clusters:  
why   is   HP1   not   released   from   chromatin   when   H3S10ph   foci   form   at   the   same  
location  during  the  G2  phase?  A  possible  explanation  might  be  the  low  density  of  the  




the  entire  nucleus.  The  idea  of  a  low  H3S10ph  density  is  based  on  the  assumption  
that   the   H3S10ph   mark   is   only   present   on   one   of   the   histone   H3   tails   within   a  
nucleosome  and  no  H3S10ph  exists  next  to  the  H3K9me2/3  mark  on  the  histone  tail  
to   which   HP1   is   bound.   It   is   possible   that   an   equilibrium   state   prevails   in   those  
H3S10ph  foci  before  Aurora  B  is  fully  activated  and  the  H3S10ph  signal  spreads  all  
over  chromatin:  If  the  H3S10ph  signal  within  the  foci  becomes  too  strong,  it  leads  to  
HP1  displacement  due  to  the  methyl/phos  switch.  As  a  result,  the  CPC  cluster  could  
be   perturbed   and   the  H3S10ph   density  may   decrease,  which  would   allow  HP1   to  
rebind  to  heterochromatin  and  re-­‐establish  a  stable  CPC  cluster  and  H3S10ph  foci.  
However,  once  Aurora  B  is  fully  activated,  its  activity  possibly  is  no  longer  dependent  
on  HP1  mediated  clustering,  and  the  H3S10ph  signal  spreads  all  over  chromatin.  
  
An  alternative  explanation  for  why  HP1  is  not  released  from  H3S10ph  foci  in  G2  
cells  may  be  provided  by  Mateescu  and  colleagues  (Mateescu  et  al.,  2004).  Their  work  
describes  that  H3S10ph  surprisingly  promotes  HP1  binding  to  chromatin  rather  than  
perturbing  it.  Instead,  a  further  histone  modification,  namely  acetylation  of  histone  
H3  residue  lysine  14,  is  necessary  in  combination  with  H3S10ph  to  release  HP1  from  
H3K9me2/3  and  occurs  only  with   the  entry   into  prophase.  Therefore,   it  would  be  
important  to  study  the  exact  contribution  of  acetylated  histone  H3K14  in  terms  of  
HP1   displacement   from   chromatin   and   CPC   mobility   in   future   experiments.   A  
potential   approach   could   be   the   use   of   fluorescently   labelled   Fabs,   which  would  
enable  the  detection  of  this  mark  in  live  cell  imaging  experiments  and  would  allow  a  
precise  temporal  resolution.  
  
  




7.11   CENP-­‐B  dimerisation  may  promote  stable  binding  to  DNA  
The   CENP-­‐B   DNA-­‐binding   domain   is   commonly   used   to   target   proteins   to  
centromeres.  However,  my  FRAP  analysis  provided  essential  information  in  choosing  
the   right   control   in   the   CB-­‐EY-­‐HP1α   tethering   experiments.   Analysing   the   binding  
dynamics  showed  that  CB-­‐EY,  which  consists  of  the  DNA-­‐binding  domain  and  EYFP  
but  is  lacking  HP1α,  has  a  t1/2  of  only  6.8  s.  This  is  ~  7  times  faster  than  the  binding  
dynamics  of  the  chimeric  CB-­‐EY-­‐HP1α  construct,  revealing  that  CB-­‐EY  is  not  a  suitable  
control.  In  contrast,  CB-­‐EY-­‐HP1αW174A  has  a  t1/2  of  recovery  of  42  s,  similar  to  that  of  
CB-­‐EY-­‐HP1α,  but  does  not  cause  an  altered  mitotic  progression  or  other  phenotypes  
when  compared  to  untransfected  cells.  Therefore,  I  used  CB-­‐EY-­‐HP1αW174A  (which  can  
dimerise   via   the   HP1α   CSD)   rather   than   CB-­‐EY   as   a   control   construct   for   all   my  
experiments.  The   slightly   faster  dynamics  of  CB-­‐EY-­‐HP1αW174A  compared   to  CB-­‐EY-­‐
HP1α  might  be  explained  by  the  observation  that  protein  binding  to  the  CSD,  which  
is  prevented   in  CB-­‐EY-­‐HP1αW174A,   strengthens  HP1α’s  dimerisation   (Mendez  et  al.,  
2011;  Kilic  et  al.,  2015).    
Indeed,  introducing  the  I165E  mutation  into  CB-­‐EY-­‐HP1α,  which  prevents  dimer  
formation  in  full-­‐length  HP1α,  results  in  a  t1/2  of  8  s,  a  value  similar  to  that  of  CB-­‐EY.  
These  findings  suggest  that  the  dimerisation  ability  of  HP1α  may  compensate  for  the  
missing  CENP-­‐B  dimerisation  domain  when  fused  to  only  the  DNA-­‐binding  domain  of  
CENP-­‐B.  Together,  these  results  argue  that  although  CENP-­‐B  can  apparently  bind  to  
α-­‐satellite   DNA   as   a   monomer,   it   probably   requires   dimer   formation   for   stable  
binding.  This  observation  could  have  implications  for  other  studies  in  which  the  DNA-­‐
binding  domain  of  CENP-­‐B  has  been  used  to  target  proteins  to  the  centromere.  
  
  




7.12   Increased  p31comet  level  may  alter  the  SAC  sensitivity  in  U2OS  cells  
I  observed  in  the  live  cell  imaging  experiments  that  U2OS  cells  do  not  show  an  
overall   delayed   progression   through  mitosis   when   expressing   CB-­‐EY-­‐HP1α   at   low  
levels.  This  contrasts  HeLa  cells,  which  show  a  distinct  mitotic  delay  upon  low-­‐level  
expression  of  CB-­‐EY-­‐HP1α.  
Low  levels  of  CB-­‐EY-­‐HP1α  presumably  cause  only  a  low-­‐level  activity  of  the  SAC,  
which   apparently   can   be   bypassed   in   U2OS   but   not   in   HeLa   cells.   A   possible  
explanation   for   the   different   response   to   low   levels   of   CB-­‐EY-­‐HP1α  might   be   the  
increased  amount  of  the  protein  p31comet  in  U2OS  cells  compared  to  HeLa  cells  (Habu  
and  Matsumoto,  2013).  It  was  previously  described  that  p31comet  contributes  to  SAC  
inactivation  through  binding  to  active  Mad2  (C-­‐Mad),  thus  competing  with  O-­‐Mad2  
activation  (Habu  et  al.,  2002;  Xia  et  al.,  2004;  Yang  et  al.,  2007)  and  by  destabilisation  
of  the  mitotic  checkpoint  complex  (MCC)  (Teichner  et  al.,  2011;  Varetti  et  al.,  2011;  
Westhorpe  et  al.,  2011).    
Therefore,  the  increased  p31comet  level  in  U2OS  cells  could  result  in  a  slippage  
through   the   SAC   in   cells   expressing   a   low   level   of   CB-­‐EY-­‐HP1α.   Furthermore,   a  
p31comet-­‐induced   SAC   impairment   and   premature   progression   into   anaphase  may  
also  be  considered  as  a  potential  explanation  why  U2OS  cells  show  a  relatively  high  




7.13   DNMT1  depletion  may  affect  HP1  clustering  
Contrary  to  my  findings  that  HP1α  and  HP1γ   induce  Aurora  B  clustering  and  
H3S10ph  focus  formation  in  G2  cells,  Monier  and  colleagues  describe  in  their  work  
that   DNMT1   depletion   causes   Aurora   B   mis-­‐localisation   and   a   decrease   of  
pericentromeric  H3S10ph  in  the  G2  phase  (Monier  et  al.,  2007).  Depletion  of  DNMT1  
did   not   inhibit   the   formation   of   HP1α   clusters.   Instead,   they   reported   that   the  
frequency  of  cells  with  HP1α  clusters  increases  upon  DNMT1  depletion,  which  was  




and  colleagues  conclude  that  HP1α  is  not  a  dominant  factor  that  determines  Aurora  
B  recruitment  to  pericentromeres.  However,  they  did  not  analyse  these  HP1α  clusters  
in  detail  but  only  distinguish  between  cells  that  either  show  HP1α  clusters  or  do  not  
show  HP1α  clusters  at  all.  It  would  have  been  useful  to  determine  various  factors  that  
may   influence   the   ability   of  HP1α   clusters   to   concentrate  Aurora   B   after  DNMT1  
depletion.   Possible   factors   include:   The   size   of   the   HP1α   foci,   the   level   of   H3K9  
methylation   and,   most   importantly,   the   dynamics   of   the   clustered   HP1α.   These  
factors   are   important   because   previous   work   demonstrated   that   the   density   of  
H3K9me2/3  determines  the  residence  time  of  HP1α  on  chromatin  (Kilic  et  al.,  2015).  
HP1α   dynamics,   in   turn,   may   affect   the   efficacy   of   CPC   clustering   and   therefore  
H3S10ph  focus  formation.    
Furthermore,   H3S10ph   foci   preferentially   form   at   large   heterochromatin  
regions  (Monier  et  al.,  2007).  This  observation  further  supports  the  idea  that  HP1α  
dynamics   could   be   important   to   establish  H3S10ph   foci   in   the  G2   phase,   as   large  
heterochromatin   regions   may   favour   the   formation   of   particularly   stable   HP1α  
clusters.  Additionally,  my  tethering  experiments  also   indicate   that  HP1α  dynamics  
have  a  critical  influence  on  CPC  localisation  and  activity  in  interphase  cells.    
Moreover,   Monier   and   colleagues   reported   that   cells   with   more   than   10  
H3S10ph   foci  did  not  show  any  clusters  of  HP1α.  This  highlights  the  difficulties  to  
interpret  data  about  the  emergence  of  H3S10ph  in  a  non-­‐synchronous  culture.  This  
described  loss  of  HP1α  clusters  is  most  likely  due  to  the  methyl/phos  switch,  which  
displaces  HP1  from  chromatin.  Therefore,  it  is  crucial  to  analyse  cells  that  are  at  the  
same  stage  of  the  cell  cycle  when  determining  factors  that  influence  H3S10ph  focus  
formation,  as  I  did  by  synchronising  cells  at  the  CDK1  arrest  point  in  this  study.  




7.14   Use  of  HeLa  CDK1-­‐as  cells  to  study  mitotic  entry    
The   characterisation   of   the   HeLa   CDK1-­‐as   cells   revealed   that   remarkable  
synchrony  of  the  entire  culture  can  be  achieved  using  the  CDK1-­‐as/1NM-­‐PP1  system.  
I  further  confirmed  this  in  my  studies  by  staining  for  H3S10ph  in  fixed  cells  and  live  
cell  imaging  experiments,  revealing  that  the  entire  culture  shows  a  uniform  H3S10ph  
staining  pattern  that  is  highly  stable  at  the  CDK1  arrest  point.  
However,  if  the  scientific  question  does  not  focus  on  cell  synchrony  at  the  CDK1  
arrest  point  but  instead  requires  a  uniform  entry  of  the  entire  culture  into  mitosis,  
further  optimisation  of  the  1NM-­‐PP1  block  will  be  necessary.  At  the  moment,  a  high  
number  of  cells  entering  mitosis  is  achieved  only  with  a  concomitant  increase  in  the  
frequency  of  cells  with  multipolar  spindles.  It  is  known  that  a  lengthy  arrest  in  the  G2  
phase,   for   example   caused   by   DNA   damage,   results   in   centrosome   amplification  
(Dodson  et  al.,  2004).  Therefore,  it  is  crucial  to  reduce  the  duration  of  the  1NM-­‐PP1  
block  in  G2  if  the  occurrence  of  multipolar  spindles  interferes  with  the  experimental  
setup.   However,   if   a   high   number   of   mitotic   cells   is   desired,   a   preceding  
synchronisation   could   be   useful,   such   as   thymidine   induced-­‐arrest   in   S   phase   or  
synchronisation  in  G1  through  CDK4/6  inhibition.  
A   further   challenge   will   be   to   achieve   a   synchronous   progression   of   cells  
through  mitosis.   In  my   initial   1NM-­‐PP1  washout   experiments,   roughly   half   of   the  
mitotic  cells  were  already  in  metaphase,  while  the  remaining  cells  were  still  at  the  
prometaphase   stage.   The   presence   of  multipolar   spindles   could   be   a   reason  why  
some  cells  show  a  delayed  mitotic  progression  and  reducing  the  number  of  cells  with  
multipolar  spindles  may  improve  the  synchrony  in  mitosis.  However,  a  certain  non-­‐
uniformity  in  mitotic  progression  will  most  likely  be  always  present,  as  the  correct  
microtubule   attachments   to   kinetochores   occur   in   a   stochastic   manner   with   the  
transient   existence   of   erroneous   attachment   that   needs   to   be   resolved.   One  
approach  could  be  to  use  cell  lines  with  a  smaller  number  of  chromosomes,  such  as  
haploid  cell  lines  which  have  only  one  copy  of  every  chromosome.  
Taken  together,  I  identified  two  suitable  HeLa  CDK1-­‐as  clones  which  show  an  




1NM-­‐PP1  washout.  In  general,  the  CDK1-­‐as/1NM-­‐PP1  system  can  allow  the  studying  
of  cells  with  remarkable  synchrony  and  temporal  precision.  The  CDK1-­‐as  cells  that  I  
characterised  can  be  useful  for  a  variety  of  scientific  questions  that  focus  on  the  G2  




7.15   Model  of  HP1-­‐driven  CPC  clustering  in  the  G2  phase  
Based  on  my  observations  and  the  relevant  literature,  I  suggest  the  following  
model   for   how   H3S10ph   foci   emerge   in   G2   cells.   Initially,   HP1   forms   clusters   at  
H3K9me2/3  rich  regions,  such  as  pericentromeric  heterochromatin  (Bannister  et  al.,  
2001;  Lachner  et  al.,  2001)  (Fig.  46A).  As  cells  progress  from  S  phase  into  G2,  the  levels  
of  CPC  components  increase  (Stewart  and  Fang,  2005).  HP1  binds  through  its  CSD  the  
PxVxL/I  motif  of   the  CPC  members   INCENP  and  possibly  borealin   (Ainsztein  et  al.,  
1998;  Nozawa  et  al.,  2010;  Kang  et  al.,  2011;  Liu  et  al.,  2014).  This  further  increases  
the   association   of   HP1   with   chromatin,   potentially   resulting   in   a   more   robust  
clustering  (Kilic  et  al.,  2015).  The  stable  HP1  clustering  may  initiate  the  formation  of  
CPC   complexes,   perhaps   supported   through   the   phase   separation   properties   of  
HP1α,   as   a   concentration   of   Aurora   B   within   HP1α-­‐formed   compartments   was  
previously   shown   (Larson   et   al.,   2017)   (Fig.   46B).   The   CPC   clustering   presumably  
promotes   the   reciprocal   trans-­‐activation   of   CPC   complexes,   resulting   in   activated  
Aurora  B  (Kelly  et  al.,  2007;  Tseng  et  al.,  2010;  Wang  et  al.,  2011a)  and  leading  to  the  
initial  H3S10ph  focus  formation  at  the  pericentromeric  heterochromatin  in  G2  cells  
(Hendzel  et  al.,  1997;  Crosio  et  al.,  2002;  Monier  et  al.,  2007)  (Fig.  46C).  Once  Aurora  
B  is  fully  activated,  the  methyl/phos  switch  triggers  the  displacement  of  HP1  from  
chromatin  (Fischle  et  al.,  2005;  Hirota  et  al.,  2005)  (Fig.  46D).  This  HP1  displacement  
may   allow   the   spreading   of   H3S10ph   throughout   the   entire   nucleus,   and   CPC  
concentration  is  then  determined  by  the  histone  marks  H3T3ph  and  H2AT120ph  at  
mitotic  centromeres.  









     
Figure  46:  Model  of  HP1-­‐driven  CPC  clustering  in  the  G2  phase.  
(A)  HP1  binds  via  its  chromo  domain  (CD)  to  histone  H3  methylated  at  residue  lysine  9  (K9me).  
HP1   clusters   form   at   regions   with   a   high   density   of   H3K9me,   such   as   the   pericentromeric  
heterochromatin.    
(B)   The   CPC   components   INCENP   and   borealin   interact   though   a   PxVxL/I   motif   with   the  
chromoshadow  domain  (CSD)  of  HP1.  The  phase  separation  properties  of  HP1  may  facilitate  a  
concentration  of  Aurora  B,  which  interacts  with  the  C-­‐terminus  of  INCENP.    
(C)  Local  enrichment  of  the  CPC  may  promote  an  initial  transactivation  of  Aurora  B  (light  orange).  
(D)   Fully   activated   Aurora   B   (dark   orange)   phosphorylates   histone   H3   at   residue   serine   10  
(S10ph),  which  displaces  HP1  from  chromatin  by  the  methyl/phos  switch  and  allows  the  shift  to  





Overall,   recent   work   indicates   that   the   role   of   HP1   goes   far   beyond   its  
contribution  to  heterochromatin  integrity.  The  newly  revealed  HP1  functions  include  
CPC  clustering  and  activation  in  interphase,  shown  by  my  work  (Ruppert  et  al.,  2018);  
contribution   to   full   Aurora   B   activity   in   mitosis   (Abe   et   al.,   2016);   and   further  
centromere  related  processes  like  cohesion  protection  (Yi  et  al.,  2018).  Therefore,  it  
will  be  crucial  to  determine  in  future  studies  the  exact  molecular  contribution  of  HP1  
in   faithful   chromosome   segregation   and   include   these   findings   in   models   of   the  
complex  centromere  signalling  network.  
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9   Appendix  
  
  
Map  of  a   plasmid   that   contains  Xenopus  CDK1as   cDNA   that  was   linked   to  a  
puromycin  resistance  gene  via  a  sequence  coding  for  the  T2A  peptide  (see  section  
6.1).  
XCDK1as_T2A_puromycin_pcDNA3-1
5918	bp
